Tokushima University / Educator and Researcher Directory --- Kuroda, Akio

Field of Study

Subject of Study

Book / Paper

Book:

1.	Akio Kuroda : 1型糖尿病, IGAKU-SHOIN Ltd.Tokyo,Japan, Jan. 2024.
2.	Munehide Matsuhisa and Akio Kuroda : 糖尿病専門医研修ガイドブック, 診断と治療者, Aug. 2023.
3.	Munehide Matsuhisa and Akio Kuroda : 内分泌代謝・糖尿病内科領域専門医研修ガイドブック, 診断と治療者, May 2023.
4.	Akio Kuroda and Munehide Matsuhisa : ライフキャリアから診る1型糖尿病, 株式会社中外医学社, Tokyo, May 2023.
5.	Akio Kuroda and Munehide Matsuhisa : ガイドラインにないリアル糖尿病薬物療法をガイドする坂根直樹編, 新興医学出版社, Tokyo, Nov. 2022.
6.	Akio Kuroda : 膵島移植実施マニュアル, 日本膵・膵島移植研究会, 2021.
7.	Akio Kuroda : 黒田式インスリンポンプの設定方法, 日本メドトロニック株式会社, 2021.
8.	Akio Kuroda : 持続グルコースモニタリングー血糖変動を把握するー, 2020.
9.	Akio Kuroda and Munehide Matsuhisa : 追加インスリン注入法の決定法, Nankodo, 2020.
10.	Akio Kuroda and Munehide Matsuhisa : 高齢発症の1型糖尿病患者, MCメディカ出版, Sep. 2020.
11.	Akio Kuroda : 持続血糖測定器とインスリンポンプ, 富士レビオ株式会社, Jul. 2017.
12.	Akio Kuroda : カーボカウント指導テキスト, 文光堂, Apr. 2017.
13.	Akio Kuroda : カーボカウントの手引き, 文光堂, Apr. 2017.
14.	菊井聡子, 筑後桃子, 小笠原有加, 長尾紀子, Akiko Matsumura, Yasuhiro Hamada and Akio Kuroda : カーボカウントを用いた血糖値コントロール法, 富士フィルムファーム株式会社, Apr. 2017.
15.	Akio Kuroda : 最新の持続血糖モニター(CGM)付きインスリンポンプ療法, Jan. 2017.
16.	Akio Kuroda : SAP症例に対する指導ミニメド620Gシステム試験的導入から1年を迎えて, 2016.
17.	Akio Kuroda : カーボカウントの活用, 株式会社診断と治療社, Mar. 2016.
18.	Akio Kuroda : 炭水化物摂取法, NIPPONRINSHOSHA Co.,Ltd., Mar. 2016.
19.	Akio Kuroda : カーボカウントの活用, Nankodo, Feb. 2016.
20.	Akio Kuroda : 血糖自己測定の指導, IGAKU-SHOIN Ltd.Tokyo,Japan, Jan. 2016.
21.	Akio Kuroda : インスリンポンプとCGM(著者FRANCINE R. KAUFMAN，翻訳村田敬・坂根直樹・松久宗英・黒田暁生他), 医歯薬出版株式会社, 2015.
22.	Akio Kuroda : 糖尿病医療機器の最新事情, 時事通信出版, Jun. 2015.
23.	Akio Kuroda : 旅行とインスリンポンプ, Ishiyaku Publishers,Inc., May 2015.
24.	Akio Kuroda and Munehide Matsuhisa : インスリンポンプ療法の適応と用量調節方法, Nakayama-Shoten Co., Ltd., May 2015.
25.	Akio Kuroda and Munehide Matsuhisa : インスリンポンプ療法の心構え, Ishiyaku Publishers,Inc., May 2015.
26.	Akio Kuroda and Munehide Matsuhisa : 糖代謝異常妊娠の管理:食事療法, KINPODO, INC., 2014.
27.	Akio Kuroda and Munehide Matsuhisa : 補正インスリン注入量の決定法, Jun. 2014.
28.	Akio Kuroda and Munehide Matsuhisa : 追加インスリン注入量の決定法, Nankodo, Jun. 2014.
29.	Akio Kuroda and Munehide Matsuhisa : 強化インスリン療法中の患者における1型糖尿病と2型糖尿病の違いとは, Jan. 2014.
30.	Akio Kuroda and Munehide Matsuhisa : 強化インスリン療法中の患者に対して応用カーボカウントを教える, Jan. 2014.
31.	Akio Kuroda and Munehide Matsuhisa : カーボカウントの基礎∼血糖応答から食品を考える視点を持つ∼, Jan. 2014.
32.	Akio Kuroda and Munehide Matsuhisa : インスリンポンプ療法における食事療法, Nankodo, 2014.
33.	Akio Kuroda and Munehide Matsuhisa : 移植医療ー膵臓移植・膵島移植, Nakayama-Shoten Co., Ltd., 2012.
34.	伊藤壽記, Munehide Matsuhisa, Akio Kuroda and 宮下和幸 : 膵臓移植の血糖管理, 医学図書出版, 2012.
35.	Akio Kuroda : どの経口血糖降下薬を使うか, Nankodo, Oct. 2011.
36.	Akio Kuroda : 人工透析，膵腎同時移植，そして妊娠・出産を経験して, Apr. 2011.
37.	Akio Kuroda and Munehide Matsuhisa : 糖尿病臨床のすべて, Nakayama-Shoten Co., Ltd., 2011.

Academic Paper (Judged Full Paper):

1.	Tomoyo Hara, Takeshi Watanabe, Hiroki Yamagami, Kosuke Miyataka, Saya Yasui, Takahito Asai, Yohsuke Kaneko, Yukari Mitsui, Shiho Masuda, Kiyoe Kurahashi, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Soichi Honda, Akira Kondo, Munehide Matsuhisa and Ken-ichi Aihara : Development of Liver Fibrosis Represented by the Fibrosis-4 Index Is a Specific Risk Factor for Tubular Injury in Individuals with Type 2 Diabetes, Biomedicines, Vol.12, No.8, 1789, 2024. (Summary) Although hyperglycemia and hypertension are well-known risk factors for glomerular injury in individuals with type 2 diabetes (T2D), specific risk factors for tubular injury remain unclear. We aimed to clarify the differences between risk factors for glomerular injury and risk factors for tubular injury in individuals with T2D. We categorized 1243 subjects into four groups based on urinary biomarkers, including the albumin-to-creatinine ratio (uACR) and L-type fatty acid-binding protein-to-creatinine ratio (uL-ABPCR) as a normal (N) group (uACR < 30 mg/gCr and uL-FABPCR < 5 μg/gCr; n = 637), a glomerular specific injury (G) group (uACR ≥ 30 mg/gCr and uL-FABPCR < 5 μg/gCr; n = 248), a tubular specific injury (T) group (uACR < 30 mg/gCr and uL-FABPCR ≥ 5 μg/gCr; n = 90), and a dual injury (D) group (uACR ≥ 30 mg/gCr and uL-FABPCR ≥ 5 μg/gCr; n = 268). Logistic regression analysis referencing the N group revealed that BMI, current smoking, and hypertension were risk factors for the G group, creatinine (Cr) and Fibrosis-4 (FIB-4) index were risk factors for the T group, and BMI, hypertension, HbA1c, Cr, and duration of diabetes were risk factors for the D group. While hypertension was a distinct specific risk factor for glomerular injury, the FIB-4 index was a specific contributor to the prevalence of tubular injury. On the other hand, the logistic regression analysis revealed that the hepatic steatosis index (HSI) did not show any significant association with the G group, T group, or D group. Taken together, the development of liver fibrosis rather than liver steatosis is an inherent threat relating to tubular injury in individuals with T2D. (Link to Publication Site) ● Publication site (DOI): 10.3390/biomedicines12081789 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 39200252 ● Summary page in Scopus @ Elsevier: 2-s2.0-85202596205 (DOI: 10.3390/biomedicines12081789, PubMed: 39200252, Elsevier: Scopus)
2.	Minae Hosoki, HORI Taiki, KANEKO Yohsuke, Kensuke Mori, Saya Yasui, Seijiro Tsuji, Hiroki Yamagami, Saki Kawata, Tomoyo Hara, Shiho Masuda, Yukari Mitsui, Kiyoe Kurahashi, Takeshi Harada, Shingen Nakamura, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Ken-ichi Aihara : Causes of In-Hospital Death and Pharmaceutical Associations with Age of Death during a 10-Year Period (2011-2020) in Individuals with and without Diabetes at a Japanese Community General Hospital., Journal of Clinical Medicine, Vol.13, No.5, 1283, 2024. (Summary) Since diabetes and its complications have been thought to exaggerate cardiorenal disease, resulting in a short lifespan, we investigated causes of death and lifespans in individuals with and without diabetes at a Japanese community general hospital during the period from 2011 to 2020. Causes of death and age of death in individuals with and those without diabetes were compared, and associations between medications used and age of death were statistically analyzed. A total of 2326 deaths were recorded during the 10-year period. There was no significant difference between the mean ages of death in individuals with and those without diabetes. Diabetic individuals had higher rates of hepato-pancreatic cancer and cardio-renal failure as causes of death. The prescription rates of antihypertensives, antiplatelets, and statins in diabetic individuals were larger than those in non-diabetic individuals. Furthermore, the use of sulfonyl urea or glinides and insulin was independently and inversely associated with the age of death. In conclusion, individuals with diabetes were treated with comprehensive pharmaceutical interventions and had life spans comparable to those of individuals without diabetes. This study's discovery of an inverse relationship between the use of insulin secretagogues or insulin and the age of death suggests that the prevention of life-threatening hypoglycemia is crucial for individuals with diabetes. (Tokushima University Institutional Repository) ● Metadata: 119252 (Link to Publication Site) ● Publication site (DOI): 10.3390/jcm13051283 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 38592103 ● Search Scopus @ Elsevier (PMID): 38592103 ● Search Scopus @ Elsevier (DOI): 10.3390/jcm13051283 (Tokushima University Institutional Repository: 119252, DOI: 10.3390/jcm13051283, PubMed: 38592103)
3.	Hiroyasu Mori, Satoshi Taniguchi, Yuu Tamaki, Motoyuki Tamaki, Yuko Akehi, Akio Kuroda and Munehide Matsuhisa : Telenutrition Education Is Effective for Glycemic Management in People with Type 2 Diabetes Mellitus: A Non-Inferiority Randomized Controlled Trial in Japan, Nutrients, Vol.16, No.2, 268, 2024. (Summary) This study examined the non-inferior efficacy of telenutrition education compared with face-to-face nutrition education in managing glycemic control in people with type 2 diabetes mellitus (T2DM). Participants had T2DM and a glycated hemoglobin (HbA1c) ranged 6.5-9.5%. Thirty participants were randomly assigned to either the telenutrition or face-to-face nutrition education group. During the 32-week intervention period, the participants received four sessions on nutrition education from a registered dietitian at the hospital. The telenutrition group received remote education via a videoconferencing platform. Face-to-face nutrition education was conducted using paper-based instructions. The main outcome measure was the non-inferiority of HbA1c levels in the telenutrition group compared to the face-to-face nutrition group. The non-inferiority of telenutrition education was considered valid if the intergroup difference in the mean values of the change in HbA1c had a bilateral 95% confidence interval (CI) upper limit below 0.40%. The intergroup difference in the mean HbA1c change from baseline to the fourth nutrition education session was -0.11 (95% CI -0.54-0.32) for both groups. The upper limit of the bilateral 95% CI was 0.32%, which was below the 0.40% non-inferiority margin (non-inferiority test; = 0.011). Telenutrition education was not inferior to face-to-face nutrition education for glycemic management in people with T2DM. (Keyword) Humans / Diabetes Mellitus, Type 2 / Educational Status / Glycated Hemoglobin / Health Education / Japan (Tokushima University Institutional Repository) ● Metadata: 119489 (Link to Publication Site) ● Publication site (DOI): 10.3390/nu16020268 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 38257162 ● Search Scopus @ Elsevier (PMID): 38257162 ● Search Scopus @ Elsevier (DOI): 10.3390/nu16020268 (Tokushima University Institutional Repository: 119489, DOI: 10.3390/nu16020268, PubMed: 38257162)
4.	Hiroki Yamagami, Tomoyo Hara, Saya Yasui, Minae Hosoki, Taiki Hori, Yousuke Kaneko, Yukari Mitsui, Kiyoe Kurahashi, Takeshi Harada, Sumiko Yoshida, Shingen Nakamura, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : Cross-Sectional and Longitudinal Associations between Skin Autofluorescence and Tubular Injury Defined by Urinary Excretion of Liver-Type Fatty Acid-Binding Protein in People with Type 2 Diabetes., Biomedicines, Vol.11, No.11, 3020, 2023. (Summary) = 0.026). In conclusion, SAF is positively correlated with uL-FABP but not with uACR in people with T2D. Thus, there is a possibility that SAF can serve as a novel predictor for the development of diabetic tubular injury. (Keyword) skin autofluorescence / type 2 diabetes / diabetic kidney disease / albuminuria / tubular injury / L-FABP (Tokushima University Institutional Repository) ● Metadata: 119108 (Link to Publication Site) ● Publication site (DOI): 10.3390/biomedicines11113020 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 38002020 ● CiNii @ National Institute of Informatics (CRID): 1050581224891895040 ● Summary page in Scopus @ Elsevier: 2-s2.0-85178346619 (Tokushima University Institutional Repository: 119108, DOI: 10.3390/biomedicines11113020, PubMed: 38002020, CiNii: 1050581224891895040, Elsevier: Scopus)
5.	Saya Yasui, Yousuke Kaneko, Hiroki Yamagami, Minae Hosoki, Taiki Hori, Akihiro Tani, Tomoyo Hara, Kiyoe Kurahashi, Takeshi Harada, Shingen Nakamura, Toshiki Otoda, Tomoyuki Yuasa, Hiroyasu Mori, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Takeshi Soeki and Ken-ichi Aihara : Dehydroepiandrosterone Sulfate, an Adrenal Androgen, Is Inversely Associated with Prevalence of Dynapenia in Male Individuals with Type 2 Diabetes., Metabolites, Vol.13, No.11, 1129, 2023. (Summary) Dehydroepiandrosterone sulfate (DHEAS) is thought to be associated with life expectancy and anti-aging. Although skeletal muscle disorders are often found in diabetic people, the clinical significance of DHEAS in skeletal muscle remains unclear. Therefore, we aimed to determine whether DHEAS is associated with the development of skeletal muscle disorders in individuals with type 2 diabetes (T2D). A cross-sectional study was conducted in 361 individuals with T2D. Serum DHEAS levels, skeletal muscle mass index (SMI), handgrip strength (HS), and gait speed (GS) were measured in the participants. Pre-sarcopenia, sarcopenia, and dynapenia were defined according to the definitions of the AWGS 2019 criteria. DHEAS level was positively associated with HS but not with SMI or GS after adjustment of confounding factors. Multiple logistic regression analyses in total subjects showed that DHEAS level had an inverse association with the prevalence of dynapenia but not with the prevalence of pre-sarcopenia or sarcopenia. Furthermore, a significant association between DHEAS level and dynapenia was found in males but not in females. ROC curve analysis indicated that cutoff values of serum DHEAS for risk of dynapenia in males was 92.0 μg/dL. Therefore, in male individuals with T2D who have low serum levels of DHEAS, adequate exercise might be needed to prevent dynapenia. (Tokushima University Institutional Repository) ● Metadata: 119107 (Link to Publication Site) ● Publication site (DOI): 10.3390/metabo13111129 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37999225 ● CiNii @ National Institute of Informatics (CRID): 1050862699868605952 ● Summary page in Scopus @ Elsevier: 2-s2.0-85178271509 (Tokushima University Institutional Repository: 119107, DOI: 10.3390/metabo13111129, PubMed: 37999225, CiNii: 1050862699868605952, Elsevier: Scopus)
6.	Takafumi Masuda, Naoto Katakami, Hirotaka Watanabe, Naohiro Taya, Kazuyuki Miyashita, Mitsuyoshi Takahara, Ken Kato, Akio Kuroda, Munehide Matsuhisa and Iichiro Shimomura : Evaluation of changes in glycemic control and diabetic complications over time and factors associated with the progression of diabetic complications in Japanese patients with juvenile-onset type 1 diabetes mellitus., Journal of Diabetes, Vol.16, No.2, e13486, 2023. (Summary) In this retrospective observational study, glycemic control and albuminuria improved; however, renal function and arteriosclerosis worsened over time. HbA1c levels, glycemic excursion, and blood pressure are associated with nephropathy progression. HbA1c levels, glycemic excursion, lipid levels, and BMI are associated with the progression of atherosclerosis. (Keyword) Humans / Adolescent / Young Adult / Adult / Diabetes Mellitus, Type 1 / Glycated Hemoglobin / Diabetes Mellitus, Type 2 / Carotid Intima-Media Thickness / Ankle Brachial Index / Glycemic Control / Glycated Serum Albumin / Japan / Pulse Wave Analysis / Diabetes Complications / Cholesterol / Diabetic Nephropathies / Risk Factors (Link to Publication Site) ● Publication site (DOI): 10.1111/1753-0407.13486 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37853936 ● Search Scopus @ Elsevier (PMID): 37853936 ● Search Scopus @ Elsevier (DOI): 10.1111/1753-0407.13486 (DOI: 10.1111/1753-0407.13486, PubMed: 37853936)
7.	Hiroyasu Mori, 谷口諭, 玉木悠, 野村友美, 鈴木麗子, Akio Kuroda, 明比祐子, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, 白神敦久, 田蒔基行, 天満仁, 長島伸光, 比木武 and Munehide Matsuhisa : 2型糖尿病患者のPersonal Health Recordを用いたセルフモニタリングに自動支援メッセージが与える効果:探索的ランダム化比較試験, 日本糖尿病インフォマティクス学会誌, Vol.22, No.2, 7-18, 2023.
8.	Masao Toyoda, Takashi Murata, Yushi Hirota, Kiminori Hosoda, Ken Kato, Kunichi Kouyama, Ryuji Kouyama, Akio Kuroda, Yuka Matoba, Munehide Matsuhisa, Shu Meguro, Junnosuke Miura, Kunihiro Nishimura, Akira Shimada, Shota Suzuki, Atsuhito Tone and Naoki Sakane : Possible Relationship between the Deteriorated Accuracy of Intermittent-Scanning Continuous Glucose Monitoring Device and the Contact Dermatitis: Post-hoc analysis of the ISCHIA Study., The Tokai Journal of Experimental and Clinical Medicine, Vol.48, No.3, 83-90, 2023. (Summary) There was negative bias in the SG levels of isCGM compared to the BG levels. There is a possibility that the complication of the contact dermatitis during isCGM use may be related with deteriorated accuracy of the SG levels. (Keyword) Humans / Blood Glucose / Blood Glucose Self-Monitoring / Quality of Life / Glucose / Dermatitis, Contact (Tokushima University Institutional Repository) ● Metadata: 119488 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37635068 ● Search Scopus @ Elsevier (PMID): 37635068 (Tokushima University Institutional Repository: 119488, PubMed: 37635068)
9.	Hiroyuki Yamasaki, Yoshiro Abe, Shunsuke Mima, Mayu Bando, Shinji Nagasaka, Yutaro Yamashita, Kazuhide Mineda, Akio Kuroda, Munehide Matsuhisa, Masahiro Takaiwa and Ichiro Hashimoto : Efect of joint limitation and balance control on gait changes in diabetic peripheral neuropathy, Diabetology International, Vol.14, 390-396, 2023. (Summary) This study analyzed the gait patterns of diabetic peripheral neuropathy (DPN) patients and changes in the center of mass sway to prevent the formation and recurrence of foot ulcers. Forty-two subjects were divided into the diabetes mellitus (DM), DPN, and diabetic foot ulcer (DFU) groups. We measured the range of motion (ROM) of the lower limb joints in the resting position and the center of mass sway in the standing position. Joint angles, ROM during walking, and distance factors were evaluated. In the DFU group, ROM limitation during walking was detected at the knee joint, and functional and ROM limitations were found at the ankle joint. The step length ratio and step width in the DFU group were significantly lower and higher than those in the DM group, respectively. The sway distances in the DFU group were greater than those in the DM and DPN groups. Functional joint limitations and gait changes due to the decreased ability to maintain the center of gravity were observed in the DFU group. As DPN progressed, the patients' gait became small, wide, and shuffled. Thus, supporting joint movement during walking may help reduce the incidence and recurrence of foot ulcers. The online version contains supplementary material available at 10.1007/s13340-023-00647-9. (Link to Publication Site) ● Publication site (DOI): 10.1007/s13340-023-00647-9 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37781462 ● Search Scopus @ Elsevier (PMID): 37781462 ● Search Scopus @ Elsevier (DOI): 10.1007/s13340-023-00647-9 (DOI: 10.1007/s13340-023-00647-9, PubMed: 37781462)
10.	Hiroyuki Yamasaki, Yoshiro Abe, Shunsuke Mima, Mayu Bando, Shinji Nagasaka, Yutaro Yamashita, Kazuhide Mineda, Akio Kuroda, Munehide Matsuhisa, Masahiro Takaiwa and Ichiro Hashimoto : Effect of joint limitation and balance control on gait changes in diabetic peripheral neuropathy., Diabetology International, Vol.14, No.4, 390-396, 2023. (Summary) The online version contains supplementary material available at 10.1007/s13340-023-00647-9. (Tokushima University Institutional Repository) ● Metadata: 118739 (Link to Publication Site) ● Publication site (DOI): 10.1007/s13340-023-00647-9 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37781462 ● Search Scopus @ Elsevier (PMID): 37781462 ● Search Scopus @ Elsevier (DOI): 10.1007/s13340-023-00647-9 (Tokushima University Institutional Repository: 118739, DOI: 10.1007/s13340-023-00647-9, PubMed: 37781462)
11.	Shiho Masuda, Tomoyo Hara, Hiroki Yamagami, Yukari Mitsui, Kiyoe Kurahashi, Sumiko Yoshida, Takeshi Harada, Toshiki Otoda, Tomoyuki Yuasa, Shingen Nakamura, Akio Kuroda, Itsuro Endo, Toshio Matsumoto, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : Vascular Endothelial Function Is Associated with eGFR Slope in Female and Non-Smoking Male Individuals with Cardiovascular Risk Factors: A Pilot Study on the Predictive Value of FMD for Renal Prognosis., Journal of Atherosclerosis and Thrombosis, 2023. (Summary) In individuals with cardiovascular risk factors, evaluation of vascular endothelial function enables prediction of renal prognosis in females and non-smoking males. (Tokushima University Institutional Repository) ● Metadata: 118250 (Link to Publication Site) ● Publication site (DOI): 10.5551/jat.63987 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37081616 ● Search Scopus @ Elsevier (PMID): 37081616 ● Search Scopus @ Elsevier (DOI): 10.5551/jat.63987 (Tokushima University Institutional Repository: 118250, DOI: 10.5551/jat.63987, PubMed: 37081616)
12.	Taiki Hori, Shingen Nakamura, Hiroki Yamagami, Saya Yasui, Minae Hosoki, Tomoyo Hara, Yukari Mitsui, Shiho Masuda, Kiyoe Kurahashi, Sumiko Yoshida, Takeshi Harada, Akio Kuroda, Toshiki Otoda, Tomoyuki Yuasa, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : Phase angle and extracellular water-to-total body water ratio estimated by bioelectrical impedance analysis are associated with levels of hemoglobin and hematocrit in patients with diabetes., Heliyon, Vol.9, No.4, 2023. (Summary) PhA and ECW/TBW but not SMI were associated with levels of Hgb and Hct in patients with diabetes. Therefore, aberrant values of PhA and ECW/TBW suggest a risk of anemia in diabetic patients. (Tokushima University Institutional Repository) ● Metadata: 118251 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.heliyon.2023.e14724 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37057050 ● Search Scopus @ Elsevier (PMID): 37057050 ● Search Scopus @ Elsevier (DOI): 10.1016/j.heliyon.2023.e14724 (Tokushima University Institutional Repository: 118251, DOI: 10.1016/j.heliyon.2023.e14724, PubMed: 37057050)
13.	Ayuka Kawakami, Mika Bandou, Tomoe Takashi, Mizuki Sugiuchi, Mizusa Hyodo, Yuna Mishima, Masashi Kuroda, Hiroyasu Mori, Akio Kuroda, Hiromichi Yumoto, Munehide Matsuhisa, Hiroshi Sakaue and Rie Tsutsumi : Umami taste sensitivity is associated with food intake and oral environment in subjects with diabetes, The Journal of Medical Investigation : JMI, Vol.70, No.1.2, 241-250, 2023. (Summary) Dysgeusia is a serious problem in patients with diabetes because it often leads to overeating, which is associated with disease progression. This study aimed to investigate the association between taste sensitivity, eating habits, and the oral environment. In this cross-sectional study of 75 subjects with diabetes, gustatory function was assessed using the whole-mouth method, and lingual taste receptor gene expression was measured by real-time PCR. Food intake was evaluated using a food frequency questionnaire based on food groups. The oral environment was assessed using xerostomia and periodontal comprehensive examination. In total, 45.3%, 28.0%, and 18.7% of subjects showed lower umami taste sensitivity, low sweet taste sensitivity, and low salt taste sensitivity, respectively. Lower umami sensitivity correlated with lower estimated glomerular filtration rate and higher energy-source food intake. Subjects with diabetes with higher plaque control record showed significantly higher T1R3 gene expression than those with lower plaque control record. Reduced umami taste sensitivity is associated with decreased renal function and high energy food intake in diabetes. Subjects with diabetes with higher plaque control record showed significantly higher T1R3 gene expression, suggesting that the oral environment affects taste gene expression. J. Med. Invest. 70 : 241-250, February, 2023. (Keyword) Humans / Taste / Cross-Sectional Studies / Taste Perception / Diabetes Mellitus / Eating (Tokushima University Institutional Repository) ● Metadata: 118208 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.70.241 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37164729 ● Summary page in Scopus @ Elsevier: 2-s2.0-85158866092 (Tokushima University Institutional Repository: 118208, DOI: 10.2152/jmi.70.241, PubMed: 37164729, Elsevier: Scopus)
14.	Group Study ISCHIA, Munehide Matsuhisa and Akio Kuroda : Prevention of hypoglycemia by intermittent-scanning continuous glucose monitoring device combined with structured education in patients with type 1 diabetes mellitus: A randomized, crossover trial., Diabetes Research and Clinical Practice, Vol.195, 110147, 2022. (Summary) The use of isCGM combined with structured education significantly reduced the time below range in patients with T1DM. (Keyword) Adult / Humans / Blood Glucose / Diabetes Mellitus, Type 1 / Blood Glucose Self-Monitoring / Cross-Over Studies / Hypoglycemia / Insulin / Hypoglycemic Agents (Tokushima University Institutional Repository) ● Metadata: 118711 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.diabres.2022.110147 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 36396114 ● Summary page in Scopus @ Elsevier: 2-s2.0-85147783072 (Tokushima University Institutional Repository: 118711, DOI: 10.1016/j.diabres.2022.110147, PubMed: 36396114, Elsevier: Scopus)
15.	Tomoyo Hara, Ryoko Uemoto, Akiko Sekine, Yukari Mitsui, Shiho Masuda, Hiroki Yamagami, Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Yasumasa Ikeda, Itsuro Endo, Soichi Honda, Katsuhiko Yoshimoto, Akira Kondo, Toshiaki Tamaki, Toshio Matsumoto, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus., Journal of Atherosclerosis and Thrombosis, 2022. (Summary) Plasma HCII activity was inversely associated with clinical hepatic fibrosis indices including FIB-4 index, NFS and APRI and with the prevalence of advanced hepatic fibrosis in patients with T2DM. The results suggest that HCII can serve as a novel biomarker for assessment of hepatic fibrosis of NAFLD in patients with T2DM. (Tokushima University Institutional Repository) ● Metadata: 118258 (Link to Publication Site) ● Publication site (DOI): 10.5551/jat.63752 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 36244745 ● Search Scopus @ Elsevier (PMID): 36244745 ● Search Scopus @ Elsevier (DOI): 10.5551/jat.63752 (Tokushima University Institutional Repository: 118258, DOI: 10.5551/jat.63752, PubMed: 36244745)
16.	Takafumi Masuda, Naoto Katakami, Naohiro Taya, Kazuyuki Miyashita, Mitsuyoshi Takahara, Ken Kato, Akio Kuroda, Munehide Matsuhisa and Iichiro Shimomura : Comparison of continuous subcutaneous insulin infusion treatment and multiple daily injection treatment on the progression of diabetic complications in Japanese patients with juvenile-onset type 1 diabetes mellitus., Journal of Diabetes Investigation, 2022. (Summary) To evaluate whether continuous subcutaneous insulin infusion attenuates the progression of diabetic complications, we retrospectively extracted data from 35 individuals who had developed type 1 diabetes mellitus aged ≤20 years and whose treatment had been changed from multiple daily injections to continuous subcutaneous insulin infusion. The annual changes in estimated glomerular filtration rate, urinary albumin excretion rate, carotid intima-media thickness and brachial-ankle pulse wave velocity during each treatment period were calculated. Although mean glycated hemoglobin under the continuous subcutaneous insulin infusion treatment was lower than that under the multiple daily injection treatment, there were no significant differences in annual changes in diabetic nephropathy and atherosclerosis between the two treatment periods. This pilot study showed that, in Japanese patients with juvenile-onset type 1 diabetes mellitus, there was no significant difference in the progression of diabetic nephropathy and atherosclerosis, at least in the early stage, between the two treatments. (Tokushima University Institutional Repository) ● Metadata: 117821 (Link to Publication Site) ● Publication site (DOI): 10.1111/jdi.13819 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35474612 ● Search Scopus @ Elsevier (PMID): 35474612 ● Search Scopus @ Elsevier (DOI): 10.1111/jdi.13819 (Tokushima University Institutional Repository: 117821, DOI: 10.1111/jdi.13819, PubMed: 35474612)
17.	Asami Okada, Misuzu Yamada-Yamashita, Yukari Tominaga, Kyoka Jo, Hiroyasu Mori, Reiko Suzuki, Masashi Ishizu, Motoyuki Tamaki, Yuko Akehi, Yuichi Takashi, Daisuke Koga, Eisuke Shimokita, Fuminori Tanihara, Kiyoe Kurahashi, Sumiko Yoshida, Yukari Mitsui, Shiho Masuda, Itsuro Endo, Ken-ichi Aihara, Shoji Kagami, Masahiro Abe, Kevin Ferreri, Yoshio Fujitani, Munehide Matsuhisa and Akio Kuroda : Novel method utilizing bisulfite conversion with dual amplification-refractory mutation system polymerase chain reaction to detect circulating pancreatic β-cell cfDNA., Journal of Diabetes Investigation, Vol.13, No.7, 1140-1148, 2022. (Summary) We developed a novel method for detecting unmethylated insulin DNA in circulation that can be performed using a conventional real-time PCR system. This method would be useful for analyzing dynamic profiles of β-cells in human disease such as type 1 diabetes. (Tokushima University Institutional Repository) ● Metadata: 117206 (Link to Publication Site) ● Publication site (DOI): 10.1111/jdi.13806 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35396829 ● Search Scopus @ Elsevier (PMID): 35396829 ● Search Scopus @ Elsevier (DOI): 10.1111/jdi.13806 (Tokushima University Institutional Repository: 117206, DOI: 10.1111/jdi.13806, PubMed: 35396829)
18.	Yukari Mitsui, Akio Kuroda, Masashi Ishizu, Hiroyasu Mori, Kiyoe Kurahashi, Takeshi Kondo, Sumiko Yoshida, Yuko Akehi, Ken-ichi Aihara, Itsuro Endo, Masahiro Abe and Munehide Matsuhisa : Basal insulin requirement in patients with type 1 diabetes depends on the age and body mass index., Journal of Diabetes Investigation, Vol.13, No.2, 292-298, 2022. (Summary) T (Tokushima University Institutional Repository) ● Metadata: 116546 (Link to Publication Site) ● Publication site (DOI): 10.1111/jdi.13547 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33740836 ● Search Scopus @ Elsevier (PMID): 33740836 ● Search Scopus @ Elsevier (DOI): 10.1111/jdi.13547 (Tokushima University Institutional Repository: 116546, DOI: 10.1111/jdi.13547, PubMed: 33740836)
19.	Kana Beppu, Ayuka Kawakami, Yuna Mishima, Rie Tsutsumi, Masashi Kuroda, Hiroyasu Mori, Akio Kuroda, Munehide Matsuhisa and Hiroshi Sakaue : Taste receptor gene expression is associated with decreased eGFR in patients with diabetes., The Journal of Medical Investigation : JMI, Vol.69, No.1.2, 120-126, 2022. (Summary) Dysgeusia is not only associated with zinc deficiency but also with certain drugs or diseases, including diabetes and renal failure. It often lowers the patient's quality of life and hinders access to proper nutrition. The underlying mechanism is unclear and there is a lack of awareness among patients. Here, we focused on lingual taste receptor gene expression in diabetes and elucidated the relationship between taste receptor gene expression and renal function. Forty-seven patients with diabetes and 10 healthy subjects (control group) were enrolled. Lingual foliate papillae were scraped and the derived cDNA was quantified by real-time polymerase chain reaction. Dysgeusia was assessed using SALSAVE?. All statistical analyses were performed using JMP? software 13. The expression of T1R1 and T1R2 was significantly upregulated in type 2 diabetes patients as compared with that in healthy subjects (P<0.01) but did not change in type 1 diabetes patients. T1R3 expression positively correlated and Scnn1 expression negatively correlated with estimated glomerular filtration rate, suggesting that altered taste receptor gene expression could reflect impaired renal function. Thus, alterations in T1R3 and Scnn1 expression in diabetes correlated with renal function. Taste receptor gene expression dysregulation could indicate dysgeusia associated with impaired renal function in patients with diabetes. J. Med. Invest. 69 : 120-126, February, 2022. (Keyword) Diabetes Mellitus, Type 2 / Dysgeusia / Gene Expression / Humans / Quality of Life / Receptors, G-Protein-Coupled / Taste (Tokushima University Institutional Repository) ● Metadata: 117023 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.69.120 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35466133 ● CiNii @ National Institute of Informatics (CRID): 1390291932617710464 ● Summary page in Scopus @ Elsevier: 2-s2.0-85128801393 (Tokushima University Institutional Repository: 117023, DOI: 10.2152/jmi.69.120, PubMed: 35466133, CiNii: 1390291932617710464, Elsevier: Scopus)
20.	Asami Okada, Misuzu Yamada, Hiroyasu Mori, 明比祐子, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Akio Kuroda : 循環血中遊離 DNA を用いた膵β細胞傷害の新規検出法の確立, Shikoku Acta Medica, Vol.77, No.5,6, 249-245, 2021. (Summary) In people with type1 diabetes(T1D), biomarkers that can sensitively and quantitatively evaluate injury of pancreatic beta cell are required in order to predict the onset of the disease at an early stage and to provide interventions to prevent the progression of the disease. We developed a new method for quantifying pancreatic beta cell-derived insulin DNA in circulation that combines bisulfite conversion and Amplification Refractory Mutation System(ARMS)PCR, which can be performed using a conventional real-time PCR system. We applied this method to T1D patients and healthy adults, both could be detected in about 30% of cases. The results in healthy adults indicate that this method may have sensitivity to detect the turnover of pancreatic beta cells at physiological conditions. In post-onset T1D patients, there were many negatives because the amount of residual pancreatic beta cells was extremely small. However, in some cases with a short duration of the disease, pancreatic beta cell-derived insulin DNA was detected in negative correlation between the duration of the disease, that suggested the residual pancreatic beta cells continue to be slowly destroyed. It was demonstrated that the time course of pathophysiology in T1D could be understood using this method. (Keyword) Insulin / DNA methylation / RT-PCR / Type1 diabetes / cell-free DNA (Tokushima University Institutional Repository) ● Metadata: 117138 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050292317645976448 (Tokushima University Institutional Repository: 117138, CiNii: 1050292317645976448)
21.	吉川紘平, 金子遥祐, 辻誠士郎, 河田沙紀, 川原綾香, 森建介, 遠藤ふうり, Tomoyo Hara, Kiyoe Kurahashi, Sumiko Yoshida, Akio Kuroda, 明比祐子, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Masahiro Abe and Munehide Matsuhisa : TIA様症状を契機に診断されたインスリノーマの1例, Shikoku Acta Medica, Vol.77, No.5-6, 275-280, 2021. (Summary) We report the case of a67-year-old woman who had symptoms suggestive of a transient ischemic attack(TIA), such as lightheadedness and transient visual changes before meals for 4 months. She experienced altered consciousness before lunch and was taken to the emergency room2weeks ago. She had repeated hypoglycemia with a blood glucose level of 31 mg/dL. Insulin secretion was not suppressed, with an immunoreactive insulin level of 14．0 μU/mL and connecting peptide immunoreactivity of 1．83 ng/mL for occasional blood glucose levels of 49 mg/dL. Dynamic CT revealed a 17‐mm mass enhanced during the arterial phase in the pancreatic uncinate process, suggestive of a pancreatic neuroendocrine tumor. A selective arterial secretagogue(calcium)injection test revealed the localization of insulinoma in the head of the pancreas. Therefore, pancreatoduodenectomy was performed. Hyperglycemia occurred after the surgery, and it was judged that the insulinoma was resected. This case showed TIA-like symptoms without signs of sympathetic overdrive associated with hypoglycemia. Thus, the diagnosis was delayed. Insulinoma may present with symptoms of neuroglycopenia but not autonomic activity due to hypoglycemia. Insulinoma should be distinguished in patients with unknown neurological symptoms since neuroglycopenia caused by insulinoma is diverse. (Keyword) Insulinoma / Hypoglycemia / Neuroglycopenia / Transient ischemic attack (Tokushima University Institutional Repository) ● Metadata: 116831 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520292182331094144 (Tokushima University Institutional Repository: 116831, CiNii: 1520292182331094144)
22.	Munehide Matsuhisa, Hiroyasu Mori, Satoshi Taniguchi, Yuu Tamaki and Akio Kuroda : 情報を活かし地域に沿った腎症重症化予防策「行政・医療機関の情報を活用したヒューマンネットワークによる糖尿病重症化」, 日本糖尿病情報学会誌 18: 43-49, 2021.8.31, Vol.18, 43-49, 2021.
23.	Sonyun Hata, Hiroyasu Mori, Tetsuyuki Yasuda, Yoko Irie, Tsunehiko Yamamoto, Yutaka Umayahara, Kayoko Ryomoto, Kazutomi Yoshiuchi, Sumiko Yoshida, Iichiro Shimomura, Akio Kuroda and Munehide Matsuhisa : A low serum IGF-1 is correlated with sarcopenia in subjects with type 1 diabetes mellitus: Findings from a post-hoc analysis of the iDIAMOND study., Diabetes Research and Clinical Practice, Vol.179, 2021. (Summary) A low serum IGF-1 level is correlated with sarcopenia and low skeletal muscle mass in subjects with T1DM. (Keyword) Cross-Sectional Studies / Diabetes Mellitus, Type 1 / Hand Strength / Humans / Insulin-Like Growth Factor I / Muscle, Skeletal / Sarcopenia (Link to Publication Site) ● Publication site (DOI): 10.1016/j.diabres.2021.108998 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34390761 ● Search Scopus @ Elsevier (PMID): 34390761 ● Search Scopus @ Elsevier (DOI): 10.1016/j.diabres.2021.108998 (DOI: 10.1016/j.diabres.2021.108998, PubMed: 34390761)
24.	Shota Suzuki, Atsuhito Tone, Takashi Murata, Kunihiro Nishimura, Yoshihiro Miyamoto, Naoki Sakane, Noriko Satoh-Asahara, Masao Toyoda, Yushi Hirota, Munehide Matsuhisa, Akio Kuroda, Ken Kato, Ryuji Kouyama, Junnosuke Miura, Akiko Suganuma, Tsutomu Tomita, Michio Noguchi, Cheol Son, Masato Kasahara, Yukie Ito, Shu Kasama and Kiminori Hosoda : Protocol for a Randomized, Crossover Trial to Decrease Time in Hypoglycemia by Combined Intervention of the Usage of Intermittent-Scanning Continuous Glucose Monitoring Device and the Structured Education Regarding its Usage: Effect of Intermittent-Scanning Continuous Glucose Monitoring to Glycemic Control Including Hypoglycemia and Quality of Life of Patients with Type 1 Diabetes Mellitus Study (ISCHIA Study)., The Tokai Journal of Experimental and Clinical Medicine, Vol.46, No.2, 59-68, 2021. (Summary) The ISCHIA study will contribute to the standardization of patient education regarding the prevention of hypoglycemia by using isCGM. (Tokushima University Institutional Repository) ● Metadata: 118709 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34216477 ● Summary page in Scopus @ Elsevier: 2-s2.0-85110829170 (Tokushima University Institutional Repository: 118709, PubMed: 34216477, Elsevier: Scopus)
25.	Munehide Matsuhisa and Akio Kuroda : 先進糖尿病治療の進歩, Journal of the The Japan Diabetes Society, Vol.13, No.6, 62-68, 2021.
26.	Hiroyasu Mori, Akio Kuroda, Sumiko Yoshida, Tetsuyuki Yasuda, Yutaka Umayahara, Sayoko Shimizu, Kayoko Ryomoto, Kazutomi Yoshiuchi, Tsunehiko Yamamoto, Taka-Aki Matsuoka, Iichiro Shimomura and Munehide Matsuhisa : High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study., Journal of Diabetes Investigation, Vol.12, No.6, 1050-1059, 2021. (Summary) Sarcopenia and dynapenia were more frequent in patients with type 1 diabetes and type 2 diabetes than in individuals without diabetes, which might contribute to their impaired quality of life and incidental falls. (Tokushima University Institutional Repository) ● Metadata: 116547 (Link to Publication Site) ● Publication site (DOI): 10.1111/jdi.13436 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33063949 ● Search Scopus @ Elsevier (PMID): 33063949 ● Search Scopus @ Elsevier (DOI): 10.1111/jdi.13436 (Tokushima University Institutional Repository: 116547, DOI: 10.1111/jdi.13436, PubMed: 33063949)
27.	Tomoyo Hara, Ryoko Uemoto, Akiko Sekine, Yukari Mitsui, Shiho Masuda, Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Yasumasa Ikeda, Itsuro Endo, Soichi Honda, Katsuhiko Yoshimoto, Akira Kondo, Toshiaki Tamaki, Toshio Matsumoto, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : Plasma Heparin Cofactor II Activity Is Inversely Associated with Albuminuria and Its Annual Deterioration in Patients with Diabetes., Journal of Diabetes Investigation, 2021. (Summary) The plasma HCII activity was inversely and specifically associated with glomerular injury in patients with diabetes. The results suggest that HCII can serve as a novel predictive factor for early-stage DKD development, as represented by albuminuria. (Tokushima University Institutional Repository) ● Metadata: 116545 (Link to Publication Site) ● Publication site (DOI): 10.1111/jdi.13602 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34043882 ● Search Scopus @ Elsevier (PMID): 34043882 ● Search Scopus @ Elsevier (DOI): 10.1111/jdi.13602 (Tokushima University Institutional Repository: 116545, DOI: 10.1111/jdi.13602, PubMed: 34043882)
28.	Munehide Matsuhisa and Akio Kuroda : Progression of the advanced technology and therapy for diabetes mellitus, The Journal of the Japanese Society of Internal Medicine, Vol.110, No.3, 420-426, 2021. (Keyword) 重症低血糖 / 持続血糖モニター(CGM) / 持続皮下インスリン注入療法(CSII) / sensor augmented pump (SAP) (Tokushima University Institutional Repository) ● Metadata: 118692 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050861228447747840 (Tokushima University Institutional Repository: 118692, CiNii: 1050861228447747840)
29.	Masashi Ishizu, Hiroyasu Mori, Mami Ohishi, Akio Kuroda, Y Akehi, Sumiko Yoshida, Ken-ichi Aihara, M Aiba, T Kawano, Seiichi Hashida and Munehide Matsuhisa : Urinary adiponectin excretion is an early predictive marker of the decline of the renal function in patients with diabetes mellitus., Journal of Diabetes and its Complications, Vol.35, No.4, 107848, 2021. (Summary) Since diabetes-associated kidney complication changes from diabetic nephropathy to diabetic kidney disease (DKD), more suitable biomarkers than urinary albumin are required. It has been hypothesized that urinary adiponectin (u-ADPN) is associated with the progression of DKD. We therefore evaluated the effectiveness of u-ADPN in predicting the decline of the renal function in patients with diabetes prior to end-stage renal disease. An ultrasensitive immune complex transfer enzyme immunoassay (ICT-EIA) was used to measure total and high molecular weight (HMW) adiponectin separately. We evaluated the relationships between the creatinine-adjusted urinary total-ADPN and HMW-ADPN, albumin (UACR) and liver-type fatty acid binding protein (L-FABP) at baseline and the 2-year change of the estimated glomerular filtration rate (ΔeGFR). This 2-year prospective observational study included 201 patients with diabetes. These patients were divided into three groups according to their ΔeGFR: ≤-10 mL/min/1.73m, >-10 and ≤0 mL/min/1.73m, and >0 mL/min/1.73m. Jonckheere-Terpstra test showed that lower ΔeGFR was associated with higher u-HMW-ADPN (p = 0.045). In logistic regression analysis, u-HMW-ADPN was associated with ΔeGFR after adjusted age, sex, and basal eGFR. Urinary HMW-ADPN could predict a declining renal function in patients with diabetes. (Tokushima University Institutional Repository) ● Metadata: 115675 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jdiacomp.2021.107848 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33558151 ● Search Scopus @ Elsevier (PMID): 33558151 ● Search Scopus @ Elsevier (DOI): 10.1016/j.jdiacomp.2021.107848 (Tokushima University Institutional Repository: 115675, DOI: 10.1016/j.jdiacomp.2021.107848, PubMed: 33558151)
30.	Masao Toyoda, Takashi Murata, Nobumichi Saito, Moritsugu Kimura, Hiroo Takahashi, Naoto Ishida, Makoto Kitamura, Miho Hida, Akinori Hayashi, Ibuki Moriguchi, Naoyuki Kobayashi, Daisuke Tsuriya, Yukitoshi Sakao, Takaya Matsushita, Yukie Ito, Shota Suzuki, Shu Kasama, Masato Kasahara, Tadashi Yamakawa, Katsuhito Mori, Akio Kuroda, Junnosuke Miura, Yushi Hirota, Masanori Abe, Masafumi Fukagawa, Naoki Sakane and Kiminori Hosoda : Assessment of the accuracy of an intermittent-scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study., Therapeutic Apheresis and Dialysis, 2021. (Summary) FreeStyle Libre has been approved for use in patients undergoing hemodialysis (HD) in Japan, unlike Europe and the United States; however, evidence regarding its accuracy in such patients is sparse. Forty-one participants with type 2 diabetes undergoing HD were recruited. The overall mean absolute relative difference and mean absolute difference were 23.4% and 33.9 mg/dL, respectively. Sensor glucose levels and capillary glucose levels were significantly correlated (r = 0.858, P < .01), although the sensor glucose levels were significantly lower than the capillary glucose levels. The accuracy of FreeStyle Libre in patients undergoing HD became deteriorated with the days of usage. The percentage of sensor results in Zones A and B in the consensus error grid analysis and in the Clarke error grid analysis were 99.7% and 99.0%, respectively. Its insufficient accuracy necessitates adjunct usage of FreeStyle Libre with self-monitoring of blood glucose in patients undergoing HD. (Link to Publication Site) ● Publication site (DOI): 10.1111/1744-9987.13618 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33403763 ● Search Scopus @ Elsevier (PMID): 33403763 ● Search Scopus @ Elsevier (DOI): 10.1111/1744-9987.13618 (DOI: 10.1111/1744-9987.13618, PubMed: 33403763)
31.	Yuichi Takashi, Shu Wakino, Hitoshi Minakuchi, Masashi Ishizu, Akio Kuroda, Hisato Shima, Manabu Tashiro, Keiko Miya, Kazuyoshi Okada, Jun Minakuchi, Shu Kawashima, Munehide Matsuhisa, Toshio Matsumoto and Seiji Fukumoto : Circulating FGF23 is not associated with cardiac dysfunction, atherosclerosis, infection or inflammation in hemodialysis patients., Journal of Bone and Mineral Metabolism, Vol.38, No.1, 70-77, 2020. (Summary) Fibroblast growth factor (FGF) 23 is a bone-derived hormone regulating serum inorganic phosphate (Pi) concentration. FGF23 is also involved in the development of chronic kidney disease (CKD)-mineral and bone disorder. Serum FGF23 concentration begins to increase early in the progression of CKD and can be remarkably high in hemodialysis patients with end-stage renal disease. It has been reported that high FGF23 concentration is a risk factor for cardiac dysfunction, atherosclerosis, infection or systemic inflammation in CKD patients. FGF23 was also shown to induce cardiac hypertrophy directly acting on cardiomyocytes. However, it is still controversial whether high FGF23 is causing cardiac dysfunction, atherosclerosis, infection or systemic inflammation in CKD patients. In the current study, we investigated whether FGF23 concentration is associated with cardiac dysfunction, atherosclerosis, infection or systemic inflammation in Japanese hemodialysis patients. We recruited 119 hemodialysis patients and examined the association between serum FGF23 concentration and several parameters concerning mineral metabolism, cardiac dysfunction, atherosclerosis, infection, and systemic inflammation. Serum FGF23 concentration was independently associated with serum calcium and Pi concentration (β = 0.276, p < 0.001; β = 0.689, p < 0.001). However, serum FGF23 concentration was not associated with parameters of cardiac dysfunction, atherosclerosis, infection, and systemic inflammation, either. Our results do not support the hypothesis that high FGF23 in dialysis patients is the cause of cardiac dysfunction, atherosclerosis, infection or systemic inflammation. (Link to Publication Site) ● Publication site (DOI): 10.1007/s00774-019-01027-7 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31420749 ● Search Scopus @ Elsevier (PMID): 31420749 ● Search Scopus @ Elsevier (DOI): 10.1007/s00774-019-01027-7 (DOI: 10.1007/s00774-019-01027-7, PubMed: 31420749)
32.	Yumi Kuwamura, Sumiko Yoshida, Kiyoe Kurahashi, 澄川真珠子, Eijiro Sakamoto, Akio Kuroda, Ken-ichi Aihara, Makoto Funaki, Hiromichi Yumoto, Hirokazu Uemura, 岡本美鈴, 大和光, Munehide Matsuhisa, Itsuro Endo and Sachi Kishida : 糖尿病患者の口腔保健行動アセスメントツールを用いた看護支援プログラムの評価, Journal of the The Japan Diabetes Society, Vol.63, No.Supplement, S117, 2020. (Keyword) diabetes mellitus / oral health behaviors / assessment / 看護支援
33.	Takashi Murata, Akio Kuroda, Munehide Matsuhisa, Masao Toyoda, Moritsugu Kimura, Yushi Hirota, Ken Kato, Hideaki Sawaki, Atsuhito Tone, Satoshi Kawashima, Akira Okada, Tomokazu Watanabe, Shinsuke Nirengi, Akiko Suganuma and Naoki Sakane : Predictive Factors of the Adherence to Real-Time Continuous Glucose Monitoring Sensors: A Prospective Observational Study (PARCS STUDY)., Journal of Diabetes Science and Technology, 2020. (Summary) Higher adherence to CGM sensors may be associated with a heavier emotional burden of diabetes and a worse QOL in relation to CSII at baseline. (Link to Publication Site) ● Publication site (DOI): 10.1177/1932296820939204 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 32762345 ● Search Scopus @ Elsevier (PMID): 32762345 ● Search Scopus @ Elsevier (DOI): 10.1177/1932296820939204 (DOI: 10.1177/1932296820939204, PubMed: 32762345)
34.	Yumi Kuwamura, Sumiko Yoshida, Kiyoe Kurahashi, Masuko Sumikawa, Eijiro Sakamoto, Ken-ichi Aihara, Hiromichi Yumoto, Akio Kuroda, Itsuro Endo, Toshiyuki Yasui and Sachi Kishida : Modified diabetes oral health assessment tool (M-DiOHAT©) for nurses and their association with efficacy beliefs and outcome expectancies in patients with diabetes, JNI : The Journal of Nursing Investigation, Vol.18, No.1, 13-26, 2020. (Keyword) diabetes mellitus / assessment / nursing / oral health behaviors (Tokushima University Institutional Repository) ● Metadata: 114058 (Link to Publication Site) ● Publication site (DOI): 10.32273/jni.JNI_018_013 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.32273/jni.JNI_018_013 (Tokushima University Institutional Repository: 114058, DOI: 10.32273/jni.JNI_018_013)
35.	Yasumitsu Takahi, Kazuyuki Miyashita, Mitsuyoshi Takahara, Naoto Katakami, Akio Kuroda, Taka-Aki Matsuoka, Munehide Matsuhisa, Toshinori Ito and Iichiro Shimomura : Predictive factors of posttransplant glucose intolerance in Japanese patients with type 1 diabetes after pancreas transplantation., Endocrine Journal, Vol.66, No.12, 1101-1112, 2019. (Summary) 120 at the initial examination. In conclusion, insulinogenic index and iAUCR from OGTT performed in the early posttransplantation period were predictive factors of future glucose intolerance. (Tokushima University Institutional Repository) ● Metadata: 118705 (Link to Publication Site) ● Publication site (DOI): 10.1507/endocrj.EJ19-0180 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31495809 ● Search Scopus @ Elsevier (PMID): 31495809 ● Search Scopus @ Elsevier (DOI): 10.1507/endocrj.EJ19-0180 (Tokushima University Institutional Repository: 118705, DOI: 10.1507/endocrj.EJ19-0180, PubMed: 31495809)
36.	Hiroyasu Mori, Akio Kuroda and Munehide Matsuhisa : Clinical impact of sarcopenia and dynapenia on diabetes., Diabetology International, Vol.10, No.3, 183-187, 2019. (Summary) Sarcopenia as a progressive and generalized skeletal muscle disorder that is associated with an increased likelihood of adverse outcomes, including falls, fractures, physical disability, and mortality. On the other hand, an age-related decline in muscle strength prior to the reduction of muscle mass, is proposed to be "dynapenia". Sarcopenia and dynapenia have recently been recognized as a diabetic complications in type 2 diabetes. We firstly indicated that sarcopenia was frequently observed in 16.6% of patients with type 1 diabetes aged even over 40 years. Additionally, we recently reported that the prevalence rate of dynapenia was higher than sarcopenia in patients with type 2 diabetes. Chronic hyperglycemia accelerates accumulation of advanced glycation end products (AGEs), which causes diabetic vascular complications through oxidative stress and chronic inflammation. We also demonstrated that skin autofluorescence (AF) as a marker of AGEs, was the independent determinant for skeletal muscle mass and strength in patients with type 2 diabetes and muscle strength in type 1 diabetes. Therefore, the early diagnosis of muscle weakness is essential for patients with diabetes and sustained good glycemic control with exercise and dietary intervention might be beneficial to prevent the progression of muscle weakness in these patients. (Tokushima University Institutional Repository) ● Metadata: 114038 (Link to Publication Site) ● Publication site (DOI): 10.1007/s13340-019-00400-1 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31275784 ● Summary page in Scopus @ Elsevier: 2-s2.0-85068062045 (Tokushima University Institutional Repository: 114038, DOI: 10.1007/s13340-019-00400-1, PubMed: 31275784, Elsevier: Scopus)
37.	Yuichi Takashi, Masashi Ishizu, Hiroyasu Mori, Kazuyuki Miyashita, Fumie Sakamoto, Naoto Katakami, Taka-Aki Matsuoka, Tetsuyuki Yasuda, Seiichi Hashida, Munehide Matsuhisa and Akio Kuroda : Circulating osteocalcin as a bone-derived hormone is inversely correlated with body fat in patients with type 1 diabetes., PLoS ONE, Vol.14, No.5, 2019. (Summary) The objective of the present study was to investigate the correlations between serum undercarboxylated osteocalcin (ucOC) or osteocalcin (OC) concentrations and %body fat, serum adiponectin and free-testosterone concentration, muscle strength and dose of exogenous insulin in patients with type 1 diabetes. We recruited 73 Japanese young adult patients with childhood-onset type 1 diabetes. All participants were receiving insulin replacement therapy. The correlations between logarithmic serum ucOC or OC concentrations and each parameter were examined. Serum ucOC and OC concentrations were inversely correlated with %body fat (r = -0.319, P = 0.007; r = -0.321, P = 0.006, respectively). Furthermore, multiple linear regression analyses were performed to determine whether or not serum ucOC or OC concentrations were factors associated with %body fat. Serum ucOC and OC concentrations remained significant factors even after adjusting for gender, HbA1c, body weight-adjusted total daily dose of insulin and duration of diabetes (β = -0.260, P = 0.027; β = -0.254, P = 0.031, respectively). However, serum ucOC and OC concentrations were not correlated with serum adiponectin or free-testosterone concentrations, muscle strength or dose of exogenous insulin. In conclusion, our study demonstrates the inverse correlation between serum ucOC or OC concentrations and body fat in patients with type 1 diabetes. (Tokushima University Institutional Repository) ● Metadata: 114023 (Link to Publication Site) ● Publication site (DOI): 10.1371/journal.pone.0216416 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31050684 ● Search Scopus @ Elsevier (PMID): 31050684 ● Search Scopus @ Elsevier (DOI): 10.1371/journal.pone.0216416 (Tokushima University Institutional Repository: 114023, DOI: 10.1371/journal.pone.0216416, PubMed: 31050684)
38.	Naoki Sakane, Takashi Murata, Atsuhito Tone, Ken Kato, Moritsugu Kimura, Satoshi Kawashima, Hideaki Sawaki, Yushi Hirota, Akira Okada, Akio Kuroda, Munehide Matsuhisa, Tomokazu Watanabe, Akiko Suganuma, Shinsuke Nirengi and Masao Toyoda : Development and Validation of the Continuous Subcutaneous Insulin Infusion-related Quality of Life (CSII-QOL) Scale., Diabetes Technology & Therapeutics, Vol.22, No.3, 216-221, 2019. (Summary) The CSII-QOL is the first CSII-related QOL scale for people with T1D. This short, validated, and reliable instrument might potentially be useful in future clinical studies and routine clinical patient care. Further validation is required to confirm these issues because of the small and potentially biased sample. (UMIN-CTR: UMIN000031595). (Link to Publication Site) ● Publication site (DOI): 10.1089/dia.2019.0216 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31638420 ● Search Scopus @ Elsevier (PMID): 31638420 ● Search Scopus @ Elsevier (DOI): 10.1089/dia.2019.0216 (DOI: 10.1089/dia.2019.0216, PubMed: 31638420)
39.	Hiroyasu Mori, Akio Kuroda, Masashi Ishizu, Mami Ohishi, Yuichi Takashi, Yinhua Otsuka, Satoshi Taniguchi, Motoyuki Tamaki, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Yuko Akehi and Munehide Matsuhisa : Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes., Journal of Diabetes Investigation, 2019. (Summary) Advanced glycation end-products (AGEs), which are a major cause of diabetic vascular complications, accumulate in various tissues under chronic hyperglycemic conditions, as well as with aging in patients with diabetes. The loss of muscle mass and strength, so-called sarcopenia and dynapenia, has recently been recognized as a diabetic complication. However, the influence of accumulated AGEs on muscle mass and strength remains unclear. The present study aimed to evaluate the association of sarcopenia and dynapenia with accumulated AGEs in patients with type 2 diabetes. We recruited 166 patients with type 2 diabetes aged 30 years (mean age 63.2 ± 12.3 years; body mass index 26.3 ± 4.9 kg/m ; glycated hemoglobin 7.1 ± 1.1%). Skin autofluorescence as a marker of AGEs, limb skeletal muscle mass index, grip strength, knee extension strength and gait speed were assessed. Sarcopenia and dynapenia were observed in 7.2 and 13.9% of participants, respectively. Skin autofluorescence was significantly higher in patients with sarcopenia and dynapenia. Skin autofluorescence was the independent determinant for skeletal muscle mass index, grip strength, knee extension strength, sarcopenia and dynapenia. Accumulated AGEs could contribute to reduced muscle mass and strength, leading to sarcopenia and dynapenia in patients with type 2 diabetes. (Tokushima University Institutional Repository) ● Metadata: 114022 (Link to Publication Site) ● Publication site (DOI): 10.1111/jdi.13014 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 30677242 ● Search Scopus @ Elsevier (PMID): 30677242 ● Search Scopus @ Elsevier (DOI): 10.1111/jdi.13014 (Tokushima University Institutional Repository: 114022, DOI: 10.1111/jdi.13014, PubMed: 30677242)
40.	Akio Kuroda : A Foreword to the Special Issue, Journal of the The Japan Diabetes Society, Vol.61, No.7, 461, 2018. (Link to Publication Site) ● Publication site (DOI): 10.11213/tonyobyo.61.461 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390001288046915712 ● Search Scopus @ Elsevier (DOI): 10.11213/tonyobyo.61.461 (DOI: 10.11213/tonyobyo.61.461, CiNii: 1390001288046915712)
41.	Akio Kuroda : 第32回日本糖尿病・妊娠学会年次学術集会第1回公開講座ピアサポート報告, 糖尿病と妊娠, Vol.18, No.18, S1-3, 2018.
42.	Takashi Murata, Shinsuke Nirengi, Naoki Sakane, Akio Kuroda, Yushi Hirota, Munehide Matsuhisa, Mitsuyoshi Namba and Tetsuro Kobayashi : Safety of the batteries and power units used in insulin pumps: A pilot cross-sectional study by the Association for the Study of Innovative Diabetes Treatment in Japan., Journal of Diabetes Investigation, Vol.9, No.4, 903-907, 2018. (Summary) As trouble related to the batteries and power units of insulin pumps was frequent, practical guidance should be provided to respective patients regarding the use of reliable batteries, and to be well prepared for unexpected insulin pump failure. (Tokushima University Institutional Repository) ● Metadata: 115508 (Link to Publication Site) ● Publication site (DOI): 10.1111/jdi.12765 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 29055098 ● Search Scopus @ Elsevier (PMID): 29055098 ● Search Scopus @ Elsevier (DOI): 10.1111/jdi.12765 (Tokushima University Institutional Repository: 115508, DOI: 10.1111/jdi.12765, PubMed: 29055098)
43.	Munehide Matsuhisa and Akio Kuroda : New risk factors of severe hypoglycemia., Journal of Diabetes Investigation, Vol.10, No.2, 219-220, 2018. (Tokushima University Institutional Repository) ● Metadata: 115362 (Link to Publication Site) ● Publication site (DOI): 10.1111/jdi.12925 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 30175462 ● Search Scopus @ Elsevier (PMID): 30175462 ● Search Scopus @ Elsevier (DOI): 10.1111/jdi.12925 (Tokushima University Institutional Repository: 115362, DOI: 10.1111/jdi.12925, PubMed: 30175462)
44.	Akio Kuroda : A Foreword to the Special Issue, Journal of the The Japan Diabetes Society, Vol.61, No.12, 804, 2018. (Link to Publication Site) ● Publication site (DOI): 10.11213/tonyobyo.61.804 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390845713035821568 ● Search Scopus @ Elsevier (DOI): 10.11213/tonyobyo.61.804 (DOI: 10.11213/tonyobyo.61.804, CiNii: 1390845713035821568)
45.	Akio Kuroda, Satoshi Taniguchi, Yuko Akehi, Hiroyasu Mori, Motoyuki Tamaki, Reiko Suzuki, Yinhua Otsuka and Munehide Matsuhisa : Accuracy and Time Delay of Glucose Measurements of Continuous Glucose Monitoring and Bedside Artificial Pancreas During Hyperglycemic and Euglycemic Hyperinsulinemic Glucose Clamp Study., Journal of Diabetes Science and Technology, Vol.11, No.6, 1096-1100, 2017. (Summary) Both CGM and AP failed to follow plasma glucose values during nonphysiologically rapid glucose rising, but indicated accurate values during physiological glucose change. (Keyword) Adult / Biomarkers / Blood Glucose / Diabetes Mellitus, Type 2 / Female / Glucose Clamp Technique / Humans / Hypoglycemic Agents / Insulin / Insulin Infusion Systems / Male / Middle Aged / Monitoring, Ambulatory / Pancreas, Artificial / Point-of-Care Systems / Predictive Value of Tests / Reproducibility of Results / Retrospective Studies / Time Factors / Treatment Outcome (Tokushima University Institutional Repository) ● Metadata: 114040 (Link to Publication Site) ● Publication site (DOI): 10.1177/1932296817735122 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28992720 ● Search Scopus @ Elsevier (PMID): 28992720 ● Search Scopus @ Elsevier (DOI): 10.1177/1932296817735122 (Tokushima University Institutional Repository: 114040, DOI: 10.1177/1932296817735122, PubMed: 28992720)
46.	Kiyoe Kurahashi, Itsuro Endo, Takeshi Kondo, Kana Morimoto, Sumiko Yoshida, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Kohhei Nakajima, Yoshifumi Mizobuchi, Shinji Nagahiro, Masahiro Abe and Seiji Fukumoto : Remarkable Shrinkage of a Growth Hormone (GH)-secreting Macroadenoma Induced by Somatostatin Analogue Administration: A Case Report and Literature Review., Internal Medicine, Vol.56, No.18, 2455-2461, 2017. (Summary) Acromegaly is caused by excessive growth hormone secretion, usually from pituitary adenomas. Somoatostatin analogues are widely used as primary or adjunctive therapy in the management of acromegaly. In this report, we present a case with remarkable shrinkage of a tumor after relatively short-term octreotide long-acting release (LAR) administration. During the 30-month follow-up after starting octreotide LAR, there was no recurrence of acromegaly with remarkable shrinkage of the tumor on pituitary magnetic resonance imaging. A literature review of the predictors for tumor shrinkage after the administration of somatostatin analogues in patients with acromegaly is also discussed in relation to this case. (Tokushima University Institutional Repository) ● Metadata: 114396 (Link to Publication Site) ● Publication site (DOI): 10.2169/internalmedicine.8223-16 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28824054 ● Summary page in Scopus @ Elsevier: 2-s2.0-85029653591 (Tokushima University Institutional Repository: 114396, DOI: 10.2169/internalmedicine.8223-16, PubMed: 28824054, Elsevier: Scopus)
47.	Hiroyasu Mori, Akio Kuroda, Michiko Araki, Reiko Suzuki, Satoshi Taniguchi, Motoyuki Tamaki, Yuko Akehi and Munehide Matsuhisa : Advanced glycation end products is a risk for muscle weakness in Japanese patients with type 1 diabetes., Journal of Diabetes Investigation, Vol.8, No.3, 377-382, 2017. (Summary) Accumulation of advanced glycation end products (AGEs) is thought to contribute to muscle weakness in a diabetic animal model. Skin autofluorescence (AF) is a proposed marker for accumulation of AGEs in the skin. We aimed to investigate the relationship between AGEs accumulation, sarcopenia, and muscle function of Japanese patients with type 1 diabetes. Thirty-six patients with type 1 diabetes participated in this cross-sectional study. Sarcopenia parameters (skeletal muscle mass index (SMI) and knee extension strength) were compared with subcutaneous AGEs accumulation using skin AF. The prevalence of sarcopenia and impaired knee extension strength was 16.6% (male: 0.0%, female: 22.2%) and 47.2% (male: 22.2%, female: 55.6%), respectively. Knee extension strength was negatively correlated with skin AF (r²= 0.14, p < 0.05), but not with SMI. In conclusion, the AGEs accumulation might be one of the reasons of impaired lower limb muscle function in Japanese patients with type 1 diabetes. This article is protected by copyright. All rights reserved. (Tokushima University Institutional Repository) ● Metadata: 114021 (Link to Publication Site) ● Publication site (DOI): 10.1111/jdi.12582 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27727515 ● Search Scopus @ Elsevier (PMID): 27727515 ● Search Scopus @ Elsevier (DOI): 10.1111/jdi.12582 (Tokushima University Institutional Repository: 114021, DOI: 10.1111/jdi.12582, PubMed: 27727515)
48.	Akio Kuroda, Tsuruo Miho, Aki Nanako, Takeshi Kondo, Oguro Yukari, Motoyuki Tamaki, Ken-ichi Aihara, Itsuro Endo, Toshio Matsumoto, Masahiro Abe and Munehide Matsuhisa : A Pirot study comparing the CGM-assessed glycemic profiles of patients with type 1 diabetes on insulin degludec and insulin glargine, Diabetology International, Vol.8, No.1, 112-115, 2017. (Link to Publication Site) ● Publication site (DOI): 10.1007/s13340-016-0289-4 (Link to Search Site for Scientific Articles) ● Summary page in Scopus @ Elsevier: 2-s2.0-85013200573 (DOI: 10.1007/s13340-016-0289-4, Elsevier: Scopus)
49.	Tomoyuki Yuasa, Kikuko Amo-Shiinoki, Shuhei Ishikura, Mitsuyoshi Takahara, Takaaki Matsuoka, Hideaki Kaneto, Akio Kuroda, Munehide Matsuhisa and Seiichi Hashida : Sequential cleavage of insulin receptor by calpain 2 and -secretase impairs insulin signalling., Diabetologia, Vol.59, No.12, 2711-2721, 2016. (Summary) Sequential cleavage of IR by calpain 2 and -secretase may contribute to insulin signalling in cells and its inhibition may be partly responsible for the glucose-lowering effects of metformin. Thus, IR cleavage may offer a new mechanism for the aetiology of insulin resistance. (Link to Publication Site) ● Publication site (DOI): 10.1007/s00125-016-4102-5 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27695899 ● Summary page in Scopus @ Elsevier: 2-s2.0-84989201840 (DOI: 10.1007/s00125-016-4102-5, PubMed: 27695899, Elsevier: Scopus)
50.	Takeshi Kondo, Itsuro Endo, Yukari Ooguro, Kana Morimoto, Kiyoe Kurahashi, Sumiko Yoshida, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Masahiro Abe and Seiji Fukumoto : Suppression of the Hypothalamic-pituitary-adrenal Axis by Maximum Androgen Blockade in a Patient with Prostate Cancer., Internal Medicine, Vol.55, No.24, 3623-3626, 2016. (Summary) A 78-year-old Japanese man showed suppression of the hypothalamic-pituitary-adrenal axis during maximum androgen blockade (MAB) therapy including chlormadinone acetate (CMA) for prostate cancer. After stopping the MAB therapy, both the basal ACTH level and the response to CRH recovered. While no reports have indicated that CMA suppresses the hypothalamic-pituitary-adrenal axis in patients with prostate cancer, CMA has been shown to inhibit this axis in animals. These observations suggest that we must monitor the hypothalamic-pituitary-adrenal axis in patients treated with CMA, especially under stressful conditions. (Keyword) Adrenal Glands / Adrenocorticotropic Hormone / Aged / Androgen Antagonists / Animals / Antineoplastic Agents / Chlormadinone Acetate / Corticotropin-Releasing Hormone / Diabetes Mellitus, Type 2 / Humans / Hypothalamo-Hypophyseal System / Male / Pituitary-Adrenal System / Prostatic Neoplasms / Treatment Outcome (Tokushima University Institutional Repository) ● Metadata: 114392 (Link to Publication Site) ● Publication site (DOI): 10.2169/internalmedicine.55.7359 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27980263 ● Summary page in Scopus @ Elsevier: 2-s2.0-85007140325 (Tokushima University Institutional Repository: 114392, DOI: 10.2169/internalmedicine.55.7359, PubMed: 27980263, Elsevier: Scopus)
51.	Saeko Osawa, Naoto Katakami, Akio Kuroda, Mitsuyoshi Takahara, Fumie Sakamoto, Dan Kawamori, Takaaki Matsuoka, Munehide Matsuhisa and Iichiro Shimomura : Skin Autofluorescence is Associated with Early-stage Atherosclerosis in Patients with Type 1 Diabetes., Journal of Atherosclerosis and Thrombosis, 2016. (Summary) Skin AF was significantly associated with the presence and/or severity of diabetic complications and was an independent risk factor for carotid atherosclerosis. (Tokushima University Institutional Repository) ● Metadata: 115485 (Link to Publication Site) ● Publication site (DOI): 10.5551/jat.35592 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27592627 ● Search Scopus @ Elsevier (PMID): 27592627 ● Search Scopus @ Elsevier (DOI): 10.5551/jat.35592 (Tokushima University Institutional Repository: 115485, DOI: 10.5551/jat.35592, PubMed: 27592627)
52.	B Allen King, Akio Kuroda, Munehide Matsuhisa and Todd Hobbs : A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes., Current Diabetes Reports, Vol.16, No.9, 2016. (Summary) Dosing guidelines for patients with type 1 diabetes using continuous subcutaneous insulin infusion (CSII), which are historically based on clinical experience and retrospective studies of patients consuming an American diet, recommend that basal insulin should represent approximately 50 % of the total daily dose (TDD). Recent prospective studies in the USA and Japan conclude that the more appropriate proportion is closer to 30-40 % of TDD. In addition, currently used formulas for calculating the carbohydrate-to-insulin ratio (CIR) and correction factor (CF) may lead to underdosing of bolus insulin by as much as 12.8-50 % for a hypothetical patient. The discrepancies between traditional formulas and data from newer studies can be accounted for by the more rigorous design of the newer studies (e.g., prospective design, controlled diets, meal omission, and frequent glucose monitoring). International differences in diet composition may also be important to consider when developing dosing recommendations for CSII. (Tokushima University Institutional Repository) ● Metadata: 115078 (Link to Publication Site) ● Publication site (DOI): 10.1007/s11892-016-0772-0 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27457238 ● Search Scopus @ Elsevier (PMID): 27457238 ● Search Scopus @ Elsevier (DOI): 10.1007/s11892-016-0772-0 (Tokushima University Institutional Repository: 115078, DOI: 10.1007/s11892-016-0772-0, PubMed: 27457238)
53.	Takeshi Kondo, Itsuro Endo, Ken-ichi Aihara, Ohnishi Yukiyo, Dong Bingzi, Oguro Yukari, Kiyoe Kurahashi, Sumiko Yoshida, Yuichi Fujinaka, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Toshio Matsumoto and Masahiro Abe : Serum carboxy-terminal telopeptide of type I collagen levels are associated with carotid atherosclerosis in patients with cardiovascular risk factors., Endocrine Journal, Vol.63, No.4, 397-404, 2016. (Summary) Carboxy-terminal telopeptide of type I collagen (ICTP) is generated through matrix metalloproteinase (MMP)-dependent type I collagen digestion, and has been widely utilized as a biomarker for bone turnover. The fact that atherosclerotic lesions are rich in both type I collagen and MMP-producing macrophages led to the hypothesis that serum ICTP concentrations may serve as a non-invasive clinical biomarker for atherosclerosis. Therefore, the association of serum ICTP concentrations with the maximum intima-media thickness (IMT) of carotid arteries, a surrogate index of systemic atherosclerosis, or brachial-ankle pulse wave velocity (baPWV) in patients with atherosclerotic risk factors was evaluated. A total of 52 male and 65 female (mean age: 62.8 yrs) patients without renal failure, malignancies or bone diseases known to affect serum ICTP concentrations were recruited. Patients with max IMTs ≥1.1 mm showed significantly higher serum ICTP concentrations compared with patients with max IMTs <1.1 mm (3.33 ± 0.97 vs 2.82 ± 0.65 ng/mL, p<0.05). Serum ICTP concentration was also positively correlated with max IMT (p<0.001) or baPWV values (p<0.05). Multivariate analyses also revealed that serum ICTP concentrations were correlated with max IMT (p<0.001; 95% CI 0.200 to 0.454). These results suggest that serum ICTP concentrations can be used as a non-invasive biomarker for systemic atherosclerosis. (Tokushima University Institutional Repository) ● Metadata: 109666 (Link to Publication Site) ● Publication site (DOI): 10.1507/endocrj.EJ15-0589 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 26877258 ● Summary page in Scopus @ Elsevier: 2-s2.0-84964267287 (Tokushima University Institutional Repository: 109666, DOI: 10.1507/endocrj.EJ15-0589, PubMed: 26877258, Elsevier: Scopus)
54.	Akio Kuroda and Munehide Matsuhisa : Carbohydrate Counting and Its Consumption, Journal of the The Japan Diabetes Society, Vol.59, No.1, 24-26, 2016. (Keyword) カーボカウント / 血糖コントロール / 食事療法 / 食品交換表 (Link to Publication Site) ● Publication site (DOI): 10.11213/tonyobyo.59.24 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390001204909511040 ● Search Scopus @ Elsevier (DOI): 10.11213/tonyobyo.59.24 (DOI: 10.11213/tonyobyo.59.24, CiNii: 1390001204909511040)
55.	Jin Temma, Munehide Matsuhisa, Toru Horie, Akio Kuroda, Hiroyasu Mori, Motoyuki Tamaki, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe and Toshio Matsumoto : Non-invasive Measurement of Skin Autofluorescence as a Beneficial Surrogate Marker for Atherosclerosis in Patients with Type 2 Diabetes, The Journal of Medical Investigation : JMI, Vol.62, No.3-4, 126-129, 2015. (Summary) Advanced glycation end-products (AGEs) are thought to play a major role in the pathogenesis of diabetic vascular complications. Skin autofluorescence (AF) was recently reported to represent tissue AGEs accumulation with a non-invasive method. The aim of the present study was to evaluate association between AF value and diabetic vascular complications, such as retinopathy, nephropathy and cervical atherosclerosis using the carotid intima-media thickness (IMT), an established marker of cardiovascular disease in patients with type 2 diabetes. A total of 68 patients with type 2 diabetes were enrolled in a cross-sectional manner. AGEs accumulation was measured with AF reader. Clinical parameters were collected at the time of AF and IMT measurement. Max-IMT was correlated with age and AF (r=0.407, p=0.001), but not with HbA1c, GA, and pentosidine. Also, AF was not correlated with HbA1c, GA and pentosidine, but was correlated with age (r=0.560, p<0.001), duration of diabetes (r=0.256, p<0.05). Multivariate regression analysis revealed that AF, but not age, was an independent determinant of max-IMT. In conclusion, AF might be a beneficial surrogate marker for evaluating carotid atherosclerosis in patients with type 2 diabetes non-invasively. J. Med. Invest. 62: 126-129, August, 2015. (Tokushima University Institutional Repository) ● Metadata: 111266 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.62.126 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 26399335 ● Summary page in Scopus @ Elsevier: 2-s2.0-84942054596 (Tokushima University Institutional Repository: 111266, DOI: 10.2152/jmi.62.126, PubMed: 26399335, Elsevier: Scopus)
56.	Kota Ishikawa, Shin Tsunekawa, Makoto Ikeniwa, Takako Izumoto, Atsushi Iida, Hidetada Ogata, Eita Uenishi, Yusuke Seino, Nobuaki Ozaki, Yoshihisa Sugimura, Yoji Hamada, Akio Kuroda, Keiko Shinjo, Yutaka Kondo and Yutaka Oiso : Long-Term Pancreatic Beta Cell Exposure to High Levels of Glucose but Not Palmitate Induces DNA Methylation within the Insulin Gene Promoter and Represses Transcriptional Activity., PLoS ONE, Vol.10, No.2, e0115350, 2015. (Summary) Recent studies have implicated epigenetics in the pathophysiology of diabetes. Furthermore, DNA methylation, which irreversibly deactivates gene transcription, of the insulin promoter, particularly the cAMP response element, is increased in diabetes patients. However, the underlying mechanism remains unclear. We aimed to investigate insulin promoter DNA methylation in an over-nutrition state. INS-1 cells, the rat pancreatic beta cell line, were cultured under normal-culture-glucose (11.2 mmol/l) or experimental-high-glucose (22.4 mmol/l) conditions for 14 days, with or without 0.4 mmol/l palmitate. DNA methylation of the rat insulin 1 gene (Ins1) promoter was investigated using bisulfite sequencing and pyrosequencing analysis. Experimental-high-glucose conditions significantly suppressed insulin mRNA and increased DNA methylation at all five CpG sites within the Ins1 promoter, including the cAMP response element, in a time-dependent and glucose concentration-dependent manner. DNA methylation under experimental-high-glucose conditions was unique to the Ins1 promoter; however, palmitate did not affect DNA methylation. Artificial methylation of Ins1 promoter significantly suppressed promoter-driven luciferase activity, and a DNA methylation inhibitor significantly improved insulin mRNA suppression by experimental-high-glucose conditions. Experimental-high-glucose conditions significantly increased DNA methyltransferase activity and decreased ten-eleven-translocation methylcytosine dioxygenase activity. Oxidative stress and endoplasmic reticulum stress did not affect DNA methylation of the Ins1 promoter. High glucose but not palmitate increased ectopic triacylglycerol accumulation parallel to DNA methylation. Metformin upregulated insulin gene expression and suppressed DNA methylation and ectopic triacylglycerol accumulation. Finally, DNA methylation of the Ins1 promoter increased in isolated islets from Zucker diabetic fatty rats. This study helps to clarify the effect of an over-nutrition state on DNA methylation of the Ins1 promoter in pancreatic beta cells. It provides new insights into the irreversible pathophysiology of diabetes. (Tokushima University Institutional Repository) ● Metadata: 114932 (Link to Publication Site) ● Publication site (DOI): 10.1371/journal.pone.0115350 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25658116 ● Summary page in Scopus @ Elsevier: 2-s2.0-84922714378 (Tokushima University Institutional Repository: 114932, DOI: 10.1371/journal.pone.0115350, PubMed: 25658116, Elsevier: Scopus)
57.	Munehide Matsuhisa, Akio Kuroda and Yuu Tamaki : Establishment of the Local Medical Care System for Diabetes Using by ICT Network in Tokushima, 日本糖尿病情報学会誌 = Journal of the Japan Association of Diabetes Informatics, No.12, 12-20, 2014. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1521699231080411776 (CiNii: 1521699231080411776)
58.	Keiko Fujisawa, Tetsuyuki Yasuda, Hideaki Kaneto, Naoto Katakami, Mayumi Tsuji, Fumiyo Kubo, Shugo Sasaki, Kazuyuki Miyashita, Toyoko Naka, Ryuuichi Kasami, Akio Kuroda, Munehide Matsuhisa and Iichiro Shimomura : Short- and long-term effect of sitagliptin after near normalization of glycemic control with insulin in poorly controlled Japanese type 2 diabetic patients., Journal of Diabetes Investigation, Vol.5, No.5, 548-553, 2014. (Summary) These findings suggest that near normalization of glycemic control with insulin improves the clinical response to sitagliptin in poorly controlled type 2 diabetic patients. (Link to Publication Site) ● Publication site (DOI): 10.1111/jdi.12176 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25411623 ● Search Scopus @ Elsevier (PMID): 25411623 ● Search Scopus @ Elsevier (DOI): 10.1111/jdi.12176 (DOI: 10.1111/jdi.12176, PubMed: 25411623)
59.	Naoki Shimo, Tetsuyuki Yasuda, Hideaki Kaneto, Naoto Katakami, Akio Kuroda, Fumie Sakamoto, Mitsuyoshi Takahara, Yoko Irie, Keiko Horikawa, Kazuyuki Miyashita, Takeshi Miyatsuka, Kazutomi Yoshiuchi, Dan Kawamori, Ken'ya Sakamoto, Taka-aki Matsuoka, Keisuke Kosugi, Iichiro Shimomura and Munehide Matsuhisa : Vitamin D deficiency is significantly associated with retinopathy in young Japanese type 1 diabetic patients., Diabetes Research and Clinical Practice, Vol.106, No.2, e41-3, 2014. (Summary) The aim of this study was to examine the possible association of vitamin D deficiency with diabetic retinopathy in 75 young Japanese type 1 diabetic patients. A multivariate regression analysis, duration of diabetes and vitamin D deficiency were independent determinants of diabetic retinopathy. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.diabres.2014.08.005 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25287616 ● Search Scopus @ Elsevier (PMID): 25287616 ● Search Scopus @ Elsevier (DOI): 10.1016/j.diabres.2014.08.005 (DOI: 10.1016/j.diabres.2014.08.005, PubMed: 25287616)
60.	Mizuho Kinouchi, Ken-ichi Aihara, Yuichi Fujinaka, Sumiko Yoshida, Yukari Ooguro, Kiyoe Kurahashi, Takeshi Kondo, Nanako Aki, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto : Diabetic conditions differentially affect the endothelial function, arterial stiffness and carotid atherosclerosis., Journal of Atherosclerosis and Thrombosis, Vol.21, No.5, 486-500, 2014. (Summary) Aim: The levels of fasting and postprandial plasma glucose, HbA1c and other risk factors for atherosclerosis have distinct effects in patients with and those without diabetes mellitus. The aim of this study was to determine the impact of diabetic surrogate markers on the endothelial function, arterial stiffness and carotid atherosclerosis in individuals with and without diabetes. Methods: A total of 320 Japanese subjects(mean age: 61.2±12.1 years) were recruited in this study. Demographic, clinical and laboratory parameters, including 75 g OGTT(155 subjects) results, were examined. The endothelial function was evaluated according to the flow-mediated vasodilation of the brachial artery(%FMD). In addition, arterial stiffness was evaluated according to the brachial-ankle pulse wave velocity(baPWV), and carotid atherosclerotic changes were estimated according to the maximum intima-media thickness(max-IMT) and resistive index of the common carotid artery(CCA-RI). A multiple regression analysis was performed to identify independent determinants of these vascular surrogate markers. Results: None of the glucose-related parameters were associated with the %FMD. In contrast, the presence of T2DM, the HbA1c level and an increased plasma glucose level at 60 minutes during 75 g OGTT were associated with an increased baPWV. The HbA1c level was also correlated with an increased max-IMT. The fasting plasma glucose(FPG) level and the presence of T2DM correlated with an increased CCA-RI. In the subjects with T2DM, the protective effects of high-density lipoprotein cholesterol(HDL-C) on the %FMD and baPWV were abolished. Conclusions: Various glucose metabolism parameters have different effects the degree of arterial stiffness and presence of carotid atherosclerosis, but not the endothelial function, suggesting that pharmacological intervention has the potential to preserve the endothelial function in diabetic individuals. In addition, the presence of T2DM blunts the vascular protective effects of HDL-C on the endothelial function and progression of arterial stiffness. (Keyword) Type 2 diabetes / Endothelial function / Arterial stiffness / Carotid atherosclerosis (Tokushima University Institutional Repository) ● Metadata: 106061 (Link to Publication Site) ● Publication site (DOI): 10.5551/jat.20834 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 24401746 ● CiNii @ National Institute of Informatics (CRID): 1390001204430842112 ● Summary page in Scopus @ Elsevier: 2-s2.0-84901494272 (Tokushima University Institutional Repository: 106061, DOI: 10.5551/jat.20834, PubMed: 24401746, CiNii: 1390001204430842112, Elsevier: Scopus)
61.	Akio Kuroda, 丸山千寿子 and Munehide Matsuhisa : Carbohydrate Content in Dishes Other than Staple Foods Based on the Food Exchange Lists (7th edition) Allowing for a 50-60 % Energy Intake from Carbohydrates, Journal of the The Japan Diabetes Society, Vol.57, No.12, 921-922, 2014. (Keyword) 食品交換表 / カーボカウント (Link to Publication Site) ● Publication site (DOI): 10.11213/tonyobyo.57.921 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390001204906835712 ● Summary page in Scopus @ Elsevier: 2-s2.0-84937120633 (DOI: 10.11213/tonyobyo.57.921, CiNii: 1390001204906835712, Elsevier: Scopus)
62.	Takeshi Kondo, Akio Kuroda, 曽我部公子, 大黒由加里, 倉橋清衛, Motoyuki Tamaki, Mizuho Kinouchi, Sumiko Yoshida, 安芸菜奈子, Itsuro Endo, Ken-ichi Aihara, Yuichi Fujinaka, Munehide Matsuhisa and Toshio Matsumoto : Comparison of Continuous Glucose Monitoring (CGM) Values before and after Adrenalectomy in a Case of Adrenaline-producing Pheochromocytoma, Journal of the The Japan Diabetes Society, Vol.57, No.9, 729-735, 2014. (Summary) A 77-year-old woman was incidentally found to have a left adrenal mass measuring 2.5 cm in January 2012. The urine metanephrine concentration was 3.0 mg/day (normal range, 0.04-0.19 mg/day), and an iodine-131 metaiodobenzylguanidine (MIBG) scan showed uptake in the area of the left adrenal gland, leading to a diagnosis of pheochromocytoma. In addition, the patient had a history of diabetes mellitus for nine years, with gradually worsening blood glucose control since 2010. The patient was subsequently admitted to our hospital for perioperative care. On admission, her fasting blood glucose level was 121 mg/dl and her HbA1c level was 8.5 %. She was treated with basal-bolus insulin therapy during hospitalization and underwent adrenalectomy at the urology department after her glycemic control had improved. The total daily insulin dose was immediately decreased from 50 to 14 units after the adrenalectomy procedure. In addition, the mean glucose level on preoperative continuous glucose monitoring (CGM) had been 141 mg/dl with a standard deviation (SD) of 54. However, after the operation, the mean glucose level increased to 153 mg/dl while the SD decreased to 24; thus, the range of glycemic fluctuation markedly decreased after surgery. Therefore, excess endogenous adrenalin primarily contributed to the glycemic fluctuations observed in this patient with pheochromocytoma. (Keyword) 褐色細胞腫 / アドレナリン / 糖尿病 / CGM(持続血糖モニター) (Link to Publication Site) ● Publication site (DOI): 10.11213/tonyobyo.57.729 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390001204908593792 ● Summary page in Scopus @ Elsevier: 2-s2.0-84908507898 (DOI: 10.11213/tonyobyo.57.729, CiNii: 1390001204908593792, Elsevier: Scopus)
63.	小林哲郎, 難波光義, Akio Kuroda, Munehide Matsuhisa, 山田研太郎, 今村洋一, 金重勝博, 浜口朋也, 川村智行, 佐藤譲, 高橋和眞, 丸山太郎, 西村理明, 勝野朋幸, 楠宜樹, 清水一紀, 柳澤克之, 粟田卓也 and 雨宮伸 : Consensus Statement on Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring, Journal of the The Japan Diabetes Society, Vol.57, No.6, 403-415, 2014. (Summary) The use of continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) in clinical practice is increasing in Japan. Against this background, the Association for the Study of Innovative Diabetes Treatment in Japan (ASINDTJ) arranged a Consensus Statement of opinions for the optimal and safe routine use of CSII and CGM. The Consensus Statement on the routine use of CSII and CGM includes patient selection and indications for clinical outcomes as well as risk management for routine use. The development of patient educational programs conducted by diabetologists in association with certified diabetes educators (CDEs) regarding the use of pumps and/or CGM is a prerequisite for clinical use. In addition, items associated with CSII and CGM, such as insulin dose adjustment, application methods for use in daily life, diet and exercise, risk management of pump difficulties, " sick day" occasions and skin problems, are included in the Consensus Statement. Our consensus opinion and suggestions also emphasize the usefulness of CSII and CGM in adult diabetic patients as well as children with type 1 and type 2 diabetes and pregnant diabetic patients. According to the Consensus Statement, the development of detailed educational guidelines for the use of CSII and CGM is needed. (Keyword) Continuous subcutaneous insulin infusion(CSII)(C-14) (Link to Publication Site) ● Publication site (DOI): 10.11213/tonyobyo.57.403 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390001204907971072 ● Summary page in Scopus @ Elsevier: 2-s2.0-84903996238 (DOI: 10.11213/tonyobyo.57.403, CiNii: 1390001204907971072, Elsevier: Scopus)
64.	弘世貴久, 渡邉隆宏, 綿田裕孝, 安孫子亜津子, 羽田勝計, 武部典子, 佐藤譲, 山口賢, 石原寿光, 前田朝美, 江藤一弘, 太田明雄, 田中逸, 武田貞二, 駒津光久, 卯木智, 前川聡, 伊藤裕進, 能宗伸輔, 廣峰義久, 川畑由美子, 池上博司, 寺前純吾, 花房俊昭, 富永貴元, 井上康, 谷澤幸生, Toshio Matsumoto, Akio Kuroda, Munehide Matsuhisa, 野見山崇, 柳瀬敏彦, 小林邦久, 近藤龍也, 荒木栄一, 石井則夫, 井形元雄, 久木留大介, 本島寛之 and 河盛隆造 : Effectiveness of miglitol combined with various types of insulin therapy for reducing the daily glycemic fluctuation on Japanese type 2 diabetic patients: Evaluation with self-monitoring blood glucose (SMBG), Therapeutic Research, Vol.34, No.12, 1503-1511, 2013. (Link to Search Site for Scientific Articles) ● Summary page in Scopus @ Elsevier: 2-s2.0-84893163294 (Elsevier: Scopus)
65.	Kazuyuki Miyashita, Tetsuyuki Yasuda, Hideaki Kaneto, Akio Kuroda, Tetsuhiro Kitamura, Michio Otsuki, Yasuyuki Okamoto, Noboru Hamada, Munehide Matsuhisa and Iichiro Shimomura : A Case of Hypocalcemia with Severe Vitamin D Deficiency following Treatment for Graves' Disease with Methimazole., Case Reports in Endocrinology, Vol.2013, 2013. (Summary) We herein report the case of a 41-year-old Japanese female office worker who developed symptomatic hypocalcemia with severe vitamin D deficiency following treatment for Graves' disease with methimazole. The patient's hypocalcemia was mainly caused by vitamin D deficiency due to unbalanced diets and inadequate exposure to sunlight in addition to the resolution of hyperthyroidism. Vitamin D deficiency is increasing worldwide, and it has been more recently shown to relate to the pathogenesis of Graves' disease. However, vitamin D deficiency as a cause of hypocalcemia has received little attention. Taken together, this case suggests that we should take more care in calcium kinetics and vitamin D status during treatment for Graves' disease with antithyroid drugs. (Link to Publication Site) ● Publication site (DOI): 10.1155/2013/512671 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23710380 ● Search Scopus @ Elsevier (PMID): 23710380 ● Search Scopus @ Elsevier (DOI): 10.1155/2013/512671 (DOI: 10.1155/2013/512671, PubMed: 23710380)
66.	Sumiko Yoshida, Akio Kuroda, 新居沙央里, 松本友里, 近藤絵里, 安藝菜奈子, Itsuro Endo, Ken-ichi Aihara, 鈴木麗子, Toshio Matsumoto and Munehide Matsuhisa : The New Paradigm 722 Insulin Pump Can Achieve Good Glycemic Control with Carbohydrate Counting Alone : A Case Report of Type 1 Diabetes Mellitus, Journal of the The Japan Diabetes Society, Vol.56, No.4, 240-245, 2013. (Summary) インスリンポンプParadigm712は，インスリン作用時間(AIT)が8時間の設定のため，十分な食後血糖補正インスリン投与を提案しないが，新しいParadigm 722はAITを2~8時間に設定できる．そこで，Paradigm 722の食後血糖補正インスリン量の妥当性を検証した．症例は1型糖尿病の50歳代女性．入院の上インスリンリスプロでParadigm 722を導入，食事スキップで基礎インスリンを設定し，糖質/インスリン比を各食前(11，15，13)g/Uとしたカーボカウントのもと，AITを3時間，インスリン効果値を60mg/dl/Uと設定した．退院前1週間の食後2時間血糖補正の際，150mg/dlを目標にインスリン効果値を用いた補正による自己算出インスリン量とポンプでの自動算出インスリン量とを比較した．食後高血糖に対する補正インスリンは，14回中7回で自己算出量よりも自動算出量が適切であった．Paradigm 722による食後補正インスリン自動算出法は，自己算出法と同等で，これを用いることで良好な血糖管理が簡便になった．(著者抄録) (Keyword) インスリン作用 / 持続皮下インスリン注入療法 / カーボカウント / 1型糖尿病 (Link to Publication Site) ● Publication site (DOI): 10.11213/tonyobyo.56.240 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390001204909103744 ● Summary page in Scopus @ Elsevier: 2-s2.0-84878045431 (DOI: 10.11213/tonyobyo.56.240, CiNii: 1390001204909103744, Elsevier: Scopus)
67.	Naoto Katakami, Hideaki Kaneto, Fumie Sakamoto, Mitsuyoshi Takahara, Yoko Irie, Keiko Fujisawa, Kazuyuki Miyashita, Tetsuyuki Yasuda, Taka-Aki Matsuoka, Kazutomi Yoshiuchi, Ken'ya Sakamoto, Akio Kuroda, Munehide Matsuhisa, Keisuke Kosugi and Iichiro Shimomura : Plasma pentraxin 3 levels are associated with carotid IMT in type 1 diabetic patients., Diabetes Research and Clinical Practice, Vol.99, No.2, 185-91, 2013. (Summary) AIMS: Pentraxin3 (PTX3), a recently discovered inflammatory mediator, is produced abundantly in various cells in atherosclerotic lesions, and therefore, its plasma level could reflect local inflammation at the site of atherosclerotic lesion. The present study evaluated whether plasma PTX3 levels are associated with subclinical atherosclerosis in young subjects with type 1 diabetes. METHODS: Plasma PTX3 levels, urinary albumin excretion, diabetic retinopathy, and carotid intima-media thickness (IMT) were examined in 78 Japanese type 1 diabetic patients (30 men and 48 women, aged 28.5±5.3 years (±SD), duration of diabetes 19.7±6.5 years). RESULTS: There was statistically significant association between plasma PTX3 levels and Max-IMT (r=0.363, p=0.001). A stepwise multivariate regression analysis including conventional coronary risk factors as independent variables revealed that plasma PTX3 levels (=0.389, p<0.001), duration of diabetes (=0.256, p=0.035), and serum triglyceride levels (=0.371, p<0.001) were independent determinants of Max-IMT. In addition, plasma PTX3 levels was an independent determinant of urinary albumin excretion, an indicator of diabetic nephropathy (=0.258, p=0.018). However, there was no significant association between plasma PTX3 levels and diabetic retinopathy. CONCLUSIONS: Increased levels of plasma PTX3 are associated with accelerated atherosclerotic change and increased albuminuria in young patients with type 1 diabetes. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.diabres.2012.11.020 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23245734 ● Search Scopus @ Elsevier (PMID): 23245734 ● Search Scopus @ Elsevier (DOI): 10.1016/j.diabres.2012.11.020 (DOI: 10.1016/j.diabres.2012.11.020, PubMed: 23245734)
68.	Akio Kuroda, Hideaki Kaneto, Satoshi Kawashima, Kenya Sakamoto, Mitsuyoshi Takahara, Toshihiko Shiraiwa, Tetsuyuki Yasuda, Naoto Katakami, Taka-Aki Matsuoka, Iichiro Shimomura and Munehide Matsuhisa : Regular insulin, rather than rapid-acting insulin, is a suitable choice for premeal bolus insulin in lean patients with type 2 diabetes mellitus., Journal of Diabetes Investigation, Vol.4, No.1, 78-81, 2013. (Summary) The aim of the present study was to compare the usefulness of premeal rapid-acting and regular insulin in type 2 diabetes patients. A total of 56 type 2 diabetic patients were investigated during hospitalization. Premeal rapid-acting insulin was applied instead of other medications. Premeal insulin was titrated to adjust premeal and bedtime blood glucose levels to 81-120 mg/dL. Premeal rapid-acting insulin was changed to regular insulin just before a meal at the same dosage if the postmeal blood glucose level was lower than the premeal blood glucose level. A total of 15 patients changed to regular insulin, and 41 patients continued rapid-acting insulin. The blood glucose level was comparable between these two groups. Body mass index was significantly lower in the patients using regular insulin. According to the multivariate logistic regression analysis, low body mass index was an independent variable accounting for the usefulness of regular insulin. Regular insulin, rather than rapid-acting insulin, is a suitable choice for premeal insulin in lean type 2 diabetic patients. (Link to Publication Site) ● Publication site (DOI): 10.1111/j.2040-1124.2012.00231.x (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 24843634 ● Summary page in Scopus @ Elsevier: 2-s2.0-84873175220 (DOI: 10.1111/j.2040-1124.2012.00231.x, PubMed: 24843634, Elsevier: Scopus)
69.	Fumie Sakamoto, Naoto Katakami, Hideaki Kaneto, Tetsuyuki Yasuda, Mitsuyoshi Takahara, Kazuyuki Miyashita, Akio Kuroda, Munehide Matsuhisa, Keisuke Kosugi and Iichiro Shimomura : Association of serum YKL-40 levels with urinary albumin excretion rate in young Japanese patients with type 1 diabetes mellitus., Endocrine Journal, Vol.60, No.1, 73-79, 2013. (Summary) YKL-40 is a marker of inflammation and endothelial dysfunction, both of which play important roles in the progression of diabetic complications. However, little information has been obtained about serum YKL-40 levels in type 1 diabetic patients. We evaluated YKL-40 levels and its association with diabetic micro- and macroandgiopathy in 131 young Japanese type 1 diabetic patients without advanced diabetic complications (aged 24.7±5.9 years) and 97 age- and gender-matched healthy controls. YKL-40 levels were significantly elevated in type 1 diabetic patients than in healthy controls (median (range) 46.4 (20.3-136.7) and 52.3 (21.4-274.1) ng/ml, respectively, p = 0.006). There was a significant positive association between YKL-40 levels and urinary albumin creatinine ratio (UACR) (r = 0.226, p = 0.013). Furthermore, a multivariate regression analysis demonstrated that YKL-40 levels were a determinant of UACR independently of conventional risk factors. In addition, YKL-40 levels were significantly higher in participants with diabetic retinopathy compared to those without it (median (range) 55.5 (23.3-274.1) and 50.3 (21.4-237.4) ng/ml, respectively, p = 0.039). Serum YKL-40 levels were elevated in type 1 diabetic patients and associated with increasing level of albuminuria. YKL-40 could be a predictor to assess the risk of diabetic microangiopathy in the early stage in type 1 diabetic patients. (Link to Publication Site) ● Publication site (DOI): 10.1507/endocrj.EJ12-0238 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22986489 ● Search Scopus @ Elsevier (PMID): 22986489 ● Search Scopus @ Elsevier (DOI): 10.1507/endocrj.EJ12-0238 (DOI: 10.1507/endocrj.EJ12-0238, PubMed: 22986489)
70.	Shugo Sasaki, Tetsuyuki Yasuda, Hideaki Kaneto, Akio Kuroda, Yukari Fujita, Keiko Fujisawa, Yukiko Tabuchi, Ryuichi Kasami, Taka-Aki Matsuoka, Munehide Matsuhisa and Iichiro Shimomura : Basal insulin requirements after progesterone treatment in a type 1 diabetic pregnant woman., Internal Medicine, Vol.52, No.2, 259-262, 2013. (Summary) We herein report the case of a 37-year-old type 1 diabetic pregnant woman treated with an insulin pump. Although the patient's glycemic control deteriorated following progesterone treatment for the prevention of preterm delivery and miscarriage, it was improved by adjusting the basal insulin rate on the days of progesterone treatment. Excess progesterone is known to impair both insulin sensitivity and secretion. The present case is the first report to evaluate deterioration of glycemic control induced by progesterone treatment and to determine the dose of insulin required in a type 1 diabetic pregnant woman whose insulin secretion was completely depleted. (Link to Publication Site) ● Publication site (DOI): 10.2169/internalmedicine.52.8675 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23318859 ● Summary page in Scopus @ Elsevier: 2-s2.0-84872424073 (DOI: 10.2169/internalmedicine.52.8675, PubMed: 23318859, Elsevier: Scopus)
71.	Miwa Yamaguchi, Akio Kuroda, Yumiko Kotani, Akiko Matsumura, Sakurako Kamano, Hirokazu Uemura, Ichiro Yokota, Shoji Kagami, Kokichi Arisawa and Munehide Matsuhisa : Evaluation of the Sugar Content in the Side Dishes Served in Elementary School Lunches, Journal of the The Japan Diabetes Society, Vol.55, No.12, 952-956, 2012. (Summary) Kuroda et al. proposed a simple method for calculating the carbohydrate content based on a food exchange list (Shokuhin Koukanhyou), with a sugar content of dietary staples of 40 % for rice, 50 % for bread, and 20 % for boiled noodles and a side dish containing 20 g sugar. This study focused on the sugar content in in school lunches, which have a nutrient composition that is different from diabetic meals. The total energy content of school lunches and the sugar content in their side dishes were investigated in 42 school lunches served in elementary school. The average energy intake in the total lunch increased depending on the school grade (670±44 to 752±50 kcal; means±standard deviation). On the other hand, the sugar content of side dishes increased from 29.7±7.5 g in the 1<sup>st</sup>-2<sup>nd</sup> grade to 31.2±8.1 g in the 5<sup>th</sup>-6<sup>th</sup> grade, thus it could be estimated to be 30 g regardless of the energy intake. Two hundred milliliters of milk containing approximately 10 g of carbohydrate was served in every school lunch, which accounted for the 10 g increase in comparison to hospital lunches. These results indicate that the sugar content in the side dishes of elementary school lunches can be estimated to be 30 g regardless of the energy intake.<br> (Keyword) 食事療法 / カーボカウント / 糖質 (Link to Publication Site) ● Publication site (DOI): 10.11213/tonyobyo.55.952 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390001204908494592 ● Summary page in Scopus @ Elsevier: 2-s2.0-84873382013 (DOI: 10.11213/tonyobyo.55.952, CiNii: 1390001204908494592, Elsevier: Scopus)
72.	Akio Kuroda, Tetsuyuki Yasuda, Mitsuyoshi Takahara, Fumie Sakamoto, Ryuichi Kasami, Kazuyuki Miyashita, Sumiko Yoshida, Eri Kondo, Ken-ichi Aihara, Itsuro Endo, Taka-Aki Matsuoka, Hideaki Kaneto, Toshio Matsumoto, Iichiro Shimomura and Munehide Matsuhisa : Carbohydrate-to-Insulin Ratio Is Estimated from 300-400 Divided by Total Daily Insulin Dose in Type 1 Diabetes Patients Who Use the Insulin Pump., Diabetes Technology & Therapeutics, Vol.14, No.11, 1077-1080, 2012. (Summary) Abstract Background: To optimize insulin dose using insulin pump, basal and bolus insulin doses are widely calculated from total daily insulin dose (TDD). It is recommended that total daily basal insulin dose (TBD) is 50% of TDD and that the carbohydrate-to-insulin ratio (CIR) equals 500 divided by TDD. We recently reported that basal insulin requirement is approximately 30% of TDD. We therefore investigated CIR after adjustment of the proper basal insulin rate. Subjects and Methods: Forty-five Japanese patients with type 1 diabetes were investigated during several weeks of hospitalization. The patients were served standard diabetes meals (25-30 kcal/kg of ideal body weight). Each meal omission was done to confirm basal insulin rate. Target blood glucose level was set at 100 and 150 mg/dL before and 2 h after each meal, respectively. After the basal insulin rate was fixed and target blood glucose levels were achieved, TBD, CIR, TDD, and their products were determined. Results: Mean (±SD) blood glucose levels before and 2 h after meals were 121±47 and 150±61 mg/dL, respectively. TDD was 31.5±9.0 U, and TBD was 27.0±6.5% of TDD. CIR×TDD of breakfast was significantly lower than those of lunch and supper (288±73 vs. 408±92 and 387±83, respectively; P<0.01). Conclusions: CIR has diurnal variance and is estimated from the formula CIR=300/TDD at breakfast or CIR=400/TDD at lunch and supper in type 1 diabetes patients. These results indicate that the insulin dose has been underestimated by using previously established calculations. (Link to Publication Site) ● Publication site (DOI): 10.1089/dia.2012.0109 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23101953 ● Search Scopus @ Elsevier (PMID): 23101953 ● Search Scopus @ Elsevier (DOI): 10.1089/dia.2012.0109 (DOI: 10.1089/dia.2012.0109, PubMed: 23101953)
73.	I Mohamed Husseiny, Akio Kuroda, N Alexander Kaye, Indu Nair, Fouad Kandeel and Kevin Ferreri : Development of a quantitative methylation-specific polymerase chain reaction method for monitoring beta cell death in type 1 diabetes., PLoS ONE, Vol.7, No.10, e47942, 2012. (Summary) DNA methylation is a mechanism by which cells control gene expression, and cell-specific genes often exhibit unique patterns of DNA methylation. We previously reported that the mouse insulin-2 gene (Ins2) promoter has three potential methylation (CpG) sites, all of which are unmethylated in insulin-producing cells but methylated in other tissues. In this study we examined Ins2 exon 2 and found a similar tissue-specific methylation pattern. These methylation patterns can differentiate between DNA from insulin-producing beta cells and other tissues. We hypothesized that damaged beta cells release their DNA into circulation at the onset of type 1 diabetes mellitus (T1DM) and sought to develop a quantitative methylation-specific polymerase chain reaction (qMSP) assay for circulating beta cell DNA to monitor the loss of beta cells. Methylation-specific primers were designed to interrogate two or more CpG in the same assay. The cloned mouse Ins2 gene was methylated in vitro and used for development of the qMSP assay. We found the qMSP method to be sensitive and specific to differentiate between insulin-producing cells and other tissues with a detection limit of 10 copies in the presence of non-specific genomic DNA background. We also compared different methods for data analysis and found that the Relative Expression Ratio method is the most robust method since it incorporates both a reference value to normalize day-to-day variability as well as PCR reaction efficiencies to normalize between the methylation-specific and bisulfite-specific components of the calculations. The assay was applied in the streptozotocin-treated diabetic mouse model and detected a significant increase in circulating beta cell DNA before the rise in blood glucose level. These results demonstrate that this qMSP assay can be used for monitoring circulating DNA from insulin-producing cells, which will provide the basis for development of assays to detect beta cell destruction in early T1DM. (Keyword) Animals / Base Sequence / Cell Death / DNA / DNA Methylation / Diabetes Mellitus, Type 1 / Exons / Insulin / Insulin-Secreting Cells / Mice / Mice, Inbred BALB C / Mice, Inbred NOD / Mice, SCID / Molecular Sequence Data / Polymerase Chain Reaction / Reproducibility of Results / Sequence Homology, Nucleic Acid (Link to Publication Site) ● Publication site (DOI): 10.1371/journal.pone.0047942 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23144715 ● Summary page in Scopus @ Elsevier: 2-s2.0-84868113134 (DOI: 10.1371/journal.pone.0047942, PubMed: 23144715, Elsevier: Scopus)
74.	Akio Kuroda and Munehide Matsuhisa : 血糖正常化 : カーボカウントを用いたアプローチ (特集血糖値の把握と正常化を目指して), Journal of the The Japan Diabetes Society, Vol.4, No.1, 78-84, 2012. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520291856194701184 (CiNii: 1520291856194701184)
75.	光井絵里, 山本恒彦, 安田哲行, 宮下和幸, 藤澤慶子, 藤木典隆, Akio Kuroda, 金藤秀明 and 下村伊一郎 : Two Cases of Type 1A Diabetes Associated with Diabetic Ketoacidosis and Thyrotoxicosis without Severe Hyperglycemia, Journal of the The Japan Diabetes Society, Vol.54, No.12, 916-921, 2011. (Summary) A 33-year-old woman who had suffered from thirst, polyposia, polyuria and body weight loss was admitted with diabetic ketoacidosis (DKA). Her plasma glucose level was mildly elevated (243 mg/d<i>l</i>), but the urinary ketone reaction was strongly positive. A 29-year-old woman who had suffered from slight fever, nausea and body weight loss was also admitted with DKA. Her plasma glucose level was moderately elevated (281 mg/d<i>l</i>), but the urinary ketone reaction was strongly positive. There seemed to be few symptoms, however thyrotoxicosis was suspected because of the low level of serum cholesterol and creatinine despite the dehydration. After the admission, painless thyroiditis and Basedow's disease were diagnosed based on the disease course, respectively. Thyrotoxicosis appeared to make a great contribution to ketone synthesis.<br> It is well known that autoimmune type 1 diabetes is closely associated with autoimmune thyroid disorder. In the case of DKA in type 1A diabetic patients with moderately elevated plasma glucose level and lower levels of serum cholesterol or creatinine as in these two cases, we should take concomitant thyrotoxicosis into consideration.<br> (Keyword) 糖尿病ケトアシドーシス / 1型糖尿病 / 甲状腺中毒症 / バセドウ病 / クレアチニン (Link to Publication Site) ● Publication site (DOI): 10.11213/tonyobyo.54.916 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390282679884881792 ● Summary page in Scopus @ Elsevier: 2-s2.0-84861357827 (DOI: 10.11213/tonyobyo.54.916, CiNii: 1390282679884881792, Elsevier: Scopus)
76.	Tetsuyuki Yasuda, Akio Kuroda, Tsunehiko Yamamoto, Mitsuyoshi Takahara, Toyoko Naka, Kazuyuki Miyashita, Keiko Fujisawa, Fumie Sakamoto, Naoto Katakami, Taka-Aki Matsuoka and Iichiro Shimomura : Subclinical hypothyroidism is independently associated with albuminuria in people with type 2 diabetes., Diabetes Research and Clinical Practice, 2011. (Summary) We examined a possible association between subclinical hypothyroidism and albuminuria in 159 people with type 2 diabetes. Patients with subclinical hypothyroidism had significantly higher levels of urinary albumin-to-creatinine ratio (UACR) than those with euthyroidism. Multivariate logistic regression analyses demonstrated that serum TSH level was an independent risk factor of albuminuria. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.diabres.2011.08.019 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21925759 ● Search Scopus @ Elsevier (PMID): 21925759 ● Search Scopus @ Elsevier (DOI): 10.1016/j.diabres.2011.08.019 (DOI: 10.1016/j.diabres.2011.08.019, PubMed: 21925759)
77.	坂本扶美枝, Akio Kuroda, 川嶋聡, 加藤研, 植田江梨子, 高原充佳, 宮下和幸, 嵩龍一, 安田哲行, 松岡孝昭, 種村匡弘, 伊藤壽記, 高原史郎, 山崎義光, Munehide Matsuhisa, 金藤秀明 and 下村伊一郎 : Pancreas after Kidney Transplant from Donor with Elevated Agonal HbA1c : A Case Report, Journal of the The Japan Diabetes Society, Vol.54, No.6, 417-424, 2011. (Keyword) 膵臓移植 / 腎移植[術] / 1型糖尿病 / インスリン分泌 (Link to Publication Site) ● Publication site (DOI): 10.11213/tonyobyo.54.417 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390001204906605952 ● Summary page in Scopus @ Elsevier: 2-s2.0-79960918086 (DOI: 10.11213/tonyobyo.54.417, CiNii: 1390001204906605952, Elsevier: Scopus)
78.	Shinsuke Koyama, Takuji Tomimatsu, Takeshi Kanagawa, Emiko Daimon, Tadashi Kimura, Akio Kuroda, Masahiro Tanemura, Yuichiro Doki and Toshinori Ito : Successful pregnancy after simultaneous pancreas-kidney transplantation from a brain-dead donor: The first case report in Japan., The Journal of Obstetrics and Gynaecology Research, Vol.37, No.11, 1711-1716, 2011. (Summary) Simultaneous pancreas-kidney transplantation is a revolutionary medical procedure to cure diabetes mellitus and its complications in one step. For women with type 1 diabetes mellitus and end-stage renal disease, this procedure not only treats their disease but may also allow them to have children. Worldwide, 77 pregnancies from 43 pancreas-kidney recipients have been reported. Here, we present the first case report of successful pregnancy after simultaneous pancreas-kidney transplantation from a brain-dead donor in Japan. She conceived spontaneously 32 months after transplantation. Her pregnancy course was favorable except for mild rejection of the grafted pancreas and development of gestational diabetes. She delivered a 2882-g healthy infant in October 2010. Pregnancy after simultaneous pancreas-kidney transplantation is discussed. (Link to Publication Site) ● Publication site (DOI): 10.1111/j.1447-0756.2011.01560.x (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21676071 ● Search Scopus @ Elsevier (PMID): 21676071 ● Search Scopus @ Elsevier (DOI): 10.1111/j.1447-0756.2011.01560.x (DOI: 10.1111/j.1447-0756.2011.01560.x, PubMed: 21676071)
79.	道倉雅仁, 柏瀬一路, 平尾円香, 佐藤まり恵, Akio Kuroda, 苅田真子, 田邊淳 and 佐藤秀幸 : 血管径が頸動脈洞のプラーク形成に与える影響について, Japanese Journal of Medical Ultrasonics, Vol.38, No.3, 267-272, 2011. (Keyword) ultrasound / carotid sinus / plaque / diameter / shear stress (Link to Publication Site) ● Publication site (DOI): 10.3179/jjmu.38.267 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390282680176402560 ● Search Scopus @ Elsevier (DOI): 10.3179/jjmu.38.267 (DOI: 10.3179/jjmu.38.267, CiNii: 1390282680176402560)
80.	Akio Kuroda, Hideaki Kaneto, Tetsuyuki Yasuda, Munehide Matsuhisa, Kazuyuki Miyashita, Noritaka Fujiki, Keiko Fujisawa, Tsunehiko Yamamoto, Mitsuyoshi Takahara, Fumie Sakamoto, Taka-Aki Matsuoka and Iichiro Shimomura : Basal Insulin Requirement Is ~30% of the Total Daily Insulin Dose in Type 1 Diabetic Patients, Who Use the Insulin Pump., Diabetes Care, Vol.34, No.5, 1089-1090, 2011. (Summary) OBJECTIVE To investigate the basal insulin requirement in total daily insulin dose in Japanese type 1 diabetic patients, who use the insulin pump. RESEARCH DESIGN AND METHODS The basal insulin requirement in 35 type 1 diabetic patients without detectable C-peptide using the insulin pump (Paradigm 712) was investigated during 2-3 weeks of hospitalization. The patients were served diabetic diets of 25-30 kcal/kg ideal body weight. Each meal omission was done to confirm stable blood glucose levels within 30 mg/dL variance until the next meal. Target blood glucose level was set at 100 mg/dL before each meal and 150 mg/dL at 2 h after each meal. RESULTS Total daily insulin dose was 31.6 ± 8.5 units, and total basal insulin requirement was 8.7 ± 2.9 units, which was 27.7 ± 6.9% of the total daily dose. CONCLUSIONS Basal insulin requirement is ∼30% of the total daily dose in Japanese type 1 diabetic patients, who use the insulin pump. (Link to Publication Site) ● Publication site (DOI): 10.2337/dc10-2149 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21430086 ● Search Scopus @ Elsevier (PMID): 21430086 ● Search Scopus @ Elsevier (DOI): 10.2337/dc10-2149 (DOI: 10.2337/dc10-2149, PubMed: 21430086)
81.	Tetsuyuki Yasuda, Hideaki Kaneto, Naoto Katakami, Akio Kuroda, Taka-Aki Matsuoka, Yoshimitsu Yamasaki, Munehide Matsuhisa and Iichiro Shimomura : YKL-40, a new biomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patients., Diabetes Research and Clinical Practice, Vol.91, No.2, e50-2, 2011. (Summary) The aim of this study was to examine the possible association between YKL-40, a new biomarker of endothelial dysfunction, and albuminuria in 180 type 2 diabetic patients. Multivariate logistic regression analyses demonstrated that serum YKL-40 level was a determinant of albuminuria independently of conventional risk factors. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.diabres.2010.11.015 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21159401 ● Search Scopus @ Elsevier (PMID): 21159401 ● Search Scopus @ Elsevier (DOI): 10.1016/j.diabres.2010.11.015 (DOI: 10.1016/j.diabres.2010.11.015, PubMed: 21159401)
82.	Ryuuichi Kasami, Hideaki Kaneto, Naoto Katakami, Satoru Sumitsuji, Keita Yamasaki, Tadashi Kuroda, Kouichi Tachibana, Tetsuyuki Yasuda, Akio Kuroda, Taka-Aki Matsuoka, Munehide Matsuhisa and Iichiro Shimomura : Relationship between carotid intima-media thickness and the presence and extent of coronary stenosis in type 2 diabetic patients with carotid atherosclerosis but without history of coronary artery disease., Diabetes Care, Vol.34, No.2, 468-470, 2011. (Summary) Our data suggest that max-IMT might be closely associated with the extent of coronary stenosis in type 2 diabetic patients without history of CAD but with carotid atherosclerosis. (Link to Publication Site) ● Publication site (DOI): 10.2337/dc10-1222 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21270201 ● Search Scopus @ Elsevier (PMID): 21270201 ● Search Scopus @ Elsevier (DOI): 10.2337/dc10-1222 (DOI: 10.2337/dc10-1222, PubMed: 21270201)

Academic Paper (Unrefereed Paper):

1.	Tomoharu Kawano, Munehide Matsuhisa, Seiichi Hashida, Satoshi Numata, Kazuyuki Fujimoto, Akio Kuroda, Tetsuyuki Yasuda, Kazuyuki Miyashita, Fumie Sakamoto, Naoto Katakami and Taka-aki Matsuoka : Development of highly sensitive enzyme immunoassay (ICT-EIA) for IA-2 autoantibody and application for detection of three islet-specific autoantibodies ( GADA, IA-2A and IAA) in type I diabetes mellitus, Research bulletin of Tokushima Bunri University, Vol.96, 35-44, 2018. (Summary) <p>Development of highly sensitive enzyme immunoassay (ICT-EIA) for IA-2 autoantibody and application for detection of three islet-specific autoantibodies ( GADA, IA-2A and IAA) in type I diabetes mellitus Tomoharu Kawano, Satoshi Numata, Yuki Fujimoto, Akio Kuroda, Tetsuyuki Yasuda,Kazuyuki Miyashita, Fumie Sakamoto, Naoto Katakami, Taka-aki Matsuoka, Munehide Matsuhisa and Seiichi Hashida Summary Detection of pancreatic islet-related autoantibodies( insulin antibody [IAA]; glutamic acid decarboxylase antibody [GADA]; and islet antigen-2 antibody [IA-2A], is essential for the diagnosis and prediction of the onset of type I diabetes mellitus. Depending on the disease duration, the detection rate of each autoantibody is different, and using only one kind of autoantibody detection risks overlooking a positive result. The detection precision of type I diabetes mellitus would thus be improved by measuring all three kinds of autoantibodies. We developed a highly sensitive enzyme immunoassay( ICT-EIA) for IA-2 autoantibody. ICT-EIAs for IAA and GADA have already been developed. Using three ICT-EIAs, we attempted to measure autoantibodies in sera from patients with type I diabetes mellitus. Patients comprised 25 males and 51 females( mean age, 33.3±5.7 years; disease duration, 23.9±6.7 years) with type I diabetes mellitus who had been undergoing treatment with insulin for between 11 and 40 years. Among these patients, urinary C-peptide-positive results were seen in three patients. IAA, GADA and IA-2A in sera were measured by ICT-EIA. The newly developed ICT-EIA for IA-2 antibodies was approximately 100-times more sensitive than the conventional ELISA. The positive ratio was 77.6%, representing a high rate of detection. In addition, even in patients with a disease duration >30 years, the positive rate was 64.3%. ICT-EIA was thus suggested to be useful in combination assays for pancreatic islet-related autoantibodies (IAA, GADA and IA-2A).</p><p> </p><p></p> (Link to Publication Site) ● Publication site (DOI): 10.24596/tokusimabunriu.96.0_35 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390001288124302336 ● Search Scopus @ Elsevier (DOI): 10.24596/tokusimabunriu.96.0_35 (DOI: 10.24596/tokusimabunriu.96.0_35, CiNii: 1390001288124302336)

Review, Commentary:

1.	Akio Kuroda : HbA1cだけではない血糖コントロールの実践, 臨床雑誌内科 [特集]患者の将来を見据えた実践的糖尿病診療, Vol.133, No.5, 1080-1083, May 2024.
2.	Akio Kuroda : 糖尿病患者が大酒家だったら血糖だけにこだわらない!, 糖尿病治療薬の考え方・使い方, Nov. 2023.
3.	Akio Kuroda and Munehide Matsuhisa : 1型糖尿病における強化インスリン療法の実際, 糖尿病・内分泌代謝内科特集成人1型糖尿病の成員, 診断, 治療アップデート, Vol.57, No.4, 433-438, Oct. 2023.
4.	Akio Kuroda and Munehide Matsuhisa : カーボカウント最前線, 別冊医学のあゆみ 1型糖尿病―診療と研究の最前線, 20-33, Mar. 2023.
5.	Akio Kuroda and Munehide Matsuhisa : 糖尿病合併症妊娠に対する食事療法とインスリン療法, 月刊糖尿病#149, Vol.59, No.2, 36-41, Feb. 2023.
6.	Akio Kuroda : 新しい血糖コントロールを考えた注射薬による治療, BIO Clinica 新しい血糖コントロールの考え方と治療薬, Vol.37, No.10, 12-17, Sep. 2022.
7.	Akio Kuroda : CGMまるわかりQ&A, 糖尿病ケア糖尿病スタッフのスキルにプラスを届ける専門誌, Vol.19, No.5, 37-42, Sep. 2022.
8.	Akio Kuroda, 鈴木麗子, 冨永ゆかり, Hiroyasu Mori, 岡本美鈴 and Munehide Matsuhisa : 1 か月で 23 回インスリンポンプ注入が 3 時間以上中断しており，ケトアシドーシス症状を繰り返していた 1 型糖尿病の一例, 第22回日本糖尿病インフォマティクス学会年次学術集会, Aug. 2022.
9.	Akio Kuroda : ハイブリッドクローズドループインスリンポンプ療法, 糖尿病と代謝(DIABETES JOURNAL), Vol.49, No.3, 112-115, Jul. 2022.
10.	Akio Kuroda and Munehide Matsuhisa : カーボカウント最前線, Journal of Clinical and Experimental Medicine, Vol.281, No.6, 606-611, May 2022. (Keyword) カーボカウント / 糖質 / 経験則 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520292182357377024 (CiNii: 1520292182357377024)
11.	Akio Kuroda and Munehide Matsuhisa : Continuous Glucose Monitoring(CGM), 日本医師会雑誌内分泌疾患・糖尿病・代謝疾患-診療のエッセンス- 150特別号, No.2, S262-S264, 2021.
12.	Akio Kuroda and Munehide Matsuhisa : 1型糖尿病のインスリン療法, 2型と何が違う?, レジデント#132, Vol.14, No.2, 61-67, Jul. 2021.
13.	Akio Kuroda : 最新のインスリン療法―コツとテクニック, 糖尿病プラクティス, Vol.38, No.3, 292-295, May 2021. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1524232505871246208 (CiNii: 1524232505871246208)
14.	Akio Kuroda : CGM・FGM使用下でおこるおもなトラブルとその対応, Calm(Approach to Glycemic Variations), Vol.8, No.1, 10-14, Feb. 2021. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1522543656024112640 (CiNii: 1522543656024112640)
15.	Akio Kuroda and Munehide Matsuhisa : 1型糖尿病の移行期医療, Journal of Clinical and Experimental Medicine, Vol.276, No.5, 550-552, Jan. 2021. (Keyword) 1型糖尿病 / 移行期医療 / 小児慢性特定疾病 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520010381311915520 (CiNii: 1520010381311915520)
16.	Akio Kuroda : 特集◎思いを叶える健康生活血糖値が高いと言われたら, いのち輝く, No.96, 2-5, Jan. 2021.
17.	Akio Kuroda and Munehide Matsuhisa : 将来のCGMはどうなりますか?, Modern Physician 新興医学出版社, Vol.40, No.2, 166-168, Jul. 2020. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1523669554572096768 (CiNii: 1523669554572096768)
18.	Akio Kuroda and Munehide Matsuhisa : 解説&症例でわかるCSII, 月刊糖尿病ケア株式会社メディカ出版, Vol.17, No.8, 37-40, Jul. 2020.
19.	Akio Kuroda : CGMセンサーによる皮膚トラブルとその対処も含めて, 糖尿病療養指導のためのDM Ensemble 特集血糖変動をどうみるか∼CGM,FGMの活用方法を探る∼ (公社)日本糖尿病協会, Vol.8, No.3, 30-32, 2019.
20.	Akio Kuroda and Munehide Matsuhisa : 実践カーボカウント, 月刊糖尿病ライフ日本糖尿病協会, Vol.59, No.10, 34-38, 2019.
21.	Akio Kuroda : DexcomG4からG6まで, 週刊日本医事新報3月4週号 No4952 39-42 2019.3.23, No.4952, 39-42, Mar. 2019.
22.	Munehide Matsuhisa and Akio Kuroda : 携帯型人工膵臓 Closed-loop insulin delivery systemの現状, Diabetes Journal, Vol.47, No.1, 29-33, Mar. 2019.
23.	Akio Kuroda : 1型糖尿病に対する食事指導のコツ, Modern Physiciam(別冊), Vol.39, No.1, 93-96, Jan. 2019.
24.	Akio Kuroda : Closed-loop control without meal announcement in type 1 diabetes, 糖尿病の最新治療, Vol.9, No.2, 86-87, Mar. 2018.
25.	Akio Kuroda : スマートポンプの可能性, 糖尿病の最新治療, Vol.9, No.2, 80-85, Mar. 2018. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520573331177129600 (CiNii: 1520573331177129600)
26.	Akio Kuroda : カーボカウントを活用する, 診断と治療, Vol.106, No.3, 357-361, Mar. 2018. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1521980705543976704 (CiNii: 1521980705543976704)
27.	Akio Kuroda : Real-time CGM, Endocrinology, Diabetology & Metabolism, Vol.46, No.2, 104-107, Feb. 2018. (Keyword) Real-time CGM / Insulin Pump / Flash Glucose Monitoring (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1523388079710992000 (CiNii: 1523388079710992000)
28.	Akio Kuroda : 米国で販売が開始された第一世代closed loop機器の実際, Practice, Vol.35, No.1, 38-43, Jan. 2018.
29.	Akio Kuroda : ノンクティカルケアにおける人口膵臓を用いた血糖コントロール, Diabetes Startegy, Vol.8, No.4, 158-159, 2018.
30.	Akio Kuroda : 人工臓器の最近の進歩とケアリング, 人工膵臓の最前線とその展望, Vol.73, No.5,6, 221-226, Dec. 2017.
31.	Akio Kuroda : 糖質制限食の適応を考える, The Japanese Journal of Clinical Nutrition, Vol.131, No.7, 911-917, Dec. 2017.
32.	Akio Kuroda : FGM導入時の注意点を教えてください, Calm, Vol.4, No.2, 22-25, Jul. 2017.
33.	Akio Kuroda : 成人2型糖尿病とこう違う!トコトンわかる1型糖尿病, 糖尿病ケア, Vol.14, No.8, 14-19, Jul. 2017.
34.	Akio Kuroda and Munehide Matsuhisa : 低血糖の対策を今一度考える, DIABETES UPDATE, Vol.6, No.3, Jul. 2017.
35.	Akio Kuroda : 1型糖尿病講義編:1型糖尿病+インスリン=健常人, べんちのーと, Vol.27, No.4, 16-17, Mar. 2017.
36.	Akio Kuroda : 食品交換表にadd-onするカーボカウント, 糖尿病診療マスター, Vol.15, No.3, 246-248, Mar. 2017.
37.	Akio Kuroda : インスリンポンプ療法の現状と展望, Medical View Point, Vol.38, No.2, 3, Feb. 2017.
38.	Akio Kuroda : 患者目線のICT医療, 月刊糖尿病, Vol.9, No.1, 106-109, Jan. 2017.
39.	Akio Kuroda : インスリンポンプ治療の進歩と今後の展望, 糖尿病診療マスター, Vol.14, No.12, 932-936, Dec. 2016.
40.	Akio Kuroda : 薬物療法トピックス③:SAP療法は究極のインスリン治療になるか, Medical Tribune, Vol.49, No.43, 7, Nov. 2016.
41.	Akio Kuroda : 2型糖尿病のインスリン療養にカーボカウントをどこまで応用するか, Medical View Point, Vol.36, No.12, 4, Nov. 2016.
42.	Akio Kuroda : カーボカウント, 内分泌・糖尿病・代謝内科, Vol.43, No.3, 254-258, Sep. 2016.
43.	Akio Kuroda and Munehide Matsuhisa : 低血糖を防ぐ∼これからの治療∼, 月刊糖尿病, Vol.8, No.9, 89-93, Sep. 2016.
44.	Akio Kuroda and Munehide Matsuhisa : 低血糖への恐怖(fear of hypoglycemia)をのりこえるために, 糖尿病診療マスター, Vol.14, No.8, 616-621, Aug. 2016.
45.	Hiroyasu Mori, 鈴木麗子, Akio Kuroda, Motoyuki Tamaki, 明比祐子, Munehide Matsuhisa, Michiko Araki and Hiroshi Sakaue : 1型糖尿病患者における皮下蓄積AGEsとサルコペニアとの関連の検討, The Journal of Adult Diseases, Vol.46, No.5, 608-609, May 2016.
46.	Akio Kuroda : 1型運尿病へのSAP療法の適応と導入時の注意点, 週刊医事新報, 60-61, Feb. 2016.
47.	Akio Kuroda : 血糖変動への新たなアプローチ, Calm, Vol.3, No.1, 2-6, Jan. 2016.
48.	Akio Kuroda : リアルタイムCGMとSAP, DITN, No.444, 2015.
49.	Akio Kuroda : カーボカウント法の実際と1型糖尿病治療における実践, 新薬と牀床, Vol.64, No.12, 1515-1519, Dec. 2015.
50.	Akio Kuroda : 2型糖尿病のインスリン療法にカーボカウントをどこまで応用するか, メディカルビューポイント, Vol.36, No.12, Dec. 2015.
51.	Akio Kuroda : 欧米におけるSAPならびにclosed loopに向けての取り組みの現状, Practice, Vol.32, No.6, 693-696, Nov. 2015.
52.	Akio Kuroda and Munehide Matsuhisa : 血糖変動を安定させることについて, 糖尿病ケア, Vol.12, No.11, 23-27, Nov. 2015.
53.	Akio Kuroda and Munehide Matsuhisa : カーボカウントの基本と臨床での適応例, 最新インスリン療法:改訂第2版, 240-247, May 2015.
54.	Akio Kuroda and Munehide Matsuhisa : 1食に含まれる糖質量をおおまかに計算する方法はあるの?, Nutrition Care, Vol.8, No.5, 49-51, May 2015. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520854806141714176 (CiNii: 1520854806141714176)
55.	Akio Kuroda and Munehide Matsuhisa : インスリンが効きやすい日と効きにくい日があるの?, Nutrition Care, Vol.8, No.5, 46-48, May 2015. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1523951030884715392 (CiNii: 1523951030884715392)
56.	Akio Kuroda and Munehide Matsuhisa : 運動するときのカーボカウントはどうするの?, Nutrition Care, Vol.8, No.5, 44-45, May 2015.
57.	Akio Kuroda : 食事療法を理解する, Diabetes Horizons, Vol.4, No.2, 34-38, Apr. 2015.
58.	Akio Kuroda and Munehide Matsuhisa : 持続皮下イインスリン注入療法(CSⅡ)の実際, 糖尿病治療のニューパラダイム, Vol.3, 79-85, Mar. 2015.
59.	Munehide Matsuhisa and Akio Kuroda : CSⅡ(持続皮下注入療法)の進歩最新の糖尿病の実地日常診療, Medical Practice, Vol.32, No.1, 114-116, Jan. 2015.
60.	Akio Kuroda : カーボカウントのメリットは何?, メディカ出版, Vol.11, No.12, 22-23, Dec. 2014.
61.	Akio Kuroda : 発症時の対処法を考える自動車の運転前は特に慎重に:特集低血糖を起こさない糖尿病管理, 日経BP社, 18-19, Aug. 2014.
62.	Akio Kuroda : 1型糖尿病における運動の意義と注意点最終回, 株式会社メディカル・ジャーナル社, No.435, Jun. 2014.
63.	Akio Kuroda : 1型糖尿病における運動の意義と注意点, 株式会社メディカル・ジャーナル社, No.422, May 2014.
64.	Akio Kuroda : 1型糖尿病を生きる, 糖尿病診療マスター, Vol.3, No.4, 320-322, Apr. 2014.
65.	Akio Kuroda and Munehide Matsuhisa : カーボカウント, 中山書店, Mar. 2014.
66.	Akio Kuroda and Munehide Matsuhisa : カーボカウント, Nutrition Care, 64-70, Jan. 2014.
67.	Akio Kuroda and Munehide Matsuhisa : 低血糖リスクを減じる糖尿病治療の実際, Practice, Vol.31, No.1, 83-88, Jan. 2014.
68.	鈴木麗子, 大和光, Kazuyoshi Kawazoe, Ken-ichi Aihara, Itsuro Endo, 安芸菜奈子, 倉橋清衛, Toshio Matsumoto, Akio Kuroda and Munehide Matsuhisa : インスリン注射により生じた皮下硬血を有する患者の実態調査とその介入の有用性の検討, Practice, Vol.31, No.6, 815-821, 2014.
69.	Akio Kuroda and Munehide Matsuhisa : 糖尿病薬物治療における低血糖回避の試みー最近の進歩④CSⅡの新時代, Diabetes Frontier, Vol.25, No.4, 465-471, 2014.
70.	Akio Kuroda and Munehide Matsuhisa : カーボカウントの考え方と実践, 糖尿病治療のニューパラダイム, Vol.1, 158-162, 2014.
71.	Akio Kuroda and Munehide Matsuhisa : 食事療法を見直す実践カーボカウントはこうして行う, Diabetes Frontier, Vol.24, No.1, 82-86, 2013.
72.	Akio Kuroda and Munehide Matsuhisa : 総解1型糖尿病いまさら聞けない2型糖尿病との違い食事療法における違い, 糖尿病ケア, Vol.10, No.2, 131-134, 2013. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520854806131708416 (CiNii: 1520854806131708416)
73.	Akio Kuroda and Munehide Matsuhisa : SMBG記録と食事記録の方法:はじめてのカーボカウント教室ポイントを知って明日からチャレンジ, 糖尿病ケア, Vol.10, No.1, 38-41, 2013. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520854806135995520 (CiNii: 1520854806135995520)
74.	Akio Kuroda : 第3回減らすカーボカウントー応用カーボカウントを利用して減量しようー, Practice, Vol.30, No.6, 689-690, Nov. 2013.
75.	Akio Kuroda : インスリン注射のコツ∼1型糖尿病患者の外食へのロードマップ∼第三回外食での応用その2∼ラーメン∼, 株式会社メディカル・ジャーナル社, No.427, Oct. 2013.
76.	Akio Kuroda : 第2回食品交換表に基づく2型糖尿病患者へのカーボカウントー適切な糖質量を摂取しようー, Practice, Vol.30, No.5, 549-552, Sep. 2013.
77.	Akio Kuroda and Munehide Matsuhisa : 膵臓移植の説明, 週刊日本医事新報特集号, No.4666, 120-123, Sep. 2013.
78.	Akio Kuroda and Munehide Matsuhisa : 食品交換表とカーボカウント, 糖尿病ケア, 162-168, Sep. 2013.
79.	Akio Kuroda : インスリン注射のコツ∼1型糖尿病患者の外食へのロードマップ∼第二回:外食での応用その1∼焼肉や宴会に行くとき∼, 株式会社メディカル・ジャーナル社, No.425, Aug. 2013.
80.	Akio Kuroda : 適正な糖質摂取比率は?, Practice, Vol.30, No.4, 407-409, Jul. 2013.
81.	Akio Kuroda : インスリン注射のコツ∼1型糖尿病患者の外食へのロードマップ∼第一回, 株式会社メディカル・ジャーナル社, No.422, May 2013.
82.	Akio Kuroda : 1型糖尿病と外食, 看護の科学社, Vol.38, No.5, 28-31, May 2013. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1522543654721537280 (CiNii: 1522543654721537280)
83.	Akio Kuroda and Munehide Matsuhisa : 糖質制限食をめぐって:カーボカウントの理論と実際ならびにその新たな展開, 糖尿病別冊, Vol.3, 72-76, May 2013. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1521417756103407488 (CiNii: 1521417756103407488)
84.	Akio Kuroda : 脳内すい移植2012 ∼自分の生活に合わせてインスリンを上手く使いこなそう∼, 月刊糖尿病ライフさかえ, Vol.53, No.4, p40-40, Apr. 2013.
85.	Akio Kuroda : 脳内すい移植2012 ∼自分の生活に合わせてインスリンを上手く使いこなそう∼, 株式会社メディカルジャーナル社, No.418, 4-5, Jan. 2013.
86.	Akio Kuroda and Munehide Matsuhisa : カーボカウントの理論と実際医師の立場からのカーボカウントの実際について, 糖尿病の療養指導2012, 97-101, 2012.
87.	Munehide Matsuhisa and Akio Kuroda : 追加インスリンで始める患者の臨床像と注意点:2型糖尿病のインスリン療法, 月刊糖尿病, Vol.4, No.10, 35-42, 2012. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520854806149458816 (CiNii: 1520854806149458816)
88.	Akio Kuroda and Munehide Matsuhisa : 糖尿病合併妊娠における血糖管理の最適化, 糖尿病と妊娠, Vol.12, No.1, 35-39, 2012.
89.	Akio Kuroda and Munehide Matsuhisa : 特殊な状況での糖尿病管理についての疑問ーインスリンの上手な使い方・膵全摘術時，ステロイド使用時，妊婦さん，シックデイ，1型糖尿病のとき, 増刊レジデントノート, Vol.14, No.8, 92-97, 2012.
90.	Akio Kuroda and Munehide Matsuhisa : インスリンポンプ療法の現状と将来, Diabetes Journal, Vol.40, No.2, 102-107, 2012.
91.	Akio Kuroda and Munehide Matsuhisa : 糖尿病における膵島破壊と再生機転, 再生医療叢書, 2-8, Oct. 2012.
92.	Munehide Matsuhisa and Akio Kuroda : Pharmacokinetic characteristics and clinical indication of insulin analogues, Nihon Rinsho. Japanese Journal of Clinical Medicine, Vol.70, No.3, 658-663, May 2012. (Keyword) 超速効型インスリン / 時効型インスリン / 超時効型インスリン / 頻回インスリン療法 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22768594 ● CiNii @ National Institute of Informatics (CRID): 1522262180490112896 ● Summary page in Scopus @ Elsevier: 2-s2.0-84868659724 (PubMed: 22768594, CiNii: 1522262180490112896, Elsevier: Scopus)
93.	Akio Kuroda and Munehide Matsuhisa : Medical nutrition therapy using food exchange list and carbohydrate counting, Nihon Rinsho. Japanese Journal of Clinical Medicine, Vol.70, No.3, 754-758, May 2012. (Keyword) 食事療法 / カーボカウント / 食品交換表 / 食後血糖値 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22768611 ● CiNii @ National Institute of Informatics (CRID): 1522825130113812992 ● Summary page in Scopus @ Elsevier: 2-s2.0-84868641272 (PubMed: 22768611, CiNii: 1522825130113812992, Elsevier: Scopus)
94.	Akio Kuroda and Munehide Matsuhisa : カーボカウントの有効な活用法, 別冊プラクティス, 64-70, Mar. 2012.
95.	Akio Kuroda and Munehide Matsuhisa : 食事療法, The Japanese journal of clinical and experimental medicine, Vol.89, No.1, 39-42, Jan. 2012.
96.	Akio Kuroda and Munehide Matsuhisa : 重症低血糖に対する対処法と注意点, Diabetes Frontier, Vol.6, No.22, 624-628, Dec. 2011.
97.	Akio Kuroda : 1型糖尿病医療30年の変遷, DITN, No.405, Dec. 2011.
98.	Akio Kuroda : 1型糖尿病でも夢を諦めない!∼レーシングドライバー・チャーリーキンボールに聞く∼, DITN, No.405, 2-3, Dec. 2011.
99.	Munehide Matsuhisa and Akio Kuroda : コントロール指標2:GA vs HbA1c, 月刊糖尿病:1型糖尿病の臨床に基づいた診断と治療, Vol.3, No.12, 55-66, Oct. 2011.
100.	Akio Kuroda and Munehide Matsuhisa : 食品交換表とカーボカウントの融合ーカーボカウントの実践, 糖尿病の療養指導2011, 66-70, Sep. 2011.
101.	Akio Kuroda and Munehide Matsuhisa : 糖尿病食事療法-個別化・多様化するニーズへの対応「カーボカウントティング法の実践応用」, Practice, Vol.28, No.5, 493-499, Sep. 2011.
102.	Akio Kuroda and Munehide Matsuhisa : カーボカウンティング法の実践応用, Practice, Vol.28, No.5, 493-499, Sep. 2011.
103.	Akio Kuroda and Munehide Matsuhisa : 糖尿病腎症見える化シート, 糖尿病ケア2011年秋季増刊, 156-159, Sep. 2011.
104.	Munehide Matsuhisa and Akio Kuroda : 透析になったら何がどうなる?∼生活・症状∼, 糖尿病ケア2011秋季増刊, 160-163, Sep. 2011.
105.	Akio Kuroda and Munehide Matsuhisa : 妊娠時のカーボカウントを用いた血糖管理, 糖尿病と妊娠, Vol.11, No.1, 41-46, Aug. 2011.
106.	Akio Kuroda and Munehide Matsuhisa : 1型糖尿病へのインスリンポンプ導入の実際と治療効果, Endocrinology, Diabetology & Metabolism, Vol.32, No.6, 581-587, Jun. 2011. (Keyword) insulin pump therapy / basal insulin / bolus insulin / temporary basal rate / carbohydrate counting (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1522262179766794368 (CiNii: 1522262179766794368)
107.	Akio Kuroda and Munehide Matsuhisa : -, 最新インスリン療法, 216-221, Jun. 2011.

Proceeding of International Conference:

1.	Hiroki Yamagami, Tomoyo Hara, Yukari Mitsui, Shiho Masuda, Kiyoe Kurahashi, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : Analysis of clinical factors involved in AGE accumulation in people with type 2 diabetes, IDF-WPR Congress 2023/15th Scientific Meeting of AASD, Jul. 2023.
2.	Yosuke Kaneko, Saya Yasui, Minae Hosoi, Akihiro Tani, Hiroki Yamagami, Hiroyasu Mori, Tomoyo Hara, Yukari Mitsui, Kiyoe Kurahashi, Sumiko Yoshida, Shingen Nakamura, Akio Kuroda, Toshiki Otoda, Tomoyuki Yuasa, Itsuro Endo, Takeshi Soeki, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : Dehydroepiandrosterone sulfate and skeletal muscle disorders in patients with type 2 diabetes, IDF-WPR Congress 2023/15th Scientific Meeting of AASD, Tokyo, Jul. 2023.
3.	Tomoyo Hara, Hiroki Yamagami, Yukari Mitsui, Shiho Masuda, Kiyoe Kurahashi, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : Clinical factors and glycemic control in Japanese people with type 2 diabetes treated with weekly Dulaglutide at a dose of 0.75 mg, IDF-WPR Congress 2023/15th Scientific Meeting of AASD, Jul. 2023.
4.	Akio Kuroda and Munehide Matsuhisa : isCGM scan frequency and exploring correlated factors: Post hoc Analysis of the ISCHIA Study, 2nd Annual Advances Hypoglycaemia Scientific Conference Virtual meeting 2022, Dec. 2022.
5.	Shiho Masuda, Tomoyo Hara, Hiroki Yamagami, Mitsui Yukari, Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Shingen Nakamura, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : Evaluation of Vascular Function for Prediction of Renal Prognosis in Japanese Patients with Lifestyle-Related Diseases, The 29th Scientific Meeting of the International Society of Hypertension, Oct. 2022.
6.	Tomoyo Hara, Mitsui Yukari, Masuda Shiho, Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : Plasma heparin cofactor activity is inversely associated with the development NAFLD in patients with diabetes, American Diabetes Association 82nd Scientific Sessions, Jun. 2022.
7.	Tomoyo Hara, Mitsui Yukari, Masuda Shiho, Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : Heparin cofactor II prevents the development of albuminuria in patients with diabetes, EASD 2021 57th Annual Meeting, Sep. 2021.
8.	Akio Kuroda, Misuzu Yamada, Asami Okada, Yukari Tominaga, Kyoka Joh, Natsuki Ohrei, Hiroyasu Mori and Munehide Matsuhisa : Circulating cell free DNA and its clinical application, The 15th Symposium of the Institute Network for Biomedical Sciences, Nov. 2020.
9.	Tomoyo Hara, H Yamagami, Y Mitsui, S Masuda, Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : Plasma heparin cofactor activity is inversely associated with the development NAFLD in patients with diabetes, American Diabetes Association 80th Scientific Session, Chicago, Jun. 2020.
10.	Murata Tskashi, Suzuki Shota, Sakane Naoki, Nishimura Kunihiro, Toyoda Masao, Hirota Yushi, Munehide Matsuhisa, Akio Kuroda, Kato Ken, Kouyama Ryuji, Miura Junnosuke, Tone Atsuhito, Suganuma Akiko, Tomita Tsutomu, Noguchi Michio, Son Cheol, Ito Yukie, Kasama Shu, Satoh-asahara Noriko, Miyamoto Yoshihiro and Hosoda Kiminori : Effect of Intermittent-scanning CGM to glycemic control including hypoglycemia and quality of life of patients with type 1 diabetes mellitus (ischia study): study design., The 13th International Conference on Advanced Technologies & Treatments for Diabetes, Feb. 2020.
11.	Misuzu Yamada, Akio Kuroda, Yukari Tominaga and Munehide Matsuhisa : Verification of Pancreatic β Cell Injury Detection Method Using Serum cfDNA, 55th EASD Annual Meeting, Sep. 2019.
12.	Masao Toyoda, Atsuhito Tone, Ken Kato, Moritsugu Kimura, Satoshi Kawashima, Hideaki Sawaki, Yushi Hirota, Akira Okada, Akio Kuroda, Munehide Matsuhisa, Tomokazu Watanabe, Akiko Suganuma, Takashi Murata and Naoki Sakane : Development and Validation of the Continuous Subcutaneous Insulin Infusion-Related Quality of Life (CSIL-QOL) Scale, American Diabetes Association 79th Scientific Sessions, Jun. 2019.
13.	Akio Kuroda, Misuzu Yamada, Yuichi Takashi, Mami Ohishi, Hiroyasu Mori, Masashi Ishizu, Reiko Suzuki, Yinhua Otsuka, Yukari Tominaga and Munehide Matsuhisa : Detection of Vascular Endothelial Cell DNA in the Circulation Using Dual Amplification Refractory Mutation System PCR., American Diabetes Association 79th Scientific Sessions, San Francisco, Jun. 2019.
14.	Yumi Kuwamura, Sumiko Yoshida, Kiyoe Kurahashi, Masuko Sumikawa, Eijiro Sakamoto, Akio Kuroda, Hikari Yamato, Misuzu Okamoto, Hirokazu Uemura, Daisuke Hinode, Hiromichi Yumoto, Ken-ichi Aihara, Makoto Funaki, Munehide Matsuhisa, Itsuro Endo and Sachi Kishida : Oral health behaviors of outpatients with diabetes based on the Revised Diabetes Oral Health Assessment Tool for nurses, Journal of Diabetes Investigation, Vol.10, No.Supplement1, 26, Sendai-City, Miyagi Prefecture, May 2019. (Keyword) oral health behaviors / diabetes nursing / assessment
15.	Akio Kuroda : Sensor-Augmented insulin pump, 18th ISPAD Science School for Physicians 2018 Shonan Village Center, Kanagawa, 2018.
16.	Akio Kuroda, Misuzu Yamada, Yukari Tominaga, Reiko Suzuki, Motoyuki Tamaki, Yuko Akehi, Yuichi Takashi, Daisuke Otsuka, Eisuke Shimokita, Fuminori Tanihara, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe, Kevin Ferreri and Munehide Matsuhisa : Detection of pancreatic beta cell DNA in the circulation using the amplification refractory mustation system PCR, American Diabetes Association 78th Scientific Sessions, Orlando, Jun. 2018.
17.	Munehide Matsuhisa, Hiroyasu Mori, Mami Ohishi, Masashi Ishizu, Reiko Suzuki, Ineko Takikawa, Satoshi Taniguchi, Motoyuki Tamaki, Yuko Akehi, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki and Akio Kuroda : The risk factors for rapid decline of renal function in Japanese patients with diabetes mellitus, American Diabetes Association 78th Scientific Sessions, Orlando, Jun. 2018.
18.	Sumiko Yoshida, Kiyoe Kurahashi, Akio Kuroda, Itsuro Endo, Ken-ichi Aihara, Seiji Fukumoto, Munehide Matsuhisa and Masahiro Abe : Changes of oxidative stress markers in patient of diabetes educational hospitalization., The Endocrine Society's Annual Meeting 2018, Chicago, Mar. 2018.
19.	Kana Morimoto, Masuda Shiho, Kiyoe Kurahashi, Motoyuki Tamaki, Takeshi Kondo, Sumiko Yoshida, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Akehi Yuko, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa and Ken-ichi Aihara : Identification of clinical determinants for coefficient of variation of - intervals in patients with type 2 diabetes., International Conference on Diabetes and Its Complications 2017, Baltimore, Nov. 2017. (Keyword) therapy / 合併症
20.	Kana Morimoto, Kiyoe Kurahashi, Takeshi Kondo, Sumiko Yoshida, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : Analysis of sodium restriction-induced blood pressure reduction in hospitalized patients with type 2 diabetes mellitus, The 10th Congress of the Asian-Pacific Society of Atherosclerosis and Vascular Diseases, Tokyo, Jul. 2016.
21.	Akio Kuroda, J Temma, T Horie, Hiroyasu Mori, Motoyuki Tamaki, Ken-ichi Aihara and Munehide Matsuhisa : Noninvasive measurement of skin autofluorescence as a beneficial surrogate marker for atherosclerosis in patients with type 2 diabetes, American Diabetes Association 75th Scientific Sessions, 2015.
22.	A King, Akio Kuroda and Munehide Matsuhisa : Combined Japanese and American prospective studies of dosing factor interrelationships support changing the current dosing recommendation for pump-treated T1DM, American Diabetes Association 74th Scientific Sessions, Jun. 2014.
23.	Akio Kuroda, 鶴尾美穂, Takeshi Kondo, 安芸奈菜子, 大黒由加里, Itsuro Endo, Ken-ichi Aihara, Motoyuki Tamaki, Toshio Matsumoto and Munehide Matsuhisa : Comparison of insulin Glargine with Insulin Degludec in Type 1 Diabetes Patients., 第74回アメリカ糖尿病学会, Jun. 2014.
24.	Akio Kuroda and Munehide Matsuhisa : Estimated glomerular filtration rate is the determinant of extended bolus insulin duration time of insulin pump., 7th International Conference on advanced technologies & Treatments for Diabetes., Feb. 2014.
25.	Akio Kuroda, Takeshi Kondo, Ken-ichi Aihara, Itsuro Endo, T Yasuda, H Kaneto, T Matsuoka, Toshio Matsumoto and Munehide Matsuhisa : The characteristics of type 1 diabetes patients who use insulin pump with square-wave bolus insulin., 73th America Diabetes Association (poster), Jun. 2013.
26.	Ken-ichi Aihara, Sumiko Yoshida, Mizuho Kinouchi, Takeshi Kondo, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto : Diabetes Spoils the Favorable Effect of HDL-Cholesterol on Endothelial Function in the Elderly with Cardiovascular Risk Factors, American Heart Association Scientific Sessions 2012, ロサンゼルス, Nov. 2012.
27.	Akio Kuroda and Munehide Matsuhisa : Basal insulin requirement is approximately 30% of the total daily insulin dose in type 1 diabetic patients who use the insulin pump, 1st Annual World Congress of Diabetes 2012 Symposium, Jun. 2012.
28.	Akio Kuroda, YASUDA TETSUYUKI, TAKAHARA MITSUYOSHI, SAKAMOTO FUMIE, KASAMI RYUUICHI, MIYASHITA KAZUYUKI, MATSUOKA TAKA-AKI, Sumiko Yoshida, KONDO ERI, Itsuro Endo, Ken-ichi Aihara, KANETO HIDEAKI, Toshio Matsumoto, SHIMOMURA IICHIRO and Munehide Matsuhisa : Carbohydrate-to-Insulin Ratio is Calculated to be 300-400 Divided by Total Daily Insulin Dose in Type 1 Diabetic Patients Who Are on Insulin Pump Therapy, American Diabetes Association 72nd Scieentific Sessions, Philadelphia, Jun. 2012.
29.	Akio Kuroda, Munehide Matsuhisa, M. Takahara, T. Yasuda, R. Kataoka, R. Kasami, F. Sakamoto, T.-A. Matsuoka, H. Kaneto and I. Shimomura : Acetaminophen and eGFR are useful clinical markers for determining bolus insulin duration time in type 1 diabetic patients using insulin pump, Advanced Technologies & Treatments for Diabetes, Feb. 2012.
30.	K Fujisawa, T Yasuda, H Kaneto, Munehide Matsuhisa, Akio Kuroda, R Kasami, M Tsuji, I Shimomura, T Sato, S Okada, K Hagino, Y Kikkawa, J Kojima, T Watanabe and H Nakajima : Measurement of Glucose Area under the Curve Using Minimally Invasive Interstitial Fluid Extraction: Use in Evaluation of Drug Efficacy, The 16th Japan-Korea Symposium on Diabetes Mellitus, Oct. 2011.

Proceeding of Domestic Conference:

1.	Masashi Ishizu, Akio Kuroda, 鈴木麗子 and Munehide Matsuhisa : 心電図異常における糖尿病の意義の検討 -令和3年度徳島県市町村国保特定健診・後期高齢者医療健診データの解析結果-, 第24回日本糖尿病インフォマティクス学会年次学術集会, Aug. 2024.
2.	Tomoyo Hara, 横田海友, 清水一磨, 浅井孝仁, Hiroki Yamagami, 三井由加里, 桝田志保, Kiyoe Kurahashi, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Ken-ichi Aihara : 心血管疾患リスクを有する患者における可溶型DPP-4/CD26と動脈硬化指標との連関解析, 第56回日本動脈硬化学会総会, Jul. 2024.
3.	山本あかね, 廣田勇士, 坂根直樹, 上田真莉子, 齋藤修一郎, 目黒周, 細田公則, 伊藤新, 加藤研, 小谷紀子, Akio Kuroda, Munehide Matsuhisa, 三浦順之助, 島田朗, 利根淳仁, 豊田雅夫 and 村田敬 : 1型糖尿病におけるisCGMによる低血糖を含む血糖管理に及ぼす効果に関する性差の検討 : ISCHIA研究post-ho解析, 第67日本糖尿病学会学術集会, May 2024.
4.	宮下和幸, 片上直人, Akio Kuroda, Munehide Matsuhisa and 下村伊一郎 : 膵腎同時移植後の体重内臓脂肪量の推移と動脈硬化に及ぼす影響, 第67日本糖尿病学会学術集会, May 2024.
5.	Munehide Matsuhisa and Akio Kuroda : 先進糖尿病医療は低血糖を予防・改善できるか, 第67日本糖尿病学会学術集会シンポジウム, May 2024.
6.	Tomoyo Hara, 横田海友, 清水一磨, 浅井孝仁, Hiroki Yamagami, 三井由加里, 桝田志保, Kiyoe Kurahashi, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Ken-ichi Aihara : 糖尿病患者における可溶型DPP-4/CD26と動脈硬化指標との関連, 第67日本糖尿病学会学術集会, May 2024.
7.	Munehide Matsuhisa, Akio Kuroda and 宮下和幸 : 膵臓移植の現状と展望, 第58回糖尿病学の進歩特別企画, Feb. 2024.
8.	Akio Kuroda and Munehide Matsuhisa : 重症低血糖・潜在的低血糖とその対策, 第58回糖尿病学の進歩, Feb. 2024.
9.	Munehide Matsuhisa and Akio Kuroda : CGM の進歩と残された課題, 第22回日本先進糖尿病治療・1型糖尿病研究会, Nov. 2023.
10.	浅井孝仁, Tomoyo Hara, 清水一磨, 吉田麻衣子, 山上絋規, 三井由加里, Kiyoe Kurahashi, Akio Kuroda, Munehide Matsuhisa and Itsuro Endo : ランレオチドを投与した14症例の糖代謝への影響に関する検討, 第33回臨床内分泌代謝Update, Nov. 2023.
11.	Tomoyo Hara, 清水一磨, 浅井孝仁, 吉田麻衣子, Hiroki Yamagami, 三井由加里, Kiyoe Kurahashi, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Ken-ichi Aihara : 2型糖尿病患者の非アルコール性脂肪性肝疾患における尿中可溶性ウロキナーゼ型プラスミノーゲン活性化受容体の臨床的意義, 第38回日本糖尿病合併症学会, Oct. 2023.
12.	益田貴史, 片上直人, 田矢直大, 渡邉裕尭, 宮下和幸, 高原充佳, 加藤研, Akio Kuroda, Munehide Matsuhisa and 下村伊一郎 : 若年発症1型糖尿病患者における血糖コントロールと糖尿病合併症の経時的変化および糖尿病合併症の進展に関連する因子, 第38回日本糖尿病合併症学会, Oct. 2023.
13.	Akio Kuroda, Asami Okada, Hiroyasu Mori, 冨永ゆかり, Masashi Ishizu and Munehide Matsuhisa : 循環血中遊離 DNA を標的とした血管内皮細胞傷害の検出, 第38回日本糖尿病合併症学会, Oct. 2023.
14.	Akio Kuroda : 新規超即効型インスリンルムジェブ(URLi)の使用について, 第21回日本先進糖尿病治療・1型糖尿病研究会合同シンポジウム, Oct. 2023.
15.	Hiroyasu Mori, Satoshi TANIGUCHI, Yuu Tamaki, 野村友美, 鈴木麗子, Akio Kuroda, 明比祐子, 長嶋伸光, 比木武 and Munehide Matsuhisa : 2型糖尿病患者の臨床用PHRを用いた自動支援メッセージがセルフモニタリングや体重管理に与える効果:無作為化比較試験, 第23回日本糖尿病インフォマティクス学会年次学術集会 YIA優秀演題賞受賞, Aug. 2023.
16.	Sumiko Yoshida, Akio Kuroda, Munehide Matsuhisa and Itsuro Endo : 糖尿病血糖管理入院における尿Titin N-terminal Fragmentの変化の検討, 第66回日本内分泌学会学術総会, Jun. 2023.
17.	Hiroki Yamagami, Tomoyo Hara, Yuki Tohjima, Takahito Asai, 三井由加里, Kiyoe Kurahashi, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : 2型糖尿病患者のSkin autofluorscenceを規定する因子の検討, 第96回日本内分泌学会学術総会, Jun. 2023.
18.	答島悠貴, Tomoyo Hara, 浅井孝仁, Hiroki Yamagami, 三井由加里, 倉橋衛清, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Ken-ichi Aihara : 当院におけるインスリングラルギン/リキシセナチド(iGlarLixi)導入症例の臨床背景および効果の検討, 第66回日本糖尿病学会年次学術集会, May 2023.
19.	Hiroki Yamagami, Tomoyo Hara, Yuki Tohjima, Takahito Asai, 三井由加里, Kiyoe Kurahashi, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : 2型糖尿病患者のAGEs蓄積に関わる臨床的因子の解析, 第66回日本糖尿病学会年次学術集会, May 2023.
20.	Yuki Tohjima, Tomoyo Hara, Takahito Asai, Hiroki Yamagami, 三井由加里, Kiyoe Kurahashi, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Ken-ichi Aihara : 当院におけるインスリングラルギン/リキシセナチド (iGlarLixi)導入症例の臨床背景および効果の検討, 第66回日本糖尿病学会年次学術集会, May 2023.
21.	Akio Kuroda : 青少年期の糖尿病治療費の問題と対策, 第66回日本糖尿病学会年次学術集会シンポジウム, May 2023.
22.	Akio Kuroda, Bogdan Sergiu Catrina, Vaever Niels Hartvig, Anne Kaas, Bech Jonas Moller and Peter Adolfsson : スマートインスリンペンを使用する 1 型糖尿病患者の来院前後の time in range(TIR)パターン, 第66回日本糖尿病学会年次学術集会, May 2023.
23.	村田敬, 坂根直樹, 廣田勇士, 豊田雅夫, Munehide Matsuhisa, Akio Kuroda, 伊藤新, 目黒周, 三浦順之助, 的場ゆか, 加藤研 and 鈴木渉太 : 1 型糖尿病患者における FreeStyle リブレ(第 3 世代アルゴリズム)の計測特性分析, 第66回日本糖尿病学会年次学術集会, May 2023.
24.	Tomoyo Hara, Yuki Tohjima, Takahito Asai, Hiroki Yamagami, 三井由加里, Kiyoe Kurahashi, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Ken-ichi Aihara : 糖尿病患者における腎糸球体および尿細管障害特異的なリスク因子の臨床的検討, 第66回日本糖尿病学会年次学術集会, May 2023.
25.	益田貴史, 片上直人, 今田侑, 藤川慧, 細江重郎, 田矢直大, 渡邉裕尭, 大森一生, 佐々木周伍, 高原充佳, 宮下和幸, 加藤研, 河盛段, Akio Kuroda, 安田哲行, Munehide Matsuhisa and 下村伊一郎 : 若年発症 1 型糖尿病患者における糖尿病性腎症，動脈硬化に関連する因子, 第66回日本糖尿病学会年次学術集会, May 2023.
26.	Akio Kuroda and Munehide Matsuhisa : 2 型糖尿病における潜在的低血糖とその対策, 第66回日本糖尿病学会年次学術集会シンポジウム, May 2023.
27.	Akio Kuroda : 最新インスリン注入デバイスを活用した治療, 第57回糖尿病学の進歩, Feb. 2023.
28.	Yuki Tohjima, Tomoyo Hara, 浅井孝仁, Hiroki Yamagami, 三井由加里, Kiyoe Kurahashi, Sumiko Yoshida, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Munehide Matsuhisa and Masahiro Abe : 首下がりを契機に診断に至ったCushing病の一例, 内科学会第127回四国地方会, Dec. 2022.
29.	Yuki Tohjima, 三井由加里, 浅井孝仁, Tomoyo Hara, Hiroki Yamagami, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Akio Kuroda, Masahiro Abe and Munehide Matsuhisa : レパグリニドとクロピドグレルの併用による遷延性低血糖を認めた一例, 日本糖尿病学会中国四国地方会第60回総会, Nov. 2022.
30.	Tomoyo Hara, Kiyoe Kurahashi, Hirofumi Hamano, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Ken-ichi Aihara : デュラグルチド使用中患者の HbA1c管理に影響を与える因子の検討, 日本糖尿病学会中国四国地方会第60回総会, Nov. 2022.
31.	豊田雅夫, 村田敬, 坂根直樹, 齋藤仁通, 加藤研, 廣田勇士, Akio Kuroda, Munehide Matsuhisa, 島田朗 and 細田公則 : 間歇スキャンCGMの精度に対する接触性皮膚炎の影響(ISCHIA研究post-hoc解析), 第21回日本先進糖尿病治療・1型糖尿病研究会, Oct. 2022.
32.	益田貴史, 片上直人, 田矢直大, 宮下和幸, 髙原充佳, Akio Kuroda, Munehide Matsuhisa and 下村伊一郎 : 日本人若年発症1型糖尿病の合併症進展にインスリンポンプ療法が及ぼす影響の検討, 第21回日本先進糖尿病治療・1型糖尿病研究会, Oct. 2022.
33.	鶴尾美穂, Akio Kuroda and Munehide Matsuhisa : FreeStyleリブレ Link 使用によりHbA1c が改善した 1 型糖尿病の 1 例, 第22回日本糖尿病インフォマティクス学会年次学術集会, Aug. 2022.
34.	三井由加里, Akio Kuroda, Tomoyo Hara, Hiroki Yamagami, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Masahiro Abe and Munehide Matsuhisa : 持続皮下インスリン注入療法下 1 型糖尿病合併妊娠における分娩直後のインスリン投与設定変更の提案, 第22回日本糖尿病インフォマティクス学会年次学術集会, Aug. 2022.
35.	鶴尾美穂, Akio Kuroda and Munehide Matsuhisa : ハイブリッド型クローズドループインスリンポンプが有効であった高齢1型糖尿病の 1 例, 第22回日本糖尿病インフォマティクス学会年次学術集会, Aug. 2022.
36.	Akio Kuroda : 1 型糖尿病とインフォマティクス, 第22回日本糖尿病インフォマティクス学会年次学術集会会長講演, Aug. 2022.
37.	Shiho Masuda, Tomoyo Hara, 三井由加里, Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Ken-ichi Aihara : 生活習慣病患者のeGFR年間変化量予測における血管内皮機能の意義, 第54回日本動脈硬化学会総会・学術集会, Jul. 2022.
38.	Tomoyo Hara, 山上紘規, 三井由加里, Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Ken-ichi Aihara : 糖尿病患者における血漿Heparin Cofactor II活性とNAFLD病態指標の連関解析, 第8回肝臓と糖尿病・代謝研究会, Jun. 2022.
39.	益田貴史, 片上直人, 今田侑, 藤川慧, 細江重郎, 田矢直大, 渡邉裕尭, 大森一生, 佐々木周伍, 下直樹, 髙原充佳, 宮下和幸, 加藤研, 河盛段, Akio Kuroda, 安田哲行, Munehide Matsuhisa and 下村伊一郎 : 日本人若年発症 1 型糖尿病患者の合併症進展にインスリンポンプ療法が及ぼす影響の検討, 第 65 回日本糖尿病学会年次学術集会, May 2022.
40.	宮下和幸, 片上直人, Akio Kuroda, Munehide Matsuhisa and 下村伊一郎 : 膵臓移植後 10 年にわたる移植膵機能の推移, 第 65 回日本糖尿病学会年次学術集会, May 2022.
41.	森博康, Akio Kuroda, 明比祐子 and Munehide Matsuhisa : 2 型糖尿病患におけるダイナペニアとサルコペニアの総エネルギー・栄養素摂取量等の影響:横断的検証, 第 65 回日本糖尿病学会年次学術集会, May 2022.
42.	Akio Kuroda : 心に刺さる針の話∼患者さん一人ひとりに適した針について考える∼, 第 65 回日本糖尿病学会年次学術集会ランチョンセミナー, May 2022.
43.	村田敬, 坂根直樹, Akio Kuroda, 三浦順之助, 廣田勇士, 加藤研, 豊田雅夫, 神山隆治, 湯山訓一, 島田朗, 川島聡, 的場ゆか, 目黒周, 楠宜樹, 肥田和之, 田中剛史, 利根淳仁, 清水一紀, 鈴木翔太, 西村邦宏, 細田公則 and ISCHIAグループ : 1 型糖尿病における isCGM のスキャン頻度と相関する要因の探索:ISCHIA 研究 post-hoc 解析, 第 65 回日本糖尿病学会年次学術集会, May 2022.
44.	Sumiko Yoshida, 辻誠一郎, Kiyoe Kurahashi, 宮恵子, 島久登, 田代学, 井上朋子, 水口潤, 中村信元, Akio Kuroda, Itsuro Endo, Masahiro Abe and Munehide Matsuhisa : 透析患者における新型コロナワクチン抗体と糖尿病の関連の検討, 第 65 回日本糖尿病学会年次学術集会, May 2022.
45.	Sumiko Yoshida, 辻誠士郎, Kiyoe Kurahashi, 宮恵子, 島久登, 田代学, 井上朋子, 水口潤, Shingen Nakamura, Akio Kuroda, Itsuro Endo, Masahiro Abe and Munehide Matsuhisa : 透析患者における新型コロナワクチン抗体と糖尿病の関連の検討, Journal of the The Japan Diabetes Society, Vol.65, No.Suppl.1, S-165, Apr. 2022. (Keyword) 血液透析ウイルス抗体腎不全-慢性(治療) 糖尿病性腎症(治療) 予防接種 COVID-19ワクチン(治療的利用) *Tozinameran(治療的利用) ヒト男女
46.	Sumiko Yoshida, 辻誠士郎, 金子遥祐, 森建介, 河田沙紀, 川原綾香, 遠藤ふうり, Tomoyo Hara, Kiyoe Kurahashi, Akio Kuroda, 明比祐子, Itsuro Endo, Masahiro Abe and Munehide Matsuhisa : 精神疾患とうつ尺度が減量入院効果に及ぼす影響, 第41回日本肥満学会・第38回日本肥満症治療学会, Mar. 2022.
47.	辻誠士郎, Sumiko Yoshida, 金子遥祐, 森建介, 河田沙紀, 川原綾香, 遠藤ふうり, Tomoyo Hara, Kiyoe Kurahashi, Akio Kuroda, 明比祐子, Itsuro Endo, Masahiro Abe and Munehide Matsuhisa : 行動療法を重視した2週間の減量入院後の減量効果の検討, 第41回日本肥満学会・第38回日本肥満症治療学会, Mar. 2022.
48.	辻誠士郎, Sumiko Yoshida, 金子遥祐, 森建介, 河田沙紀, 川原綾香, 遠藤ふうり, Tomoyo Hara, Kiyoe Kurahashi, Akio Kuroda, 明比祐子, Itsuro Endo, Masahiro Abe and Munehide Matsuhisa : 行動療法を重視した2週間の減量入院後の減量効果の検討, 第42回日本肥満学会第39回日本肥満症治療学会学術集会, Mar. 2022.
49.	宮下和幸, 富丸慶人, 片上直人, 小林省吾, Akio Kuroda, Munehide Matsuhisa, 江口英利 and 下村伊一郎 : 膵臓移植後10年にわたる移植膵機能の推移, 第49回日本膵・膵島移植研究会, Mar. 2022.
50.	山崎裕行, Yutaro Yamashita, Kazuhide Mineda, 石田創士, 安倍吉郎, Akio Kuroda, Munehide Matsuhisa, 高岩昌弘 and 橋本一郎 : 糖尿病末梢神経障害による歩容変化と重心動揺性 ―3次元歩行解析による検討―, 第2回日本フットケア・足病医学会年次学術集会, Dec. 2021.
51.	山崎裕行, Yutaro Yamashita, Kazuhide Mineda, Soushi Ishida, Yoshiro Abe, Akio Kuroda, Munehide Matsuhisa, Masahiro Takaiwa and Ichiro Hashimoto : 糖尿病性末梢神経障害による歩容変化と重心動揺性ー 3次元歩行解析による検討ー, 第2回日本フットケア・足病医学会年次学術集会, Dec. 2021.
52.	青山理央, 川原綾香, Kiyoe Kurahashi, Tomoyo Hara, Sumiko Yoshida, Akio Kuroda, Munehide Matsuhisa, Munehide Matsuhisa, Seiji Fukumoto, Itsuro Endo and Masahiro Abe : 1型糖尿病とバセドウ病を同時に診断した1例, 日本内科学会第125回四国地方会, Dec. 2021.
53.	Shiho Masuda, Tomoyo Hara, 三井由加里, Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Ken-ichi Aihara : 生活習慣病患者におけるeGFR年間変化量と血管内皮機能の連関解析, 第6回日本糖尿病・生活習慣病ヒューマンデータ学会, Dec. 2021.
54.	Tomoyo Hara, Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Ken-ichi Aihara : 糖尿病患者における血漿Heparin Cofactor II活性とNAFLD病態指標の連関, 第6回日本糖尿病・生活習慣病ヒューマンデータ学会, Dec. 2021. (Keyword) ヘパリンコファクターII / NAFLD / diabetes
55.	Hiroyasu Mori, 秦誠倫, 安田哲行, 山本恒彦, 馬屋原豊, 良本佳代子, 吉内和富, Sumiko Yoshida, Akio Kuroda and Munehide Matsuhisa : 1型糖尿病における低IGF-1血症が骨格筋量の低下やサルコペニア合併に及ぼす影響の検討:横断的研究, 第20回日本先進糖尿病治療研究会・第18回1型糖尿病研究会, Nov. 2021.
56.	Akio Kuroda and Munehide Matsuhisa : 食後血糖管理を目的とする食事の際の追加インスリンの選び方, 第20回日本先進糖尿病治療研究会・第18回1型糖尿病研究会, Nov. 2021.
57.	川原綾香, Kiyoe Kurahashi, 河田沙紀, 金子遥祐, 遠藤ふうり, Tomoyo Hara, 辻誠士郎, Sumiko Yoshida, Akio Kuroda, Itsuro Endo and Munehide Matsuhisa : 肝膿瘍とサイトメガロウイルス胃炎を合併した2型糖尿病の一例, 日本糖尿病学会中国四国地方会第59回総会, Oct. 2021.
58.	金子遥祐, Tomoyo Hara, 河田沙紀, 川原綾香, 遠藤ふうり, 辻誠士郎, Kiyoe Kurahashi, Sumiko Yoshida, Akio Kuroda, Itsuro Endo and Munehide Matsuhisa : PD-1抗体が1型糖尿病発症に関与したと考えられる非典型的な3例(29文字), 日本糖尿病学会中国四国地方会第59回総会, Oct. 2021.
59.	河田沙紀, Kiyoe Kurahashi, 川原綾香, 金子遥祐, 遠藤ふうり, Tomoyo Hara, 辻誠士郎, Sumiko Yoshida, Akio Kuroda, Itsuro Endo and Munehide Matsuhisa : 糖尿病ケトアシドーシスが改善後にケトーシスが再燃した2型糖尿病の1例, 日本糖尿病学会中国四国地方会第59回総会, Oct. 2021.
60.	Asami Okada, Misuzu Yamada, Hiroyasu Mori, 明比祐子, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Akio Kuroda : 1型糖尿病患者における膵β細胞傷害の定量化の試み, 日本糖尿病学会中国四国地方会第59回総会, Oct. 2021.
61.	Munehide Matsuhisa and Akio Kuroda : 血糖変動を可視化する新しい血糖管理目標Time in range(TIR), 第36回日本糖尿病合併症学会・第27回糖尿病眼学会総会シンポジウム, Oct. 2021.
62.	Akio Kuroda : 移植前・移植後の生活管理の変化と血糖コントロールについて, 第57回日本移植学会総会, Sep. 2021.
63.	Akio Kuroda : インスリンポンプ療法の進歩, 第21回日本糖尿病インフォマティクス学会年次学術集会ランチョンセミナー, Aug. 2021.
64.	Akio Kuroda, Masashi Ishizu, 鶴尾美穂, Hiroyasu Mori, 明比祐子, 岡本美鈴, 鈴木麗子, 寺澤敏秀 and Munehide Matsuhisa : 持続グルコースモニタリングの推定HbA1c値と実測HbA1c値との解離に関する検討, 第21回日本糖尿病インフォマティクス学会年次学術集会, Aug. 2021.
65.	Asami Okada, Misuzu Yamada, Hiroyasu Mori, 明比祐子, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Akio Kuroda : 循環血中遊離DNAを用いた膵β細胞障害の新規検出法の確立, 第263回徳島医学会学術集会, Aug. 2021.
66.	吉川紘平, 金子遥祐, 辻誠士郎, 河田沙紀, 川原綾香, 森健介, 遠藤ふうり, 原倫世, Kiyoe Kurahashi, Sumiko Yoshida, Akio Kuroda, 明比祐子, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe and Seiji Fukumoto : TIA様発作を契機に診断されたインスリノーマの一例, 第263回徳島医学会, Aug. 2021.
67.	Akio Kuroda : 血糖管理におけるCGM・SAP・FGM活用法, 第63回日本糖尿病学会年次学術集会教育講演, May 2021.
68.	豊田雅夫, 村田敬, 村田敬, 齊藤仁通, 木村守次, 石田直人, 北村真, 飛田美穂, 林哲範, 森口いぶき, 小林直之, 釣谷大輔, 坂尾幸俊, 松下隆哉, 伊藤雪絵, 鈴木渉太, 笠間周, 笠原正登, 山川正, 森克仁, Akio Kuroda, 三浦順之助, 廣田勇士, 阿部雅紀, 深川雅史, 坂根直樹 and 細田公則 : 透析中の2型糖尿病患者における間歇スキャン持続血糖測定器の精度評価に関する研究(AIDT2H研究), 第64回日本糖尿病学会年次学術集会, May 2021.
69.	Akio Kuroda : インスリンポンプ療法, 第64回日本糖尿病学会年次学術集会, May 2021.
70.	Hiroyasu Mori, Akio Kuroda, Sumiko Yoshida, 安田哲行, 馬屋原豊, 清水彩洋子, 良本佳代子, 吉内和富, 山本恒彦 and Munehide Matsuhisa : 2型糖尿病患者のサルコペニア合併に血清グリコアルブミン/HbA1cが関連する, 第64回日本糖尿病学会年次学術集会, May 2021.
71.	Akio Kuroda : カーボカウント最前線(専門医更新のための指定講演), 第64回日本糖尿病学会年次学術集会, May 2021.
72.	Munehide Matsuhisa, Hiroyasu Mori and Akio Kuroda : 高齢 1 型糖尿病の病態と診療上の課題, 第64回日本糖尿病学会年次学術集会, May 2021.
73.	辻誠士郎, Sumiko Yoshida, 平岡栞名, Kohsuke Miyataka, Minae Hosoki, Tomoyo Hara, 三井由加里, Kiyoe Kurahashi, Akio Kuroda, 明比祐子, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Masahiro Abe and Munehide Matsuhisa : 行動療法を中心とした2週間の減量入院プログラムの退院後の減量効果, 第64回日本糖尿病学会年次学術集会, May 2021.
74.	Tomoyo Hara, Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo and Munehide Matsuhisa : 血漿 Heparin Cofactor \|\| 活性とNAFLD病態指標の連関解析, 第94回日本内分泌学会学術総会, Apr. 2021.
75.	Akio Kuroda : インスリン治療の歴史, 第94回日本内分泌学会学術総会特別シンポジウム, Apr. 2021.
76.	Tomoyo Hara, Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Ken-ichi Aihara : 血漿Heparin Cofactor II活性とNAFLD病態指標の連関解析, 第94回日本内分泌学会学術総会, Apr. 2021.
77.	山崎裕行, Yutaro Yamashita, Kazuhide Mineda, Yoshiro Abe, Akio Kuroda, Munehide Matsuhisa, Masahiro Takaiwa and Ichiro Hashimoto : シンポジウム: 歩容分析から糖尿病性足病変の予防を検討する ∼特徴的な歩容変化と重心動揺性について∼, 第64回日本形成外科学会総会・学術集会, Apr. 2021.
78.	益田貴史, 宮下和幸, 富丸慶人, 小林省吾, 片山直人, Akio Kuroda, 伊藤壽記, 土岐祐一郎, 江口栄利, Munehide Matsuhisa and 下村伊一郎 : 膵臓移植後に動脈硬化性疾患を発症した6症例の検討, 第48回日本膵・膵島移植研究会, Mar. 2021.
79.	Munehide Matsuhisa, Akio Kuroda and 宮下和幸 : 膵臓移植におけるチーム医療と糖尿病専門医の役割, 第48回日本膵・膵島移植研究会ワークショップ, Mar. 2021.
80.	Akio Kuroda : 小児1型糖尿病のインスリン療法は進歩したか」小児期1型糖尿病発症の演者の経験から, 第55回糖尿病学の進歩シンポジウム, Mar. 2021.
81.	Munehide Matsuhisa and Akio Kuroda : 糖尿病地域医療連携のICT化への試み, 第35回日本糖尿病合併症学会第26回日本糖尿病眼学会総会合同シンポジウム, Dec. 2020.
82.	Hiroyasu Mori, Akio Kuroda, Sumiko Yoshida, 安田哲行, 馬屋原豊, 清水彩洋子, 良本佳代子, 吉内和富, 山本恒彦, 下村伊一郎 and Munehide Matsuhisa : 2型糖尿病患者におけるダイナぺニアとサルコペニアの臨床的特徴, 日本糖尿病学会中国四国地方会第58総会, Oct. 2020.
83.	Akio Kuroda, Masashi Ishizu, 鶴尾美穂, Hiroyasu Mori, 明比祐子, 岡本美鈴, 鈴木麗子, 寺澤敏秀 and Munehide Matsuhisa : 持続グルコースモニタリングの推定HbA1c値と実測HbA1c値との解離に関する検討, 日本糖尿病学会中国四国地方会第58総会, Oct. 2020.
84.	Masashi Ishizu, Hiroyasu Mori, 明比祐子, Akio Kuroda, Motoyuki Tamaki, Sumiko Yoshida, Ken-ichi Aihara, 藍場元弘, 河野友晴, Seiichi Hashida and Munehide Matsuhisa : 糖尿病性腎症における尿アディポネクチンの意義(第2報), 日本糖尿病学会中国四国地方会第58総会, Oct. 2020.
85.	平岡栞名, 三井由加里, 細木美苗, 宮高紘輔, 辻誠士朗, 三井由加里, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Akio Kuroda, Masahiro Abe and Munehide Matsuhisa : 原田病，重症筋無力症を合併した1型糖尿病の1例, 日本糖尿病学会中国四国地方会第58総会, Oct. 2020.
86.	辻誠士朗, Kiyoe Kurahashi, 平岡栞名, 細木美苗, 宮高紘輔, 三井由加里, Sumiko Yoshida, Akio Kuroda, Itsuro Endo, Masahiro Abe and Munehide Matsuhisa : びまん性膵腫大を契機に膵癌再発と診断したGAD抗体陽性の糖尿病の一例, 日本糖尿病学会中国四国地方会第58総会, Oct. 2020.
87.	山崎裕行, Yutaro Yamashita, Kazuhide Mineda, Soushi Ishida, Yoshiro Abe, Akio Kuroda, Munehide Matsuhisa, 高岩昌弘 and Ichiro Hashimoto : 糖尿病患者の歩行に関する3D解析調査∼糖尿病足病変患者の歩行支援に向けて∼, 第29回日本形成外科学会基礎学術集会, Oct. 2020.
88.	山崎裕行, Yutaro Yamashita, Kazuhide Mineda, Soushi Ishida, Yoshiro Abe, Akio Kuroda, Munehide Matsuhisa, 高岩昌弘 and Ichiro Hashimoto : 糖尿病患者の歩行に関する3D解析調査∼糖尿病足病変患者の歩行支援に向けて∼, 第29回日本形成外科学会基礎学術集会, Oct. 2020.
89.	山崎裕行, Yutaro Yamashita, Kazuhide Mineda, Soushi Ishida, Yoshiro Abe, Akio Kuroda, Munehide Matsuhisa, 高岩昌弘 and Ichiro Hashimoto : 糖尿病患者の歩行に関する3D解析調査∼糖尿病足病変患者の歩行支援に向けて∼, 第29回日本形成外科学会基礎学術集会, Oct. 2020.
90.	山崎裕行, Yutaro Yamashita, Kazuhide Mineda, Soushi Ishida, Yoshiro Abe, Akio Kuroda, Munehide Matsuhisa, 高岩昌弘 and Ichiro Hashimoto : 糖尿病患者の歩行に関する3D解析調査∼糖尿病足病変患者の歩行支援に向けて∼, 第29回日本形成外科学会基礎学術集会, Oct. 2020.
91.	山崎裕行, Yutaro Yamashita, Kazuhide Mineda, Soushi Ishida, Yoshiro Abe, Akio Kuroda, Munehide Matsuhisa, 高岩昌弘 and Ichiro Hashimoto : 糖尿病患者の歩行に関する3D解析調査∼糖尿病足病変患者の歩行支援に向けて∼, 第29回日本形成外科学会基礎学術集会, Oct. 2020.
92.	山崎裕行, Yutaro Yamashita, Kazuhide Mineda, Soushi Ishida, Yoshiro Abe, Akio Kuroda, Munehide Matsuhisa, 高岩昌弘 and Ichiro Hashimoto : 糖尿病患者の歩行に関する3D解析調査∼糖尿病足病変患者の歩行支援に向けて∼, 第29回日本形成外科学会基礎学術集会, Oct. 2020.
93.	山崎裕行, Yutaro Yamashita, Kazuhide Mineda, Soushi Ishida, Yoshiro Abe, Akio Kuroda, Munehide Matsuhisa, 高岩昌弘 and Ichiro Hashimoto : 糖尿病患者の歩行に関する3D解析調査∼糖尿病足病変患者の歩行支援に向けて∼, 第29回日本形成外科学会基礎学術集会, Oct. 2020.
94.	清水彩洋子, 馬屋原豊, 清水成, 畑雅久, 藤田洋平, 桂央士, 良本佳代子, 安田哲行, 山本恒彦, 吉内和富, Sumiko Yoshida, 良本佳代子, Akio Kuroda, Hiroyasu Mori, 下村伊一郎 and Munehide Matsuhisa : 2型糖尿病の肝線維化が血清IGF 1と筋肉量・筋力低下に与える影響, 第63回日本糖尿病学会年次学術集会, Oct. 2020.
95.	秦誠倫, Hiroyasu Mori, 竹本有里, 藤井浩平, 永田慎平, 山本裕一, 狭間洋至, Sumiko Yoshida, 吉内和富, 山本恒彦, 馬屋原豊, 良本佳代子, Akio Kuroda, 安田哲行, 下村伊一郎 and Munehide Matsuhisa : 1型糖尿病患者のサルコペニアには血清IGF-1低値が関連する, 第63回日本糖尿病学会年次学術集会, Oct. 2020.
96.	Hiroyasu Mori, Akio Kuroda, Sumiko Yoshida, 安田哲行, 馬屋原豊, 清水彩洋子, 良本佳代子, 吉内和富, 山本恒彦, 下村伊一郎 and Munehide Matsuhisa : 1型および2型糖尿病患におけるダイナぺニアとサルコペニアの臨床的特徴 iDIAMOND Studyからの報告, 第63回日本糖尿病学会年次学術集会, Oct. 2020.
97.	Sumiko Yoshida, 工藤千晶, 辻本賀美, 安井沙耶, 遠藤ふうり, 桝田志保, 三井由加里, Kiyoe Kurahashi, Akio Kuroda, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Seiji Fukumoto, Masahiro Abe and Munehide Matsuhisa : 血糖管理入院でのテストステロン値の変化の検討, 第63回日本糖尿病学会年次学術集会, Oct. 2020.
98.	Akio Kuroda, Masashi Ishizu, 鶴尾美穂, Hiroyasu Mori, 明比祐子, 岡本美鈴, 鈴木麗子, 寺澤敏秀 and Munehide Matsuhisa : 持続グルコースモニタリングの推定HbA1c値と実測HbA1c値との解離に関する検討, 第20回日本糖尿病情報学会年次学術集会, Sep. 2020.
99.	Tomoyo Hara, Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Ken-ichi Aihara : NAFLD病態指標血漿Heparin Cofactor IIの連関, 第52回日本動脈硬化学会総会・学術集会, Aug. 2020.
100.	Sumiko Yoshida, 工藤千晶, 辻本賀美, 安井沙耶, 遠藤ふうり, 桝田志保, 三井由香里, Kiyoe Kurahashi, Akio Kuroda, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa, Masahiro Abe and Seiji Fukumoto : 糖尿病教育入院でのテストステロン値の変化の検討, 第93回日本内分泌学会学術総会, Vol.96, No.1, 287, Jul. 2020.
101.	Tomoyo Hara, Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Ken-ichi Aihara : NAFLD病態指標Fib4-indexと血漿Heparin Cofactor Ⅱの連関, 第52回日本動脈硬化学会総会・学術集会, Jul. 2020. (Keyword) NAFLD / Heparin Cofactor Ⅱ
102.	Hiroyasu Mori, Akio Kuroda, 安田哲行, 馬屋原豊, 清水彩洋子, 良本佳代子, 吉内和富, 山本恒彦, Sumiko Yoshida and Munehide Matsuhisa : 2型糖尿病のダイナぺニアの臨床的特徴の検討, 第54回日本成人病(生活習慣病)学会, Jan. 2020.
103.	Tomoyuki Yuasa, 鶴尾美穂, 岸潤, Akio Kuroda, 寺澤敏秀 and Munehide Matsuhisa : ANCA関連血管炎にステロイドを投与し血糖コントロールが改善した1型糖尿病の1例, 日本糖尿病学会中国四国地方会第57回総会, Dec. 2019.
104.	毛利咲恵, 鶴尾美穂, 坂東佐知子, 添木武, 松本直也, Tomoyuki Yuasa, Akio Kuroda, Masataka Sata, Masahiro Abe, 寺澤敏秀 and Munehide Matsuhisa : 発熱，高血糖，低K血症を契機に一時的にBrugada型心電図を呈した糖尿病の1例, 日本糖尿病学会中国四国地方会第57回総会, Dec. 2019.
105.	奥村慈子, 鶴尾美穂, Tomoyuki Yuasa, 瀬尾浩二, 木内美瑞穂, 金川泰彦, Akio Kuroda, 松本俊夫, Masahiro Abe, 寺澤敏秀 and Munehide Matsuhisa : 急激にせん妄状態が悪化した高齢2型糖尿病の1例, 日本糖尿病学会中国四国地方会第57回総会, Dec. 2019.
106.	上野裕子, 鶴尾美穂, Tomoyuki Yuasa, Akio Kuroda, 木内美瑞穂, 西正晴, Saya Yasui, Masahiro Abe, 寺澤敏秀 and Munehide Matsuhisa : 高齢者糖尿病患者に対するLCDEと徳島市糖尿病サポーター(TCDS)の連携した取り組み, 日本糖尿病学会中国四国地方会第57回総会, Dec. 2019.
107.	三井由加里, Akio Kuroda, Masashi Ishizu, 桝田志保, Kiyoe Kurahashi, Sumiko Yoshida, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe and Munehide Matsuhisa : 頻回インスリン注射療法下の1型糖尿病患者における基礎インスリン比率の検討, 日本糖尿病学会中国四国地方会第57回総会, Dec. 2019.
108.	桝田志保, Sumiko Yoshida, 安井沙耶, 辻本賀美, 工藤千晶, Furi Endo, 三井由加里, Kiyoe Kurahashi, Akio Kuroda, Itsuro Endo and Munehide Matsuhisa : 肥満外科手術後早期に基礎インスリン必要量が減少した高度肥満1型用尿病の1例, 日本糖尿病学会中国四国地方会第57回総会, Dec. 2019.
109.	Misuzu Yamada, Akio Kuroda, 冨永ゆかり and Munehide Matsuhisa : 1型糖尿病患者血中循環遊離DNAと関連する因子の解析, 日本糖尿病学会中国四国地方会第57回総会, Dec. 2019.
110.	Furi Endo, Sumiko Yoshida, 工藤千晶, 辻本賀美, 安井沙耶, 桝田志保, 三井由加里, Kiyoe Kurahashi, Akio Kuroda, Itsuro Endo and Munehide Matsuhisa : 免疫チェックポイント阻害薬関連1型糖尿病の5例, 日本糖尿病学会中国四国地方会第57回総会, Dec. 2019.
111.	鶴尾美穂, Akio Kuroda, Tomoyuki Yuasa, 木内美瑞穂, 安井沙耶, Toshio Matsumoto, Masahiro Abe, 寺澤敏秀 and Munehide Matsuhisa : TIR(Time-In-Range)とHbA1cとの関連∼HbA1cと組み合わせる血糖管理方法∼, 日本糖尿病学会中国四国地方会第57回総会, Dec. 2019.
112.	森岡隆子, Akio Kuroda, 鶴尾美穂, 堀筋冨士子, 秋田賢子, 松本幸恵, Tomoyuki Yuasa, Toshio Matsumoto, Masahiro Abe, 寺澤敏秀 and Munehide Matsuhisa : 予測低血糖自動注入停止型インスリンポンプが有効だった高齢1型糖尿病例, 日本糖尿病学会中国四国地方会第57回総会, Dec. 2019.
113.	安井沙耶, 桝田志保, 辻本賀美, 工藤千晶, Furi Endo, 三井由加里, Kiyoe Kurahashi, Sumiko Yoshida, Akio Kuroda, Itsuro Endo and Munehide Matsuhisa : 基礎インスリン適正化とスクエアボーラス導入で血糖管理が改善した1型糖尿病の1例, 日本糖尿病学会中国四国地方会第57回総会, Dec. 2019.
114.	斎村玉緒, Akio Kuroda, 鶴尾美穂, 福井健壮, 掘貫理恵, 藤原敏孝, Tomoyuki Yuasa, Toshio Matsumoto, Masahiro Abe, 寺澤敏秀 and Munehide Matsuhisa : 脳悪性リンパ腫を発症した2がた糖尿病の1例, 日本糖尿病学会中国四国地方会第57回総会, Dec. 2019.
115.	Hiroyasu Mori, Akio Kuroda and Munehide Matsuhisa : 高齢糖尿病患者の肥満と筋障害との関連, 第40回日本肥満学会・第37回日本肥満症治療学会, Nov. 2019.
116.	Akio Kuroda, 鶴尾美穂, Masashi Ishizu and Munehide Matsuhisa : Time-In-RangeとHbA1cとの関連∼HbA1cと組み合わせる血糖管理方法∼, 第19回日本先進糖尿病治療研究会・第17回1型糖尿病研究会, Nov. 2019.
117.	村田敬, 利根淳仁, 加藤研, 豊田雅夫, 澤木秀明, Akio Kuroda, 廣田勇士, 川嶋聡, Munehide Matsuhisa and 坂根直樹 : リアルタイム持続血糖測定器(CGM)センサーのアドヒアランスとインスリンポンプ療法におけるQOLの関連(PARCS研究第2報), 第19回日本先進糖尿病治療研究会・第17回1型糖尿病研究会, Nov. 2019.
118.	三井由加里, Akio Kuroda, Masashi Ishizu, Kiyoe Kurahashi, Sumiko Yoshida, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe and Munehide Matsuhisa : 頻回インスリン注射療法下の1型糖尿病患者における基礎インスリン比率の検討, 第19回日本先進糖尿病治療研究会・第17回1型糖尿病研究会, Nov. 2019.
119.	Masashi Ishizu, Hiroyasu Mori, Mami Ohishi, 鈴木麗子, 岡本美鈴, 明比祐子, Akio Kuroda, Motoyuki Tamaki, Yuichi Takashi, Sumiko Yoshida, Ken-ichi Aihara, 藍場元弘, 河野友晴, Seiichi Hashida and Munehide Matsuhisa : 糖尿病性腎臓病における尿中アディポネクチン排泄の臨床的意義, 第40回日本肥満学会・第37回日本肥満症治療学会, Nov. 2019.
120.	安井沙耶, 桝田志保, Sumiko Yoshida, 辻本賀美, 工藤千晶, 遠藤ふうり, 三井由加里, Kiyoe Kurahashi, Akio Kuroda, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Munehide Matsuhisa, Masahiro Abe and Seiji Fukumoto : 成長ホルモン分泌不全症と甲状腺機能低下症を呈した小児がん経験者の一例, 第259回徳島医学会学術集会(令和元年度夏期), Aug. 2019.
121.	鈴木麗子, Hiroyasu Mori, Masashi Ishizu, Yuu Tamaki, Satoshi Taniguchi, Akio Kuroda and Munehide Matsuhisa : スマートスピーカーを活用した個別化糖尿病自己管理支援システムの開発糖尿病患者の行動変容を目指して, 第19回日本糖尿病情報学会年次学術集会, Aug. 2019.
122.	Akio Kuroda : ライフステージに応じた1型糖尿病治療(妊娠後)特別企画「ライフステージ別の1型糖尿病女性の管理と多職種連携」, 第19回日本糖尿病情報学会年次学術集会, Aug. 2019.
123.	Akio Kuroda and Munehide Matsuhisa : インスリンポンプ療法，CGM の進歩, 第25回日本小児・思春期糖尿病学会年次学術集会シンポジウム, Jul. 2019.
124.	Misuzu Yamada, Akio Kuroda, Rie Tsutsumi, 冨永ゆかり, Hiroshi Sakaue and Munehide Matsuhisa : 循環血中遊離DNAを標的とした血管内皮細胞傷害の検出, 第62回日本糖尿病学会年次学術集会, May 2019.
125.	田矢直大, 片上直人, 宮下和幸, 高原充佳, 加藤研, 安田哲行, 河盛段, Akio Kuroda, Munehide Matsuhisa, 松岡孝昭 and 下村伊一郎 : 日本人1型糖尿病患者における腎症の発症・進展に関わる因子, 第62回日本糖尿病学会年次学術集会, May 2019.
126.	豊田雅夫, 利根淳仁, 加藤研, 木村守次, 川嶋聡, 澤木秀明, 廣田勇士, 岡田朗, Akio Kuroda, Munehide Matsuhisa, 渡邉知一, 村田敬, 菅沼彰子 and 坂根直樹 : 新規インスリンポンプ使用中患者用QOL尺度(CSIIQOL)の開発および妥当性と信頼性の検証, 第62回日本糖尿病学会年次学術集会, May 2019.
127.	安田純, 池田雅彦, Akio Kuroda, Munehide Matsuhisa and 久保田稔 : 1型糖尿病スカイプミーティング(いちスカ)の総括と展望―インターネット開催の強みを活かした運営の特徴と成果―, 第62回日本糖尿病学会年次学術集会, May 2019.
128.	Masashi Ishizu, Hiroyasu Mori, Mami Ohishi, 鈴木麗子, 岡本美鈴, 明比祐子, Akio Kuroda, Motoyuki Tamaki, Yuichi Takashi, Sumiko Yoshida, Ken-ichi Aihara, 藍場元弘, 河野友晴, Seiichi Hashida and Munehide Matsuhisa : 糖尿病性腎臓病における尿中アディポネクチン排泄率の臨床的意義の検討, 第62回日本糖尿病学会年次学術集会, May 2019.
129.	村田敬, 坂根直樹, 加藤研, 三浦順之助, 豊田雅夫, 利根淳仁, 廣田勇士, 神山隆治, Akio Kuroda, Munehide Matsuhisa, 菅沼彰子, 菅沼彰子, 野口倫生, 宮本恵宏, 西村邦宏 and 細田公則 : 1型糖尿病における間歇スキャンCGMが低血糖も含む血糖コントロールに及ぼす効果の研究(ISCHIA 研究):研究デザイン, 第62回日本糖尿病学会年次学術集会, May 2019.
130.	宮高絋輔, Sumiko Yoshida, Furi Endo, 枡田志保, 三井由加里, Kiyoe Kurahashi, Akio Kuroda, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Seiji Fukumoto, Makoto Funaki, Yoshihiro Matsudate, Hiroshi Nokihara, Yasuhiko Nishioka, Masahiro Abe and Munehide Matsuhisa : 免疫チェックポイント阻害薬投与後に1型糖尿病を発症した2例, 第62回日本糖尿病学会年次学術集会, May 2019.
131.	Hiroyasu Mori, Yuu Tamaki, Satoshi Taniguchi, 野村友美, 大塚銀花, 岡本美鈴, 鈴木麗子, Akio Kuroda and Munehide Matsuhisa : テレビカンファレンスシステム活用遠隔栄養指導が2型糖尿病患者の病態や食行動に及ぼす影響:無作為化比較試験, 第62回日本糖尿病学会年次学術集会, May 2019.
132.	Munehide Matsuhisa, Hiroyasu Mori, Satoshi Taniguchi, Yuu Tamaki and Akio Kuroda : EHRと連携するPHR「電子糖尿病ダイアリー」, 第62回日本糖尿病学会年次学術集会シンポジウム, May 2019.
133.	Akio Kuroda : 1型糖尿病治療の進歩, 第46回日本膵・膵島移植研究会教育セミナー, Mar. 2019.
134.	Akio Kuroda : カーボカウント指導と運用の実際:医師の立場から, 第53回糖尿病学の進歩シンポジウム, Mar. 2019.
135.	Kohsuke Miyataka, Furi Endo, 三井由加里, 枡田志保, Kiyoe Kurahashi, Sumiko Yoshida, Akio Kuroda, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Seiji Fukumoto, Hiroshi Nokihara, Yasuhiko Nishioka, Masahiro Abe and Munehide Matsuhisa : 抗PD-1抗体投与後に1型糖尿病を発症した1例, 第258回徳島医学会学術集会ポスターセッション, Feb. 2019.
136.	Munehide Matsuhisa, Hiroyasu Mori, Satoshi Taniguchi, Masashi Ishizu, 明比祐子, Yuu Tamaki and Akio Kuroda : 徳島県での地域医療連携基盤の構築とデータ利活用への試み, 第3回日本糖尿病・生活習慣病ヒューマンデータ学会シンポジウム3, Dec. 2018.
137.	Misuzu Yamada, Akio Kuroda, 冨永ゆかり and Munehide Matsuhisa : 組織特異的なエピジェネティック修飾を用いた内皮細胞障害の検出, 第30回分子糖尿病学シンポジウム, Dec. 2018.
138.	秋田賢子, 鶴尾美穂, 森岡隆子, 堀筋冨士子, 上野裕子, 斎村玉緒, 藤島周子, 奥村慈子, 松本幸恵, 福井健壮, 堀貫理恵, 森久志, 細川智也, 野上貴盛, 森上雄三, 橋本章聖, Tomoyuki Yuasa, Akio Kuroda, 寺澤敏秀 and Munehide Matsuhisa : 糖尿病教育入院時の療養指導カードの使用についてのスタッフの評価, 日本糖尿病学会中国四国地方会第56回総会, Oct. 2018.
139.	Misuzu Yamada, Akio Kuroda, 冨永ゆかり and Munehide Matsuhisa : 特異的遺伝子メチル化パターンを用いた膵β細胞障害の検出, 日本糖尿病学会中国四国地方会第56回総会, Oct. 2018.
140.	Masashi Ishizu, Hiroyasu Mori, Mami Ohishi, 鈴木麗子, 明比祐子, Akio Kuroda, Motoyuki Tamaki, Yuichi Takashi, Sumiko Yoshida, Ken-ichi Aihara, 藍場元弘, 河野友晴, Seiichi Hashida and Munehide Matsuhisa : 糖尿病性腎臓病における尿アディポネクチンの意義, 日本糖尿病学会中国四国地方会第56回総会, Oct. 2018.
141.	鶴尾美穂, Akio Kuroda, Tomoyuki Yuasa, Mizuho Kinouchi, Kimiko Sogabe, 加部一行, 瀬尾浩二, Masaharu Nishi, Naoya Matsumoto, Yasuhiko Kanagawa, Masahiro Abe, Toshio Matsumoto, 寺澤敏秀 and Munehide Matsuhisa : リブレ使用糖尿病患者の検討, 日本糖尿病学会中国四国地方会第56回総会, Oct. 2018.
142.	Hiroyasu Mori, Akio Kuroda, Masashi Ishizu, Yuichi Takashi, Satoshi Taniguchi, Motoyuki Tamaki, 明比祐子 and Munehide Matsuhisa : 2型糖尿病患者における肥満と筋傷害との関連の検証, 第39回日本肥満学会, Oct. 2018.
143.	Akio Kuroda : フラッシュ・グルコース・モニタリング, 第18回日本先進糖尿病治療研究会教育講演, Sep. 2018.
144.	Misuzu Yamada, Akio Kuroda, 冨永ゆかり and Munehide Matsuhisa : 血清細胞外小胞中DNAを用いた膵β細胞傷害検出のマウスによる検証, 第18回日本先進糖尿病治療研究会, Sep. 2018.
145.	村田敬, 利根淳仁, 加藤研, 豊田雅夫, 澤木秀明, Akio Kuroda, 廣田勇士, 川嶋聡, Munehide Matsuhisa and 坂根直樹 : リアルタイム持続血糖測定器(CGM)センサーのアドヒアランス予測因子に関する前向き観察研究(PARCS研究), 第18回日本先進糖尿病治療研究会, Sep. 2018.
146.	Kiyoe Kurahashi, Furi Endo, 桝田志保, Sumiko Yoshida, Akio Kuroda, Ken-ichi Aihara, Seiji Fukumoto, Itsuro Endo and Munehide Matsuhisa : 足趾上腕血圧比定値を契機に末梢動脈疾患を診断しえた，重症下肢軟部組織感染症を繰り返す2型糖尿病の一例, 第3回日本下肢救済・足病学会中国四国地方会学術集会, Sep. 2018.
147.	Yuichi Takashi, Masashi Ishizu, Shu Wakino, 水口斉, 島久登, 田代学, 宮恵子, 水口潤, Akio Kuroda, Toshio Matsumoto, Munehide Matsuhisa and Seiji Fukumoto : 血液透析患者における心不全・動脈硬化・感染のリスク因子としてのFGF23, 第18回日本内分泌学会四国支部学術集会, Sep. 2018.
148.	Ken-ichi Aihara, Sumiko Yoshida, Furi Endo, 筒井康継, Tomoyo Hara, 桝田志保, Kiyoe Kurahashi, Toshiki Otoda, Tomoyuki Yuasa, Itsuro Endo, Kana Morimoto, Akio Kuroda, 明比祐子, Makoto Funaki, Munehide Matsuhisa, Seiji Fukumoto and Masahiro Abe : 原発性アルドステロン症におけるミネラルコルチコイド受容体拮抗薬の血管機能への影響, 第18回日本内分泌学会四国支部学術集会, Sep. 2018.
149.	Hiroyasu Mori, Michiko Araki, Akio Kuroda, Masashi Ishizu, Yuichi Takashi, Satoshi Taniguchi, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Motoyuki Tamaki, 明比祐子 and Munehide Matsuhisa : 1型糖尿病患者の血清IGF-1とサルコペニア合併に関する横断的検証, 第18回日本内分泌学会四国支部学術集会, Sep. 2018.
150.	Hiroyasu Mori, Yuu Tamaki, Satoshi Taniguchi, 野村友美, 鈴木麗子, 瀧川稲子, Akio Kuroda and Munehide Matsuhisa : テレビカンファレンスシステムを用いた遠隔栄養指導の介入が2型糖尿病患者の代謝状態や食行動に与える影響, 第18回日本糖尿病情報学会, Aug. 2018.
151.	Satoshi Taniguchi, Yuu Tamaki, Hiroyasu Mori, 鈴木麗子, Motoyuki Tamaki, 白神敦久, 明比祐子, Akio Kuroda and Munehide Matsuhisa : 電子糖尿病ダイアリーの糖尿病患者の自己管理への効果と課題の検証, 第18回日本糖尿病情報学会, Aug. 2018.
152.	Sumiko Yoshida, 原倫世, 桝田志保, Kiyoe Kurahashi, Akio Kuroda, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe and Munehide Matsuhisa : 高齢者における糖尿病教育入院中の体組成の変化, 第60回日本老年医学会学術集会, Jun. 2018.
153.	Yuichi Takashi, Masashi Ishizu, Hiroyasu Mori, Akio Kuroda and Munehide Matsuhisa : 骨産生ホルモンであるオステオカルシンは1型糖尿病患者の体脂肪を制御する, 第118回日本内科学会四国地方会, Jun. 2018.
154.	Akio Kuroda : カーボカウントのエビデンス, 第61回日本糖尿病学会年次学術集会, May 2018.
155.	高比康充, 宮下和幸, 宮下和幸, 宮下和幸, Akio Kuroda, 松岡孝昭, Munehide Matsuhisa, 伊藤壽記 and 下村伊一郎 : 日本人1型糖尿病膵移植患者におけるインスリン分泌指標の意義の検討, 第61回日本糖尿病学会年次学術集会, May 2018.
156.	宮下和幸, 高比康充, 田矢直大, 高原充佳, 片上直人, 松岡孝昭, 伊藤壽記, Akio Kuroda, Munehide Matsuhisa, 今川彰久 and 下村伊一郎 : 移植膵機能廃絶にかかわる因子の検討, 第61回日本糖尿病学会年次学術集会, May 2018.
157.	Akio Kuroda, Misuzu Yamada, 冨永ゆかり, 鈴木麗子, Motoyuki Tamaki, 明比祐子, Yuichi Takashi, Masashi Ishizu, 古賀大輔, Issei Imoto, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe, Kevin Ferreri and Munehide Matsuhisa : 膵β細胞特異的PCRによる膵β細胞死の検出, 第61回日本糖尿病学会年次学術集会, May 2018.
158.	Sumiko Yoshida, 原倫世, 細井美希, 山上紘規, 山口佑樹, 桝田志保, Kiyoe Kurahashi, Akio Kuroda, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Seiji Fukumoto, Masahiro Abe and Munehide Matsuhisa : 糖尿病教育入院における筋肉量の変化, 第61回日本糖尿病学会年次学術集会, May 2018.
159.	Yuichi Takashi, Masashi Ishizu, Hiroyasu Mori, 宮下和幸, 坂本扶美枝, 片上直人, 松岡孝昭, 安田哲行, Seiichi Hashida, Akio Kuroda and Munehide Matsuhisa : 骨産生ホルモンucOCは1型糖尿病患者の体脂肪率と関係する, 第61回日本糖尿病学会年次学術集会, May 2018.
160.	Misuzu Yamada, Akio Kuroda, 冨永ゆかり and Munehide Matsuhisa : 血清中エクソソームを用いた膵β細胞障害検出のマウスによる検証, 第61回日本糖尿病学会年次学術集会, May 2018.
161.	山上紘規, Sumiko Yoshida, 原倫世, 細井美希, 山口佑樹, 桝田志保, Kiyoe Kurahashi, Akio Kuroda, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Seiji Fukumoto, Masahiro Abe, Yoshihiro Matsudate and Munehide Matsuhisa : 免疫チェックポイント阻害薬投与後に甲状腺機能異常と劇症1型糖尿病を発症した1例, 第61回日本糖尿病学会年次学術集会, May 2018.
162.	河野友晴, 沼田聡, 藤本侑季, Akio Kuroda, 安田哲行, 宮下和幸, 坂本扶美枝, 片上直人, 松岡孝明, Munehide Matsuhisa and Seiichi Hashida : 超感度測定法(ICT-EIA法)による若年性1型糖尿病患者における3種の膵島関連自己抗体, 第61回日本糖尿病学会年次学術集会, May 2018.
163.	Masashi Ishizu, Yuichi Takashi, 脇野修, 水口斉, 田代学, 宮恵子, Yoshihiko Noma, 小松まち子, 水口潤, Akio Kuroda, Seiji Fukumoto and Munehide Matsuhisa : 血液透析患者における糖尿病をはじめとする動脈硬化リスク因子の検討, 第61回日本糖尿病学会年次学術集会, May 2018.
164.	Hiroyasu Mori, 鈴木麗子, 瀧川稲子, Masashi Ishizu, Mami Ohishi, Satoshi Taniguchi, 明比祐子, Akio Kuroda and Munehide Matsuhisa : 糖尿病腎症の急速進行に関連するリスク因子の検証:前向き観察研究, 第61回日本糖尿病学会年次学術集会, May 2018.
165.	Motoyuki Tamaki, Yuichi Takashi, Toshiki Otoda, Seiji Fukumoto, Akio Kuroda, 明比祐子, Hiroyasu Mori, Satoshi Taniguchi, 鈴木麗子, Misuzu Yamada, Masashi Ishizu, Mami Ohishi, 白神敦久, Ken-ichi Aihara, Makoto Funaki and Munehide Matsuhisa : かかりつけ患者に対するSGLT2阻害薬の投与開始タイミングの特徴と投与開始後の体重・eGFR・ALT・脂質代謝の変化, 第61回日本糖尿病学会年次学術集会, May 2018.
166.	Ken-ichi Aihara, 上元良子, 石川カズ江, Kana Morimoto, 桝田志保, Hiroki Yamagami, Yuki Yamaguchi, Tomoyo Hara, 細井美希, Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, 明比祐子, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa, Hiroyuki Azuma and Masahiro Abe : 生活習慣病患者の尿中酸化ストレス指標における糖尿病および薬物療法の影響, 第61回日本糖尿病学会年次学術集会, May 2018.
167.	Sumiko Yoshida, 原倫世, 細井美希, 山上紘規, 山口佑樹, 桝田志保, Kiyoe Kurahashi, Akio Kuroda, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Seiji Fukumoto, Daisuke Hamada, Munehide Matsuhisa and Masahiro Abe : 待機的高リスク整形外科手術における血糖管理の効果, 第91回日本内分泌学会学術総会, Apr. 2018.
168.	Akio Kuroda : カーボカウントの理論と実際, 第52回糖尿病の進歩, Mar. 2018.
169.	Tomoyo Hara, 桝田志保, Sumiko Yoshida, 細井美希, 山上紘規, 山口佑樹, Kiyoe Kurahashi, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Masahiro Abe : 急性合併症を来した高齢1型糖尿病の2症例, 第29回日本老年医学会四国地方会, Feb. 2018.
170.	Tomoyo Hara, Kiyoe Kurahashi, Kana Morimoto, 細井美希, Hiroki Yamagami, 山口佑樹, 桝田志保, Sumiko Yoshida, Akio Kuroda, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa, Yoshimi Bando and Seiji Fukumoto : オクトレオチドが有効であったGH-TSH同時産生下垂体腺腫の一例, 第27回臨床内分泌代謝Update, Nov. 2017.
171.	桝田志保, 明比祐子, Sumiko Yoshida, Hiroki Yamagami, Yuki Yamaguchi, 細井美希, Tomoyo Hara, Kiyoe Kurahashi, Itsuro Endo, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Makoto Funaki and 福本誠ニ : 123I-MIBGシンチグラフィ陽性の副腎皮質腺腫の一例, 第27回臨床内分泌代謝Update抄録集, Nov. 2017.
172.	細井美希, Kana Morimoto, Takeshi Kondo, Hiroki Yamagami, Yuki Yamaguchi, Tomoyo Hara, 桝田志保, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, 明比祐子, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa and 福本誠ニ : 多発性骨髄腫治療を契機にプランマー病と判明した一例, 第27回臨床内分泌代謝Update抄録集, Nov. 2017.
173.	斎村玉緒, 鶴尾美穂, Akio Kuroda, Tomoyuki Yuasa, 加部一行, Mizuho Kinouchi, Sumiko Yoshida, Hiroki Yamagami, Takeshi Kondo, 西正晴, 松本直也, Toshio Matsumoto, Masahiro Abe, 寺澤敏秀 and Munehide Matsuhisa : フラッシュグルコースモニタリングシステムにより施設入所可能となった高齢1型糖尿病の一例, 日本糖尿病学会中国四国地方会第55回総会抄録集, Nov. 2017.
174.	Yuki Yamaguchi, Sumiko Yoshida, Tomoyo Hara, 細井美希, Hiroki Yamagami, 桝田志保, Kiyoe Kurahashi, Akio Kuroda, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, 福本誠ニ, Masahiro Abe, Hideya Kashihara, Kouzou Yoshikawa and Munehide Matsuhisa : 高度肥満症に対するスリーブ状胃切除術の長期の耐糖能異常改善効果の検討, 日本糖尿病学会中国四国地方会第55回総会抄録集, Nov. 2017.
175.	Naoto Kunikata, Sumiko Yoshida, Tomoyo Hara, 細井美希, Hiroki Yamagami, Yuki Yamaguchi, 桝田志保, Kiyoe Kurahashi, Akio Kuroda, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, 福本誠ニ, Masahiro Abe, Daisuke Hamada and Munehide Matsuhisa : 待機的整形外科手術の術後経過における糖尿病の影響, 日本糖尿病学会中国四国地方会第55回総会抄録集, Nov. 2017.
176.	Mami Ohishi, Hiroyasu Mori, 鈴木麗子, 明比祐子, Akio Kuroda, Motoyuki Tamaki, Satoshi Taniguchi, Masashi Ishizu, Hiroshi Sakaue and Munehide Matsuhisa : 急速進行性糖尿病腎症に関連するリスク因子の検討, 日本糖尿病学会中国四国地方会第55回総会抄録集, Nov. 2017.
177.	細井美希, Kiyoe Kurahashi, Tomoyo Hara, Yuki Yamaguchi, Hiroki Yamagami, 桝田志保, Sumiko Yoshida, Akio Kuroda, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, 福本誠ニ and Munehide Matsuhisa : 低血糖脳症をきたしたACTH単独欠損症合併1型糖尿病の一例, 日本糖尿病学会中国四国地方会第55回総会抄録集, Nov. 2017.
178.	鶴尾美穂, Toshio Matsumoto, Akio Kuroda, Tomoyuki Yuasa, 加部一行, Takeshi Kondo, Mizuho Kinouchi, 井野口卓, Hiroki Yamagami, 松本直也, 西正晴, 寺澤敏秀, Masahiro Abe and Munehide Matsuhisa : SLADHを発症した高齢1型糖尿病の一例, 日本糖尿病学会中国四国地方会第55回総会抄録集, Nov. 2017.
179.	Akio Kuroda : 応用カーボカウントのエビデンスと糖尿病合併症:果たして合併症の発症・進展予防に役立つのか, 第32回日本糖尿病合併症学会, Oct. 2017.
180.	Hiroyasu Mori, Mami Ohishi, 鈴木麗子, Akio Kuroda, Satoshi Taniguchi, Motoyuki Tamaki, 明比祐子, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki and Munehide Matsuhisa : 2型糖尿病患者における末梢神経障害の合併が骨格筋力の質的低下に及ぼす影響, 第32回日本糖尿病合併症学会, Oct. 2017.
181.	原倫世, Sumiko Yoshida, 山上紘規, 山口佑樹, 細井美希, 桝田志保, Kiyoe Kurahashi, Itsuro Endo, 明比祐子, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Makoto Funaki and Seiji Fukumoto : Frequent syncope and marked blood pressure fluctuation due to antiparkinson drugs: A case report, 2017年10月20日-22日ひめぎんホール, Oct. 2017.
182.	Tomoyo Hara, Sumiko Yoshida, 山上紘規, 山口佑樹, 細井美希, 桝田志保, Kiyoe Kurahashi, Itsuro Endo, 明比祐子, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Makoto Funaki and Seiji Fukumoto : 抗パーキンソン病薬により頻回な失神と著明な血圧変動をきたした一例, 第40回日本高血圧学会総会, Oct. 2017.
183.	山上紘規, Kiyoe Kurahashi, 山口佑樹, 細井美希, 原倫世, 桝田志保, Sumiko Yoshida, Itsuro Endo, 明比祐子, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Makoto Funaki and Seiji Fukumoto : バセドウ病とTSH産生下垂体腺腫の合併の一例, 第60回日本甲状腺学会学術集会, Oct. 2017.
184.	細井美希, Sumiko Yoshida, 山上紘規, 山口佑樹, 原倫世, 桝田志保, Kiyoe Kurahashi, Itsuro Endo, 明比祐子, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Makoto Funaki and Seiji Fukumoto : 無セルロプラスミン血症に合併した甲状腺乳頭癌の一例, 第60回日本甲状腺学会学術集会, Oct. 2017.
185.	Akio Kuroda : 急性代謝障害, 第6回くすりと糖尿病学会学術集会教育講演, Sep. 2017.
186.	桝田志保, Kiyoe Kurahashi, Takeshi Kondo, 細井美希, Yuki Yamaguchi, Tomoyo Hara, Hiroki Yamagami, Sumiko Yoshida, Akio Kuroda, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa, Makoto Funaki and 福本誠ニ : デノスマブ投与により術後の血清Ca/P値を容易に管理しえた巨大異所性副甲状腺腺腫の一例, 第17回日本内分泌学会四国支部学術集会抄録集, Sep. 2017.
187.	Tomoyo Hara, Sumiko Yoshida, Yuki Yamaguchi, 細井美希, Hiroki Yamagami, 桝田志保, Kiyoe Kurahashi, Akio Kuroda, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa, Makoto Funaki, 福本誠ニ and Masahiro Abe : 当院での免疫チェックポイント阻害薬による下垂体機能低下症の5例, 第17回日本内分泌学会四国支部学術集会抄録集, Sep. 2017.
188.	山口佑樹, Sumiko Yoshida, 細井美希, 山上紘規, 原倫世, 桝田志保, Kiyoe Kurahashi, Akio Kuroda, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa, Makoto Funaki, Seiji Fukumoto and Hiromitsu Takizawa : 当院での免疫チェックポインント阻害薬による内分泌異常の発生と有害事象対策, 第255回徳島医学会学術集会(平成29年度夏期), Aug. 2017.
189.	Akio Kuroda : 人工膵臓の最前線とその展望, 第255回徳島医学会学術集会, Aug. 2017.
190.	Kana Morimoto, 桝田志保, Kiyoe Kurahashi, Motoyuki Tamaki, Takeshi Kondo, Sumiko Yoshida, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Seiji Fukumoto, Munehide Matsuhisa, Masahiro Abe, Hiroyuki Azuma and Ken-ichi Aihara : 生活習慣病患者における血管内皮機能制御に関わる臨床指標の検討, 第49回日本動脈硬化学会総会・学術集会, Jul. 2017.
191.	Sumiko Yoshida, Ken-ichi Aihara, Kiyoe Kurahashi, Takeshi Kondo, Kana Morimoto, Motoyuki Tamaki, Tomoyuki Yuasa, Akio Kuroda, 明比祐子, Itsuro Endo, Makoto Funaki, 福本誠ニ and Munehide Matsuhisa : 糖尿病教育入院での酸化ストレスマーカーの変化の検討, 第60回日本糖尿病学会年次学術集会抄録集, May 2017.
192.	Motoyuki Tamaki, Akio Kuroda, Kiyoe Kurahashi, Ken-ichi Aihara, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, 山口普史, 白神敦久 and Munehide Matsuhisa : 課程用電気筋刺激装置(EMS)の10週間継続使用は運動障害を有する2型糖尿病患者の血糖コントロールを改善する, 第60回日本糖尿病学会年次学術集会抄録集, May 2017.
193.	Akio Kuroda : リアルタイムCGMの最前線, 第60回日本糖尿病学会年次学術集会, May 2017.
194.	Kana Morimoto, 桝田志保, Kiyoe Kurahashi, Motoyuki Tamaki, Takeshi Kondo, Sumiko Yoshida, Tomoyuki Yuasa, Akio Kuroda, 明比祐子, Itsuro Endo, Makoto Funaki, 福本誠ニ, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : 糖尿病患者における自律神経機能をアルブミン尿の相互関連および各病態に影響を及ぼす因子解析, 第60回日本糖尿病学会年次学術集会, May 2017.
195.	Michiko Araki, Hiroyasu Mori, Akio Kuroda, 鈴木麗子, Mami Ohishi, Satoshi Taniguchi, Motoyuki Tamaki, 明比祐子, Hiroshi Sakaue, Kiyoe Kurahashi, Takeshi Kondo, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki and Munehide Matsuhisa : 1型糖尿病患者における血清IGF-1とサルコペニア罹患との関連, 第60回日本糖尿病学会年次学術集会, May 2017.
196.	秦誠倫, 入江暢子, 竹本有里, 永田慎平, 藤井浩平, 白木梓, 片岡隆太郎, 大楠崇弘, 坂本扶美枝, 河盛段, 片上直人, Akio Kuroda, 松岡孝昭, Munehide Matsuhisa, 下村伊一郎 and 安田哲行 : 1型糖尿病患者の骨格筋量に影響を及ぼす因子，および骨格筋量と糖尿病合併症の関連についての検討, 第60回日本糖尿病学会年次学術集会抄録集, May 2017.
197.	Hiroyasu Mori, Akio Kuroda, Michiko Araki, 鈴木麗子, Mami Ohishi, Satoshi Taniguchi, Motoyuki Tamaki, 明比祐子, Kiyoe Kurahashi, Takeshi Kondo, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki and Munehide Matsuhisa : 2型糖尿病患者における皮下AGE蓄積が筋機能低下に及ぼす影響, 第60回日本糖尿病学会年次学術集会抄録集, May 2017.
198.	Satoshi Taniguchi, 天満仁, Akio Kuroda, 堀江徹, Hiroyasu Mori, 鈴木麗子, 浅野弥生, Michiko Araki, Yuu Tamaki and Munehide Matsuhisa : EHR自己測定機器と連係したPHRの開発と有用性の検証, 第60回日本糖尿病学会年次学術講演会抄録集, May 2017.
199.	Sumiko Yoshida, Akio Kuroda, Minoru Irahara, Kiyoe Kurahashi, Takeshi Kondo, Itsuro Endo, Ken-ichi Aihara and Munehide Matsuhisa : 加重型妊娠高血圧腎症を来し集学的治療で分娩に至った糖尿病腎症の2症例, 第6回臨床高血圧フォーラム, May 2017.
200.	Kana Morimoto, Yuka Takahashi, Saori Yamashita, 上元良子, 石川カズ江, Kiyoe Kurahashi, Takeshi Kondo, Sumiko Yoshida, Akio Kuroda, Itsuro Endo, Tomoyuki Yuasa, Munehide Matsuhisa, 東博之, Masahiro Abe and Ken-ichi Aihara : 生活習慣病患者の血管内皮機能に関わる因子の臨床的検討, 第90回日本内分泌学会学術集会抄録集, Apr. 2017.
201.	Akio Kuroda : インスリンポンプの療養指導, 第51回糖尿病学の進歩, Feb. 2017.
202.	Michiko Araki, Hiroyasu Mori, Akio Kuroda, 鈴木麗子, Mami Ohishi, Satoshi Taniguchi, Motoyuki Tamaki, 明比祐子, Hiroshi Sakaue and Munehide Matsuhisa : 1型糖尿病患者の血清IGF-1がサルコペニア羅患に及ぼす影響, 第20回日本病態栄養学会年次学術集会, Jan. 2017.
203.	Hiroyasu Mori, Akio Kuroda, Michiko Araki, 鈴木麗子, Mami Ohishi, Satoshi Taniguchi, Motoyuki Tamaki, 明比祐子, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki and Munehide Matsuhisa : 2型糖尿病患者におけるサルコペニアのリスク因子解析, 第51回日本成人病学会学術集会, Jan. 2017.
204.	桝田志保, Sumiko Yoshida, Kiyoe Kurahashi, Takeshi Kondo, Itsuro Endo, Masahiro Abe, Akio Kuroda, Munehide Matsuhisa, Ken-ichi Aihara and Seiji Fukumoto : メーグルコシダーゼ阻害薬による腸管気腫症の一例, 第115回日本内科学会四国地方会, Nov. 2016.
205.	Tomoyo Hara, Kiyoe Kurahashi, Takeshi Kondo, Sumiko Yoshida, Itsuro Endo, Akio Kuroda, Munehide Matsuhisa, Ken-ichi Aihara and Seiji Fukumoto : イピリムマブ投与後に続発性副腎不全を発症した一例, 第115回日本内科学会四国地方会, Nov. 2016.
206.	上田浩之, Itsuro Endo, Takeshi Kondo, Kiyoe Kurahashi, Sumiko Yoshida, Masahiro Abe, Akio Kuroda, Munehide Matsuhisa, Ken-ichi Aihara and Seiji Fukumoto : デノスマブによる耐糖能改善, 第115回日本内科学会四国地方会, Nov. 2016.
207.	Takeshi Kondo, Itsuro Endo, 明比祐子, Kiyoe Kurahashi, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Masahiro Abe and Seiji Fukumoto : 免疫チェックポイント阻害剤で中枢性副腎不全を来した2例, 第26回臨床内分泌代謝Update, Nov. 2016.
208.	岡本恵暢, Sumiko Yoshida, Kiyoe Kurahashi, Takeshi Kondo, Kana Morimoto, Motoyuki Tamaki, Akio Kuroda, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Munehide Matsuhisa and Seiji Fukumoto : IGF-2産生神経内分泌癌による重症低血糖の一例, 第26回臨床内分泌代謝Update, Nov. 2016.
209.	Sumiko Yoshida, Kiyoe Kurahashi, Takeshi Kondo, Kana Morimoto, Motoyuki Tamaki, Akio Kuroda, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Munehide Matsuhisa and Seiji Fukumoto : 当院のニボルマブおよびイピリムマブ投与21例の内分泌異常の検討, 第26回臨床内分泌代謝Update, Nov. 2016.
210.	Mami Ohishi, Satoshi Taniguchi, 明比祐子, Hiroyasu Mori, Yuu Tamaki, Akio Kuroda, Motoyuki Tamaki, Michiko Araki, Hiroshi Sakaue and Munehide Matsuhisa : eGFR変化量を用いた透析導入高リスク群抽出アルゴリズムの妥当性の検討, 日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
211.	Satoshi Taniguchi, 天満仁, Akio Kuroda, 堀江徹, Hiroyasu Mori, 鈴木麗子, 浅野弥生, Michiko Araki, Yuu Tamaki and Munehide Matsuhisa : EHRと連係したPHRの開発と有用性の検証, 日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
212.	山下沙織, Sumiko Yoshida, 高橋優花, Ken-ichi Aihara, Kiyoe Kurahashi, Takeshi Kondo, Kana Morimoto, Motoyuki Tamaki, Tomoyuki Yuasa, Akio Kuroda, 明比祐子, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa and Masahiro Abe : 糖尿病教育入院における酸化ストレス減少に影響を及ぼす因子の検討, 日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
213.	鶴尾美穂, Akio Kuroda, Tomoyuki Yuasa, Takeshi Kondo, Mizuho Kinouchi, Naoko Matsui, 細井恵美子, Masahiro Abe, Toshio Matsumoto, Munehide Matsuhisa and 寺澤敏秀 : γグロブリン療養後に一過性のGAD抗体価上昇がみられた糖尿病の一例, 日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
214.	Michiko Araki, Hiroyasu Mori, Akio Kuroda, 鈴木麗子, Mami Ohishi, Satoshi Taniguchi, Motoyuki Tamaki, 明比祐子, Hiroshi Sakaue, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki and Munehide Matsuhisa : 1型糖尿病患者の血清IGF-1がサルコペニア罹患に及ぼす影響, 日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
215.	Hiroyasu Mori, Akio Kuroda, Michiko Araki, 鈴木麗子, Mami Ohishi, Satoshi Taniguchi, Motoyuki Tamaki, 明比祐子, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki and Munehide Matsuhisa : 2型糖尿病患者におけるAGE蓄積とサルコペニアとの関連の検討, 日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
216.	斎村玉緒, 鶴尾美穂, Akio Kuroda, Takeshi Kondo, Tomoyuki Yuasa, Mizuho Kinouchi, Masahiro Abe, Toshio Matsumoto, 寺澤敏秀 and Munehide Matsuhisa : インスリンポンプの院内検定の試み, 日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
217.	荒瀬美晴, Takeshi Kondo, Akio Kuroda, Kiyoe Kurahashi, Motoyuki Tamaki, Sumiko Yoshida, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Seiji Fukumoto, Masahiro Abe and Munehide Matsuhisa : 術前後で持続血糖モニター(CGM)を比較したアドレナリン優位褐色細胞腫の二例, 日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
218.	上田浩之, Takeshi Kondo, Akio Kuroda, Kiyoe Kurahashi, Motoyuki Tamaki, Sumiko Yoshida, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Seiji Fukumoto, Masahiro Abe and Munehide Matsuhisa : 基礎インスリンが不要であった膵性糖尿病の一例, 日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
219.	Kana Morimoto, 桝田志保, Kiyoe Kurahashi, Motoyuki Tamaki, Takeshi Kondo, Sumiko Yoshida, Tomoyuki Yuasa, Akio Kuroda, 明比祐子, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : 糖尿病患者における心電図R-R間隔変動係数に影響を及ぼす因子の検討, 日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
220.	Michiko Araki, Hiroyasu Mori, Akio Kuroda, 鈴木麗子, Mami Ohishi, Satoshi Taniguchi, Motoyuki Tamaki, 明比祐子, Hiroshi Sakaue, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki and Munehide Matsuhisa : 1型糖尿病患者の血清IGF-1がサルコペニア罹患に及ぼす影響, 第14回1型糖尿病研究会, Nov. 2016.
221.	大澤彩恵子, 片上直人, 高原充佳, 坂本扶美枝, 河盛段, 松岡孝昭, Akio Kuroda, Munehide Matsuhisa and 下村伊一郎 : 1型糖尿病患者における皮下AGEs蓄積量と糖尿病血管合併症との関連の検討, 第14回1型糖尿病研究会, Nov. 2016.
222.	Akio Kuroda : 1型糖尿病治療の現在と未来, 第16回中四国糖尿病研修セミナー, Sep. 2016.
223.	高橋優花, 山下沙織, Sumiko Yoshida, 桝田志保, Kana Morimoto, Kiyoe Kurahashi, Motoyuki Tamaki, Takeshi Kondo, Akio Kuroda, Tomoyuki Yuasa, Itsuro Endo, Munehide Matsuhisa, Seiji Fukumoto, Hiroyuki Azuma, Masahiro Abe and Ken-ichi Aihara : 生活習慣病患者における血管内皮機能正常群および低下群の臨床指標に関する検討, 第16回日本内分泌学会四国支部学術集会, Sep. 2016.
224.	山上紘規, Kiyoe Kurahashi, Kana Morimoto, Takeshi Kondo, Itsuro Endo, 明比祐子, Sumiko Yoshida, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Seiji Fukumoto and Masahiro Abe : バセドウ病を合併したTSH産生下垂体腺腫の一例, 第16回日本内分泌学会四国支部学術集会, Sep. 2016.
225.	Satoshi Taniguchi, 天満仁, Akio Kuroda, 堀江徹, Hiroyasu Mori, 鈴木麗子, 浅野弥生, Michiko Araki, Yuu Tamaki and Munehide Matsuhisa : EHRとPHRの開発と従来の紙媒体記録との比較検証, 第16回日本糖尿病情報学会年次学術集会, Sep. 2016.
226.	遠藤ふうり, Kiyoe Kurahashi, Kana Morimoto, Takeshi Kondo, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Akio Kuroda, 明比祐子, Makoto Funaki, Munehide Matsuhisa, Seiji Fukumoto and Masahiro Abe : 日和見感染を合併したACTH依存性Cushing症候群の1例, 第253回徳島医学会学術集会(平成28年度夏期), Jul. 2016.
227.	Michiko Araki, Hiroyasu Mori, 鈴木麗子, Satoshi Taniguchi, Motoyuki Tamaki, 明比祐子, Akio Kuroda, Hiroshi Sakaue and Munehide Matsuhisa : 1型糖尿病患者における血清IGF-1の低下とサルコペニア羅漢との関連, 第253回徳島医学会学術集会, Jul. 2016.
228.	Akio Kuroda : 医療従事者兼患者の視点から見たインスリンポンプとSAPについて, 1型糖尿病先進治療大阪サミット2016, Jul. 2016.
229.	Satoshi Taniguchi, Munehide Matsuhisa, Hiroyasu Mori, Akio Kuroda and Yuu Tamaki : The Effects of using PHR on Self-management Activities in Patients with Diabetes, The 10th Anniversary Meeting of the Japana Association of Applied IT Healthcare, May 2016. (Keyword) PHR / self-management / diabetes mellitus
230.	橋本晶慶, 鶴尾美穂, 秋田賢子, 森岡隆子, Akio Kuroda, Tomoyuki Yuasa, Takeshi Kondo, Mizuho Kinouchi, Toshio Matsumoto, Masahiro Abe, Munehide Matsuhisa and 寺澤敏秀 : 糖尿病教室のスタッフ間の相互評価による改善効果, 第59回日本糖尿病学会年次学術集会, May 2016.
231.	Sumiko Yoshida, Ken-ichi Aihara, Kana Morimoto, Kiyoe Kurahashi, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, Itsuro Endo, 明比祐子, Makoto Funaki, Seiji Fukumoto and Munehide Matsuhisa : 当院検診受診者における筋肉量がメタボリックパラメーターに及ぼす影響の検討, 第59回日本糖尿病学会年次学術集会, May 2016.
232.	宮下和幸, 高原充佳, 坂本扶美枝, 片上直人, 松岡孝昭, Akio Kuroda, Munehide Matsuhisa, 山崎義光, 伊藤壽記, 今川彰久 and 下村伊一郎 : 膵移植後グラフト機能評価としてのアルギニン負荷試験の有用性, 第59回日本糖尿病学会年次学術集会, May 2016.
233.	大澤彩恵子, 片上直人, 高原充佳, 坂本扶美枝, 河盛段, 松岡孝昭, Akio Kuroda, Munehide Matsuhisa and 下村伊一郎 : 1型糖尿病患者における皮下AGEsの蓄積量と糖尿病血管合併症との関連の検討, 第59回日本糖尿病学会年次学術集会, May 2016.
234.	Hiroyasu Mori, Michiko Araki, 鈴木麗子, Akio Kuroda, Motoyuki Tamaki, 明比祐子 and Munehide Matsuhisa : 1型糖尿病患者における皮下AGEsの蓄積が筋機能低下に及ぼす影響, 第59回日本糖尿病学会年次学術集会, May 2016.
235.	Kana Morimoto, Ken-ichi Aihara, Sumiko Yoshida, Kiyoe Kurahashi, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa and Masahiro Abe : 減塩による2型糖尿病入院症例の降圧予測指標, 第59回日本糖尿病学会年次学術集会, May 2016.
236.	Sumiko Yoshida, Ken-ichi Aihara, Kana Morimoto, Kiyoe Kurahashi, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, Itsuro Endo, 明比祐子, Makoto Funaki, Seiji Fukumoto and Munehide Matsuhisa : 当院検診受診者における筋肉量が高血圧に及ぼす影響の検討, 第5回臨床高血圧フォーラム, May 2016.
237.	Kana Morimoto, Ken-ichi Aihara, Sumiko Yoshida, Kiyoe Kurahashi, Motoyuki Tamaki, Takeshi Kondo, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Masahiro Abe : 血糖管理入院症例における減塩降圧効果と関連する因子および降圧薬に関する検討, 第5回臨床高血圧フォーラム, May 2016.
238.	Kana Morimoto, Ken-ichi Aihara, Sumiko Yoshida, Kiyoe Kurahashi, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Masahiro Abe : 2型糖尿病患者の塩分制限による降圧効果を規定する因子の検討, 第89回日本内分泌学会学術総会, Apr. 2016.
239.	Ken-ichi Aihara, Sumiko Yoshida, Kana Morimoto, Kiyoe Kurahashi, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Masahiro Abe : 心筋リモデリングおよび頸動脈硬化症におけるアンジオテンシンII受容体拮抗薬の効果検証, 第89回日本内分泌学会学術総会, Apr. 2016.
240.	宮下和幸, 高原充佳, 坂本扶美枝, Akio Kuroda, 浅岡忠史, 片上直人, 種村匡弘, 江口英利, 今川彰久, Munehide Matsuhisa, 山崎義光, 伊藤壽記 and 下村伊一郎 : 当院における膵移植後患者の移植膵機能の推移, 第43回日本膵・膵島移植研究会ホテルグランビア広島, Mar. 2016.
241.	Akio Kuroda : 学ぶ順番は基礎カーボカウント→血糖補足→応用カーボカウント→経験則, 第50回糖尿病学の進歩, Feb. 2016.
242.	Akio Kuroda : カーボカウンティング, 第50回糖尿病学の進歩, Feb. 2016.
243.	山上紘規, Kiyoe Kurahashi, 森本佳奈, Takeshi Kondo, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Akio Kuroda, 明比祐子, Makoto Funaki, Munehide Matsuhisa, Seiji Fukumoto and Masahiro Abe : インターフェロンβ治療中に糖尿病ケトアシドーシスを契機とし，急性発症1A型糖尿病と診断された一例, 第252回徳島医学会学術集会長井記念ホール, Feb. 2016.
244.	森本佳奈, Ken-ichi Aihara, Sumiko Yoshida, Kiyoe Kurahashi, Motoyuki Tamaki, Takeshi Kondo, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Masahiro Abe : 2型糖尿病患者における血糖指標と減塩がもたらす血圧低下との連関, 第252回徳島医学会学術集会長井記念ホール, Feb. 2016.
245.	森本佳奈, Takeshi Kondo, Itsuro Endo, 倉橋清衛, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe : 著明な低カルシウム血症を来した胃癌の骨転移の一例, 第25回臨床内分泌Update, Nov. 2015.
246.	小山広士, Takeshi Kondo, 森本佳奈, Itsuro Endo, 倉橋清衛, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe : ACTH，コルチゾール基礎値正常のACTH単独欠損症の一例, 第25回臨床内分泌Update, Nov. 2015.
247.	Takeshi Kondo, Itsuro Endo, 森本佳奈, 倉橋清衛, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe : テタニーで来院し，Gitelman症候群を疑った一例, 第25回臨床内分泌Update, Nov. 2015.
248.	Akio Kuroda : センサー付きインスリンポンプ療法を成功させるために, 第15回日本先進糖尿病治療研究会, Nov. 2015.
249.	Ken-ichi Aihara, Sumiko Yoshida, Kana Morimoto, Kiyoe Kurahashi, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, 明比祐子, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa and Masahiro Abe : 2型糖尿病患者の左室形態および機能における強化インスリン療法の効果, 日本糖尿病学会第53回中国四国地方会, Oct. 2015.
250.	鶴尾美穂, Akio Kuroda, Takeshi Kondo, Tomoyuki Yuasa, Mizuho Kinouchi, Masahiro Abe, Toshio Matsumoto, Munehide Matsuhisa and 寺澤敏秀 : Sensor Angmented Pump(SAP)療法が有効であった高齢1型糖尿病の1例, 第53回日本糖尿病学会中国四国地方会, Oct. 2015.
251.	森岡隆子, 鶴尾美穂, Akio Kuroda, Tomoyuki Yuasa, Takeshi Kondo, Mizuho Kinouchi, Toshio Matsumoto, Munehide Matsuhisa and 寺澤敏秀 : SGLT2阻害薬が著効したprader, 第53回日本糖尿病学会中国四国地方会米子コンベンションセンター, Oct. 2015.
252.	岡田祐輝, Takeshi Kondo, 森本佳奈, Kiyoe Kurahashi, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe : 高CPR血症からグリメピリド誤内服を診断し得た遷延性低血糖の一例, 第53回日本糖尿病学会中国四国地方会米子コンベンションセンター, Oct. 2015.
253.	Ken-ichi Aihara, Sumiko Yoshida, 森本佳奈, Kiyoe Kurahashi, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, 明比祐子, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa and Masahiro Abe : 2型糖尿病患者の左室形態および機能における強化インスリン療法の効果, 第53回日本糖尿病学会中国・四国地方会米子コンベンションセンター, Oct. 2015.
254.	Hiroyasu Mori, Munehide Matsuhisa, Akio Kuroda, Motoyuki Tamaki, Satoshi Taniguchi, Yuu Tamaki, 大塚明廣, Yoshihiko Noma and 徳島県医師会糖尿病対策班 : 徳島県の糖尿病診療の現状と課題∼平成22年と26年の比較∼, 第53回日本糖尿病学会中国・四国地方会米子コンベンションセンター, Oct. 2015.
255.	林亜紀, Sumiko Yoshida, Akio Kuroda, 七篠あつ子, Minoru Irahara, 鶴尾美穂, 森本佳奈, 倉橋清衛, Takeshi Kondo, Motoyuki Tamaki, 明比祐子, Itsuro Endo, Makoto Funaki, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe : 分娩前に10g/日以上の蛋白尿を合併し，出産に至った糖尿病腎症の1例, 日本糖尿病学会中国四国地方会第53回総会, Oct. 2015.
256.	荒木迪子, Hiroyasu Mori, Hisami Okumura, 多々納浩, Motoyuki Tamaki, Akio Kuroda, Hiroshi Sakaue and Munehide Matsuhisa : 食事エネルギー密度は日本人2型糖尿病患者の肥満と関連する, 第53回日本糖尿病学会中国四国地方会米子コンベンションセンター, Oct. 2015.
257.	Satoshi Taniguchi, Akio Kuroda, Motoyuki Tamaki, Hwa In, 森本佳奈, Kiyoe Kurahashi, Takeshi Kondo, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe and Munehide Matsuhisa : CGM iPRO2と人工膵臓STG-55との測定グルコース濃度の比較, 第53回日本糖尿病学会中国・四国地方会米子コンベンションセンター, Oct. 2015.
258.	Hisami Okumura, 和田宵湖, 新井田裕樹, Hideya Kashihara, Masaaki Nishi, Kouzou Yoshikawa, 森本佳奈, 倉橋清衛, Takeshi Kondo, Sumiko Yoshida, Motoyuki Tamaki, Akio Kuroda, 明比祐子, Itsuro Endo, Ken-ichi Aihara, Mitsuo Shimada and Munehide Matsuhisa : 本院の腹腔鏡下袖状胃切除術後1年で異なった経過を示した2症例の報告, 第53回糖尿病学会中四国大会, Oct. 2015.
259.	森本佳奈, Ken-ichi Aihara, Sumiko Yoshida, 倉橋清衛, Motoyuki Tamaki, Takeshi Kondo, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Masahiro Abe : Significance of glycemic markers for sodium restriction-induced blood pressure reduction in hospitalized patients with type 2 diabetes, 第38日本高血圧学会総会, Oct. 2015.
260.	Ken-ichi Aihara, Sumiko Yoshida, 森本佳奈, 倉橋清衛, Motoyuki Tamaki, Takeshi Kondo, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Masahiro Abe : Evaluation for long-term efficacy of angiotensin II receptor blocker-based antihypertensive therapy on cardiac remodeling and carotid atherosclerosis, 第38日本高血圧学会総会, Oct. 2015.
261.	森本佳奈, Takeshi Kondo, Itsuro Endo, Kiyoe Kurahashi, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe : 診断まで長時間を要したACTH分泌低下症の一例, 第15回日本内分泌学会四国支部学術集会高知大学, Sep. 2015.
262.	加藤正樹, 森本佳奈, Ken-ichi Aihara, Sumiko Yoshida, 倉橋清衛, Motoyuki Tamaki, Takeshi Kondo, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Seiji Fukumoto and Masahiro Abe : 2型糖尿病患者の減塩療法による血圧低下に関連する因子の解析, 第15回日本内分泌学会四国支部学術集会, Sep. 2015.
263.	Satoshi Taniguchi, Yuu Tamaki, Motoyuki Tamaki, Akio Kuroda, 田蒔正治, 林秀樹 and Munehide Matsuhisa : 多職種による在宅糖尿病患者ケアにおける医療介護情報連携システム活用の有用性検証, 第15回日本糖尿病情報学会年次学術集会, Aug. 2015.
264.	Hiroyasu Mori, Munehide Matsuhisa, Akio Kuroda, Motoyuki Tamaki, Satoshi Taniguchi, Yuu Tamaki, Yoshihiko Noma and 大塚明廣 : 徳島県における糖尿病の治療中断と地域医療連携の推進に関連する医療側の課題の検討, 第15回日本糖尿病情報学会年次学術集会, Aug. 2015.
265.	荒木迪子, Hiroyasu Mori, Hisami Okumura, 鞍田三貴, 福尾惠介, Motoyuki Tamaki, Akio Kuroda, Hiroshi Sakaue and Munehide Matsuhisa : 低エネルギー密度食が2型糖尿病患者の食行動や代謝改善に与える効果の検討, 第251回徳島医学会学術集会ポスター, Aug. 2015.
266.	森本佳奈, Ken-ichi Aihara, Sumiko Yoshida, 倉橋清衛, Motoyuki Tamaki, Takeshi Kondo, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Masahiro Abe : 2型糖尿病における血糖指標と減塩がもたらす血圧低下との連関, 第251回徳島医学会学術集会ポスター, Aug. 2015.
267.	Akio Kuroda : SAPの使用経験, 第21回小児思春期糖尿病治療研究会, Jul. 2015.
268.	Yuu Tamaki, Munehide Matsuhisa, Akio Kuroda, Motoyuki Tamaki, Satoshi Taniguchi and Hiroyasu Mori : Construction of Electronic Health Record using IHE profiles, 第19回日本医療情報学会春季学術大会, Jun. 2015.
269.	後藤廣平, 鶴尾美穂, Akio Kuroda, 伊澤真弓, Mizuho Kinouchi, Takeshi Kondo, Tomoyuki Yuasa, Toshio Matsumoto, Munehide Matsuhisa and 寺澤敏秀 : SGLT2阻害薬の強化インスリン療法への併用効果の検討, 第58回日本糖尿病学会年次学術集会口演, May 2015.
270.	宮下和幸, 高原充佳, 坂本扶美枝, Akio Kuroda, 安田哲行, 片上直人, 松岡孝昭, 山﨑義光, 伊藤壽記, Munehide Matsuhisa, 今川彰久 and 下村伊一郎 : 膵移植患者における移植膵機能の推移の検討口演, 第58回日本糖尿病学会年次学術集会, May 2015.
271.	Akio Kuroda : インスリンポンプ療法を推奨する側から, 第58回日本糖尿病学会年次学術集会, May 2015.
272.	池田雅彦, Akio Kuroda, Motoyuki Tamaki, 賀川義光, 能勢洋介, 寺方孝守, 木村那智 and Munehide Matsuhisa : 全国ヤングDMカンファの現状と展望, 第58回日本糖尿病学会年次学術集会ポスター, May 2015.
273.	天満仁, 堀江徹, Hiroyasu Mori, Akio Kuroda and Munehide Matsuhisa : 2型糖尿病患者における皮下AGEと糖尿病血管合併症との関連の検討, 第58回日本糖尿病学会年次学術集会口演, May 2015.
274.	Ken-ichi Aihara, Sumiko Yoshida, 大黒由加里, Motoyuki Tamaki, Takeshi Kondo, 倉橋清衛, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto : ARB基盤高血圧治療の長期心腎保護効果における糖尿病の影響, 第58回総会日本糖尿病学会年次学術集会, May 2015.
275.	Akio Kuroda : Closed-loop Insulin Pump 療法のアップデート, 第58回日本糖尿病学会年次学術集会, May 2015.
276.	Ken-ichi Aihara, Sumiko Yoshida, 大黒由加里, 倉橋清衛, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto : 本態性高血圧患者におけるアンジオテンシンII受容体拮抗薬単独およびカルシウム拮抗薬併用による長期心筋保護効果の検証, 第88回日本内分泌学会学術総会, Apr. 2015.
277.	Motoyuki Tamaki, 藤谷与士夫, 原朱美, 福中彩子, 荻原健, 宮塚健, Akio Kuroda, Toshio Matsumoto, 河盛隆造, Munehide Matsuhisa and 綿田裕孝 : 糖尿病発症・進展に関わる新規メカニズムの解明, 第88回日本内分泌学会学術総会シンポジウム, Apr. 2015.
278.	Takeshi Kondo, Itsuro Endo, 大黒由加里, 倉橋清衛, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto : 遠位尿細管性アシドーシスの確定診断としてアミノレバンRは有用である．, 第112回日本内科学会総会・講演会, Apr. 2015.
279.	Akio Kuroda : リアルタイムCGMとインスリンポンプ療法の実際, 第49回糖尿病学の進歩, Feb. 2015.
280.	大黒由加里, Akio Kuroda, Motoyuki Tamaki, 倉橋清衛, Takeshi Kondo, 安芸菜奈子, Itsuro Endo, Ken-ichi Aihara, Toshio Matsumoto and Munehide Matsuhisa : 皮下注射による強化インスリン療養中の1型糖尿病患者における基礎インスリン比率の検討, 第250回徳島医学会学術集会(大塚講堂), Feb. 2015.
281.	Akio Kuroda, Takeshi Kondo, 安田哲行, 高原充佳, Ken-ichi Aihara, Itsuro Endo, 金藤秀明, 下村伊一郎, Toshio Matsumoto and Munehide Matsuhisa : インスリンポンプ療法での追加インスリン注入時間を規定する因子の検討, 第14回日本先進糖尿病治療研究会(あわぎんホール), Dec. 2014.
282.	大黒由加里, Akio Kuroda, Motoyuki Tamaki, 倉橋清衛, Takeshi Kondo, 安芸菜奈子, Itsuro Endo, Ken-ichi Aihara, Toshio Matsumoto and Munehide Matsuhisa : 皮下注射による強化インスリン療法1型糖尿病患者における基礎インスリン比率の検討, 第12回1型糖尿病研究会(イーグレ姫路), Nov. 2014.
283.	浅井廣平, 鶴尾美穂, Akio Kuroda, Tomoyuki Yuasa, 伊澤真弓, Takeshi Kondo, Mizuho Kinouchi, Toshio Matsumoto, Munehide Matsuhisa and 寺澤敏秀 : SGLT阻害薬の臨床効果の検討, 日本糖尿病学会中国四国地方会第52回総会, Oct. 2014.
284.	鶴尾美穂, Akio Kuroda, Tomoyuki Yuasa, 松本直也, Takeshi Kondo, Mizuho Kinouchi, Toshio Matsumoto, Munehide Matsuhisa and 寺澤敏秀 : SGLT2阻害薬が著効したPrader Willi syndrome 合併糖尿病の1例, 日本糖尿病学会中国四国地方会第52回総会, Oct. 2014.
285.	荒木迪子, Motoyuki Tamaki, Akio Kuroda, 大黒由加里, 倉橋清衛, Takeshi Kondo, Ken-ichi Aihara, Itsuro Endo, 安芸菜奈子, Toshio Matsumoto and Munehide Matsuhisa : 2型糖尿病患者におけるeGFRの妥当性について, 日本糖尿病学会中国四国地方会第52回総会, Oct. 2014.
286.	Motoyuki Tamaki, 荒木迪子, 野崎綾音, 大黒由加里, 倉橋清衛, Takeshi Kondo, Ken-ichi Aihara, Itsuro Endo, 安芸菜奈子, Toshio Matsumoto, Munehide Matsuhisa and Akio Kuroda : 肥満2型糖尿病患者のeGFRは24hrCCrと比較して過小評価されている, 第29回日本糖尿病合併症学会, Oct. 2014.
287.	森本佳奈, Ken-ichi Aihara, 大黒由加里, 倉橋清衛, Takeshi Kondo, Motoyuki Tamaki, 安藝菜奈子, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto : 多剤併用降圧療法と臓器障害モニタリングにより長期にわたり心腎大血管障害の改善が得られた加速型高血圧-悪性高血圧の1例, 第14回日本内分泌学会四国支部学術集会, Sep. 2014.
288.	Masato Tagi, Yuu Tamaki, Akio Kuroda, Munehide Matsuhisa and Hiroki Moriguchi : 報酬手段を利用した生活習慣改善の試み∼歩数量に応じたポイント付与∼, 日本糖尿病情報学会年次学術集会, Vol.14, Aug. 2014.
289.	Ken-ichi Aihara, 大黒由加里, 倉橋清衛, Takeshi Kondo, Mizuho Kinouchi, Itsuro Endo, Toshio Matsumoto, Motoyuki Tamaki, Akio Kuroda and Munehide Matsuhisa : エゼチミブとコレスチミドの併用で脂質プロフィルが改善した多発性筋炎合併家族性高コレステロール血症へテロ接合体の一例, 第110回日本内科学会四国地方会, Jun. 2014.
290.	森本佳奈, Ken-ichi Aihara, 大黒由加里, 倉橋清衛, Mizuho Kinouchi, Motoyuki Tamaki, 安藝菜奈子, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto : 多剤併用降圧療法により長期的な心・腎・大血管障害の改善が得られた高レニン性高血圧症の1例, 第3回臨床高血圧フォーラム, May 2014.
291.	Akio Kuroda : Pancreas Transplantation to the Brain ~Open Loop MD Logic Insulin Pump therapy, 第57回日本糖尿病学会年次学術集会会長特別講演(大阪国際会議場), May 2014.
292.	大黒由加里, Akio Kuroda, Motoyuki Tamaki, 倉橋清衛, Takeshi Kondo, Mizuho Kinouchi, 近藤絵里, Sumiko Yoshida, 安芸菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto : 皮下注射による強化インスリン療法1型糖尿病患者における基礎インスリン比率の検討, 第57回日本糖尿病学会年次学術集会口演, May 2014.
293.	Akio Kuroda : カーボカウントの功罪(是の立場), 第57回日本糖尿病学会年次学術集会(大阪国際会議場), May 2014.
294.	松本幸恵, 鶴尾美穂, Akio Kuroda, Tomoyuki Yuasa, 秋田賢子, Mizuho Kinouchi, Takeshi Kondo, Munehide Matsuhisa, Toshio Matsumoto and 寺澤敏秀 : 糖尿病患者の考える指示エネルギー量，指示主食量の調査とその介入, 第57回日本糖尿病学会年次学術集会口演, May 2014.
295.	松本幸恵, 鶴尾美穂, Akio Kuroda, Tomoyuki Yuasa, 秋田賢子, Mizuho Kinouchi, Takeshi Kondo, Munehide Matsuhisa, Toshio Matsumoto and 寺澤敏秀 : 糖尿病患者の考える指示エネルギー量，指示主食量の調査とその介入, 第57回日本糖尿病学会年次学術集会, May 2014.
296.	鶴尾美穂, 白神敦久, Munehide Matsuhisa, 福島泰江, 新谷保実, 小松まち子, 藤中雄一, 天満仁, Akio Kuroda, 安芸菜奈子, 大島康志, 金崎淑子, Tomoyuki Yuasa, 近藤絵里, 阿部多賀子, 加藤修司, 伊藤祐司, 倉橋清衛, 三浦眞司, 野間喜彦, 島健二 and 川島周 : -, 第57回日本糖尿病学会年次学術集会, May 2014.
297.	Akio Kuroda and Munehide Matsuhisa : 1型糖尿病患者の低血糖回避に向けて(リーガロイヤルホテル大阪), 第57回日本糖尿病学会年次学術集会, May 2014.
298.	Ken-ichi Aihara, Mizuho Kinouchi, 大黒由加里, 倉橋清衛, Takeshi Kondo, 安藝菜奈子, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto : 生活習慣病治療薬が血管内皮機能に及ぼす影響の検証, 第111回日本内科学会講演会, Apr. 2014.
299.	Akio Kuroda : 1型糖尿病におけるインスリン治療, 第48回糖尿病学の進歩ランチョンセミナー, Mar. 2014.
300.	Akio Kuroda : インスリン治療の現状と展望, 第48回糖尿病学の進歩, Mar. 2014.
301.	森本佳奈, Ken-ichi Aihara, 大黒由加里, 倉橋清衛, Takeshi Kondo, Mizuho Kinouchi, Motoyuki Tamaki, 安芸菜奈子, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto : 6年間にわたる多剤併用降圧療法が心・腎・大血管障害の改善に寄与した高レニン性高血圧症の1例, 第248回徳島医学会学術集会, Feb. 2014.
302.	大黒由加里, Takeshi Kondo, 倉橋清衛, 安芸菜奈子, Akio Kuroda, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto : 下垂体の経時的な変化を捉えたシーハン症候群の一例, 第23回臨床内分泌代謝Update, Jan. 2014.
303.	Hwa In, Akio Kuroda, Yuu Tamaki, Masato Tagi, Hiroki Moriguchi, Toshio Matsumoto, Yuichi Fujinaka, 安藝宏信, Tomiaki Morikawa and Munehide Matsuhisa : ITを活用した徳島県糖尿病医療連携システム構築のこころみ, 日本先進糖尿病治療研究会雑誌, Vol.9, 47, Jan. 2014.
304.	Akio Kuroda, Takeshi Kondo, 安田哲行, 高原充佳, Ken-ichi Aihara, Itsuro Endo, 金藤秀明, 下村伊一郎, Toshio Matsumoto and Munehide Matsuhisa : インスリンポンプ療法での追加インスリン注入時間を規定する因子の検討, 第13回日本先進糖尿病治療研究会, Nov. 2013.
305.	大和光, 瀧川稲子, Akiko Matsumura, 山田静恵, 谷佳子, Ken-ichi Aihara, Toshio Matsumoto, Hwa In, Akio Kuroda and Munehide Matsuhisa : 徳島大学病院における糖尿病透析予防指導の有用性の検討, 日本糖尿病学会中国四国地方会第51回総会, Nov. 2013.
306.	大黒由加里, Takeshi Kondo, Akio Kuroda, 倉橋清衛, Mizuho Kinouchi, 安芸菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto : 過剰基礎インスリン量が不適切な間食摂取に関連したインスリンポンプ使用1型糖尿病の2例, 日本糖尿病学会中国四国地方会第51回総会, Nov. 2013.
307.	松本幸恵, Akio Kuroda, 秋田賢子, 鶴尾美穂, Mizuho Kinouchi, Takeshi Kondo, Tomoyuki Yuasa, Munehide Matsuhisa, Toshio Matsumoto and 寺澤敏秀 : 主食の摂取状況調査, 日本糖尿病学会中国四国地方会第51回総会, Nov. 2013.
308.	Takeshi Kondo, 大黒由加里, Akio Kuroda, 倉橋清衛, Mizuho Kinouchi, 安芸菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto : テストステロン補充で速やかにインスリン抵抗性が改善した汎下垂体機能低下症合併糖尿病例, 日本糖尿病学会中国四国地方会第51回総会, Nov. 2013.
309.	Ken-ichi Aihara, Mizuho Kinouchi, 大黒由加里, Takeshi Kondo, 倉橋清衛, 安藝菜奈子, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto : メタボリックシンドロームおよび糖尿病の有無が血管内皮機能に及ぼす影響, 日本糖尿病学会中国四国地方会第51回総会, Nov. 2013.
310.	Takeshi Kondo, 大黒由加里, Akio Kuroda, 倉橋清衛, Mizuho Kinouchi, 安芸菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto : テストステロン補充で速やかにインスリン抵抗性が改善した汎下垂体機能低下症合併糖尿病例, 日本糖尿病学会中国四国地方会第51回総会, Nov. 2013.
311.	Ken-ichi Aihara, Mizuho Kinouchi, Sumiko Yoshida, 大黒由加里, 倉橋清衛, Takeshi Kondo, 安藝菜奈子, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto : 糖代謝異常の血管機能評価に及ぼす効果, 第36回日本高血圧学会総会, Oct. 2013.
312.	Akio Kuroda : 1型糖尿病の病期に応じた`care'について, 第11回JTID1型糖尿病研究会, Oct. 2013.
313.	Akio Kuroda : インスリン治療の最近の話題, 第47回日本小児内分泌学会学術集会, Oct. 2013.
314.	大黒由加里, Takeshi Kondo, Shiroh Fujii, Shingen Nakamura, 倉橋清衛, Akio Kuroda, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto : 著名な汎血球減少と肝筋逸脱酵素高値を呈した神経性食欲不振症の一例, 第13回日本内分泌学会四国支部学術集会, Sep. 2013.
315.	Takeshi Kondo, 岩佐昌美, 大黒由加里, 倉橋清衛, Akio Kuroda, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto : 不動が惹起した高カルシウム血症で頻回の意識障害を来たした一例, 第13回日本内分泌学会四国支部学術集会, Sep. 2013.
316.	鈴木麗子, 大和光, 瀧川稲子, Ken-ichi Aihara, Itsuro Endo, 安芸菜奈子, 倉橋清衛, Toshio Matsumoto, Akio Kuroda and Munehide Matsuhisa : フットケア外来におけるインスリン皮下硬結の実態調査と皮下硬血患者への介入の結果報告, 第13回日本糖尿病情報学会年次学術集会, Aug. 2013.
317.	Mizuho Kinouchi, Ken-ichi Aihara, Sumiko Yoshida, 大黒由加里, 倉橋清衛, Takeshi Kondo, 安藝菜奈子, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto : 臨床血管機能における糖代謝異常の影響の解析, 第247回徳島医学会学術集会, Aug. 2013.
318.	Ken-ichi Aihara, Mizuho Kinouchi, Sumiko Yoshida, 岩佐昌美, 倉橋清衛, Takeshi Kondo, 安藝菜奈子, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Toshio Matsumoto : Evaluation for influence of diabetes on clinical vascular function, 第45回日本動脈硬化学会総会・学術集会, Jul. 2013.
319.	鈴木麗子, 瀧川稲子, 大和光, 菊恵木田, Ken-ichi Aihara, Itsuro Endo, 安芸菜奈子, 倉橋清衛, Toshio Matsumoto, Akio Kuroda and Munehide Matsuhisa : フットケア外来におけるインスリン皮下硬結の実態調査と皮下硬結患者への介入の有用性検討, 第56回日本糖尿病学会年次学術集会, May 2013.
320.	藤島周子, 森岡隆子, 高田妙子, 岩谷沙紀, 斎村玉緒, 秋田賢子, 松本幸恵, Takeshi Kondo, Sumiko Yoshida, Tomoyuki Yuasa, 鶴尾美穂, Akio Kuroda, Munehide Matsuhisa, Toshio Matsumoto and 寺澤敏秀 : 当院の参加型糖尿病教室の取り組み, 第56回日本糖尿病学会年次学術集会, May 2013.
321.	伊澤真弓, Akio Kuroda, 上野裕子, 堀筋富士子, 鶴尾美穂, Sumiko Yoshida, Takeshi Kondo, Tomoyuki Yuasa, Munehide Matsuhisa, Toshio Matsumoto and 寺澤敏秀 : インスリン注入器に関する患者の意識調査, 第56回日本糖尿病学会年次学術集会, May 2013.
322.	鶴尾美穂, Akio Kuroda, Sumiko Yoshida, Takeshi Kondo, Tomoyuki Yuasa, Toshio Matsumoto, Munehide Matsuhisa and 寺澤敏秀 : インスリン治療患者に対するチーム医療で行う段階的糖尿病療養指導の試み, 第56回日本糖尿病学会年次学術集会, May 2013.
323.	Akio Kuroda, 鶴尾美穂, Ken-ichi Aihara, Itsuro Endo, 安芸菜奈子, Sumiko Yoshida, Takeshi Kondo, Toshio Matsumoto and Munehide Matsuhisa : 1型糖尿病患者におけるインスリングラルギンからインスリンデグルデッグへの同量での切り替え:CGMSを用いた検討, 第56回日本糖尿病学会年次学術集会, May 2013.
324.	下直樹, 安田哲行, 片上直人, Akio Kuroda, 坂本賢哉, 坂本扶美枝, 山本裕一, 大澤彩恵子, 辻真由美, 嵩龍一, 高原佳充, 宮下和幸, 宮塚健, 河盛段, 吉内和富, 松岡孝昭, 金藤秀明, 小杉圭右, 下村伊一郎 and Munehide Matsuhisa : 若年発症1型糖尿病患者における血清25(OH)D3濃度と血管合併症との関連, 第56回日本糖尿病学会年次学術集会, May 2013.
325.	Akio Kuroda : インスリンアナログ製剤の下手な使い方, 第56回日本糖尿病学会年次学術集会ランチョンセミナー, May 2013.
326.	中内佳奈子, 村上尚嗣, 上田紗代, 井上広基, 宮井優, 島田直, 金崎淑子, 新谷保実, 鶴尾美穂 and Akio Kuroda : インスリンアナログ過量投与による遷延性低血糖をきたした高齢者糖尿病の2例, 第56回日本糖尿病学会年次学術集会ポスター, May 2013.
327.	Takeshi Kondo, Akio Kuroda, Sumiko Yoshida, 安芸菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto : 頻回インスリン療法による厳格な血糖管理下におけるシダグリプチン併用のインスリン所要量現象効果の検討, 第56回日本糖尿病学会年次学術集会ポスター, May 2013.
328.	奥村滋子, Akio Kuroda, 片田英子, 澤井敏子, 鶴尾美穂, Sumiko Yoshida, Takeshi Kondo, Tomoyuki Yuasa, Munehide Matsuhisa, Toshio Matsumoto and 寺澤敏秀 : 運転中の低血糖についての意識調査, 第56回日本糖尿病学会年次学術集会, May 2013.
329.	Yumi Kuwamura, 松田宣子, Ayako Tamura, Takako Ichihara, Takako Minagawa, hikari yamato, Akiyo Kanazawa, Ken-ichi Aihara, kiyoe kurahashi, Sumiko Yoshida, Masami Yoshioka, Daisuke Hinode, Munehide Matsuhisa and Akio Kuroda : 糖尿病患者の口腔保健行動に及ぼす影響要因の検討―第1報口腔保健行動に対する認識との関係から―, 第56回日本糖尿病学会年次学術集会, Vol.56, No.Supplement 1, S-167, May 2013.
330.	Takeshi Kondo, Akio Kuroda, 曽我部公子, Sumiko Yoshida, 安藝菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto : 術前後で持続血糖測定(CGM)を比較しえたアドレナリン優位褐色細胞腫の1例, 第56回日本糖尿病学会年次学術集会, May 2013.
331.	下直樹, 安田哲行, 片上直人, Akio Kuroda, 坂本賢哉, 坂本扶美枝, 山本裕一, 大澤彩恵子, 辻真由美, 嵩龍一, 高原佳充, 宮下和幸, 宮塚健, 河盛段, 吉内和富, 松岡孝昭, 金藤秀明, 小杉圭右, Munehide Matsuhisa and 下村伊一郎 : 若年発症1型糖尿病患者における血清25(OH)D3濃度と血管合併症との関連, 第86回日本内分泌学会学術総会, Apr. 2013.
332.	松本和久, Sumiko Yoshida, Ken-ichi Aihara, 岩佐昌美, Takeshi Kondo, 倉橋清衛, Mizuho Kinouchi, Itsuro Endo, 安芸菜奈子, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto : 膵臓の鉄過剰沈着とインスリン分泌不全を呈した無セルロプラスミン血症合併糖尿病の1例, 第86回日本内分泌学会学術総会, Apr. 2013.
333.	安田哲行, 片上直人, Akio Kuroda, 坂本賢哉, 坂本扶美枝, 下直樹, 山本裕一, 大澤彩恵子, 辻真由美, 嵩龍一, 高原佳充, 宮下和幸, 宮塚健, 河盛段, 吉内和富, 松岡孝昭, 金藤秀明, 小杉圭右, Munehide Matsuhisa and 下村伊一郎 : 自己免疫性甲状腺疾患を合併した1型糖尿病患者における血清ビタミンD濃度の検討, 第86回日本内分泌学会学術総会, Apr. 2013.
334.	松本和久, Ken-ichi Aihara, Sumiko Yoshida, Mizuho Kinouchi, Takeshi Kondo, 倉橋清衛, 安藝菜奈子, Itsuro Endo, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto : 膵臓の鉄過剰沈着とインスリン分泌不全を呈した無セルロプラスミン血症合併糖尿病の1例, 第86回日本内分泌学会学術総会, Apr. 2013.
335.	Akio Kuroda : 療養指導に必要な知識カーボカウントの実際, Feb. 2013.
336.	Akio Kuroda : 2型糖尿病のカーボカウント, 第16回日本病態栄養学会, Jan. 2013.
337.	曽我部公子, Takeshi Kondo, Akio Kuroda, Sumiko Yoshida, Nanako Kataoka, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto : 術前後で持続血糖測定(CGM)を比較しえた褐色細胞腫の一例, 第22回臨床内分泌代謝Update, Jan. 2013.
338.	牟田口惇, Takeshi Kondo, Itsuro Endo, Sumiko Yoshida, Nanako Kataoka, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto : 尿細管性アシドーシスの診断にアミノレバンが有用であった一例, 第22回臨床内分泌代謝Update, Jan. 2013.
339.	幸田舞子, Takeshi Kondo, Itsuro Endo, Sumiko Yoshida, Nanako Kataoka, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto : 悪性症候群様の症状から診断されたACTH分泌低下症の一例, 第22回臨床内分泌代謝Update, Jan. 2013.
340.	Akio Kuroda : インスリンポンプを装着している1型糖尿病患者に対するアプローチ, Dec. 2012.
341.	松崎苑美, Ken-ichi Aihara, Sumiko Yoshida, 倉橋清衛, Takeshi Kondo, Itsuro Endo, Toshio Matsumoto, Nanako Kataoka, Akio Kuroda and Munehide Matsuhisa : 血栓性微小血管障害症様の病態を示したメタボリックシンドロームの1例, 第107回日本内科学会四国地方会, Dec. 2012.
342.	佐埜弘樹, Ken-ichi Aihara, Sumiko Yoshida, Takeshi Kondo, 倉橋清衛, Itsuro Endo, Toshio Matsumoto, Akio Kuroda, Munehide Matsuhisa and Nanako Kataoka : 正常MRI所見を示し，ADH放出障害が主因と考えられた中枢性尿崩症の1例, 日本内科学会第107回四国地方会, Dec. 2012.
343.	Akio Kuroda : ボーラスウィザードを使った血糖管理, 第12回日本先進糖尿病治療研究会, Dec. 2012.
344.	Akio Kuroda, 新居沙央里, Sumiko Yoshida, 近藤絵里, Itsuro Endo, Ken-ichi Aihara, 松本友里, Nanako Kataoka, Toshio Matsumoto and Munehide Matsuhisa : 新たなインスリンポンプParadigm722によってカーボカウントのみで血糖管理が可能となった1症例, 第12回日本先進糖尿病治療学会研究会, Dec. 2012.
345.	Akio Kuroda, 高原充佳, 安田哲行, 松岡孝昭, Takeshi Kondo, Itsuro Endo, Ken-ichi Aihara, Sumiko Yoshida, Toshio Matsumoto, 下村伊一郎, 金藤秀明 and Munehide Matsuhisa : 日本人1型糖尿病患者における「500ルールとは?」, 第12回日本先進糖尿病治療研究会, Dec. 2012.
346.	幸田舞子, Takeshi Kondo, Akio Kuroda, Sumiko Yoshida, 安芸菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto : シタグリプチン投与によりインスリン所要量の減少効果が得られた高齢2型糖尿病の一例, 日本糖尿病学会中国四国地方会第50回総会, Nov. 2012.
347.	Takeshi Kondo, Akio Kuroda, 曽我部公子, Sumiko Yoshida, 安芸菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto : 術前後で持続血糖測定(CGM)を比較しえたアドレナリン優位褐色細胞腫の一例, 日本糖尿病学会中国四国地方会第50回総会, Nov. 2012.
348.	Takeshi Kondo, Akio Kuroda, 曽我部公子, Sumiko Yoshida, 安芸菜奈子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto : アドレナリン優位の褐色細胞腫の術前後で持続血糖測定(CGM)により血糖変動を比較した一例, 日本糖尿病学会中国四国地方会第50回総会, Nov. 2012.
349.	伊澤真弓, Akio Kuroda, 上野裕子, 鶴尾美穂, Sumiko Yoshida, Takeshi Kondo, Tomoyuki Yuasa, Munehide Matsuhisa, Toshio Matsumoto and 寺澤敏秀 : インスリン注入器に関する患者の意識調査, 日本糖尿病学会中国四国地方会第50回総会, Nov. 2012.
350.	幸田舞子, Takeshi Kondo, Akio Kuroda, Sumiko Yoshida, Nanako Kataoka, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa and Toshio Matsumoto : シタグリプチン投与によりインスリン所要量の減少効果が得られた高齢2型糖尿病の一例, 日本糖尿病学会中国四国地方会第50回総会, Nov. 2012.
351.	岩佐昌美, Akio Kuroda, Sumiko Yoshida, Takeshi Kondo, Nanako Kataoka, Itsuro Endo, Ken-ichi Aihara, 福島泰江, Munehide Matsuhisa and Toshio Matsumoto : 血糖管理基準を満たすために分割食を必要としなかった2型糖尿病合併妊娠の1例, 日本糖尿病学会中国四国地方会第50回総会, Nov. 2012.
352.	奥村滋子, Akio Kuroda, 片田英子, 鶴尾美穂, Sumiko Yoshida, Takeshi Kondo, Tomoyuki Yuasa, 松本直也, 笠松哲司, Munehide Matsuhisa, Toshio Matsumoto and 寺澤敏秀 : 運転中の低血糖についての意識調査, 日本糖尿病学会中国四国地方会第50回総会, Nov. 2012.
353.	白河綾, Ken-ichi Aihara, Sumiko Yoshida, 倉橋清衛, Takeshi Kondo, Itsuro Endo, 安藝菜奈子, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto : 副腎不全症状を呈し，診断に苦慮した両側副腎B細胞リンパ腫の1例, 第12回日本内分泌学会四国支部学術集会, Sep. 2012.
354.	Itsuro Endo, Sumiko Yoshida, 倉橋清衛, Mizuho Kinouchi, Nanako Kataoka, Takeshi Kondo, 近藤絵里, Ken-ichi Aihara, Toshio Matsumoto, Akio Kuroda and Munehide Matsuhisa : Werner症候群に伴う糖尿病の治療経過, 第106回日本内科学会四国地方会, Jun. 2012.
355.	Ken-ichi Aihara, Sumiko Yoshida, 倉橋清衛, Takeshi Kondo, 近藤絵里, Nanako Kataoka, Itsuro Endo, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto : インクレチン関連薬を用いた周術期血糖管理の有用性, 第106回日本内科学会四国地方会, Jun. 2012.
356.	鶴尾美穂, 寺澤敏秀, 木戸里佳, Sumiko Yoshida, Tomoyuki Yuasa, Takeshi Kondo, 笠松哲司, 近藤絵里, Mizuho Kinouchi, Akio Kuroda, Munehide Matsuhisa, Toshio Matsumoto and Masashi Akaike : 粥状動脈硬化病変を呈した高Lp(a)血症合併糖尿病の姉妹例, 第55回日本糖尿病学会年次学術集会, May 2012.
357.	坂本芙美枝, 片上直人, 高原充佳, 宮下和幸, 山本かをる, Akio Kuroda, 坂本賢哉, Munehide Matsuhisa, 小杉圭右, 金藤秀明 and 下村伊一郎 : 1型糖尿病におけるIMT進展に関連する因子の検討, 第55回日本糖尿病学会年次学術集会, May 2012.
358.	上野裕子, 堀筋富士子, 森岡隆子, 鶴尾美穂, Tomoyuki Yuasa, 木戸里佳, Sumiko Yoshida, Mizuho Kinouchi, Takeshi Kondo, 近藤絵里, 笠松哲司, Akio Kuroda, Munehide Matsuhisa, Toshio Matsumoto and 寺澤敏秀 : サイトローテーションシート(SLS)を使用したインスリン自己注射の指導, 第55回日本糖尿病学会年次学術集会, May 2012.
359.	秋田賢子, 鶴尾美穂, 木戸里佳, Sumiko Yoshida, 近藤絵里, Mizuho Kinouchi, Takeshi Kondo, 笠松哲司, Tomoyuki Yuasa, Akio Kuroda, Munehide Matsuhisa, Toshio Matsumoto and 寺澤敏秀 : カーボカウントを導入した高齢1型糖尿病の3例, 第55回日本糖尿病学会年次学術集会, May 2012.
360.	Miwa Yamaguchi, Yumiko Kotani, Akiko Matsumura, Ichiro Yokota, Shoji Kagami, Kokichi Arisawa, Akio Kuroda and Munehide Matsuhisa : 学校給食の副食糖質量の検討, 第55回日本糖尿病学会年次学術集会, May 2012.
361.	Akio Kuroda, 宮下和幸, 川嶋聡, 安田哲行, 松岡孝昭, 金藤秀明, 山﨑義光, 下村伊一郎 and Munehide Matsuhisa : 内因性インスリン分泌能残存と糖尿病合併症進展の関連についての検討, 第55回日本糖尿病学会年次学術集会, May 2012.
362.	Akio Kuroda and Munehide Matsuhisa : カーボカウント活用∼医師の立場から∼, 第55回日本糖尿病学会年次学術集会, May 2012.
363.	大黒由加里, Ken-ichi Aihara, Sumiko Yoshida, 近藤絵里, Takeshi Kondo, 倉橋清衛, Mizuho Kinouchi, Itsuro Endo, Nanako Kataoka, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto : 摂食障害による著明な低K血症を呈した視床下部性ACTH分泌低下症の1例, 第85回日本内分泌学会学術総会, Apr. 2012.
364.	Sumiko Yoshida, Ken-ichi Aihara, 近藤絵里, 倉橋清衛, Takeshi Kondo, Mizuho Kinouchi, Itsuro Endo, Toshio Matsumoto, Nanako Kataoka, Akio Kuroda and Munehide Matsuhisa : 糖尿病はHDLコレステロールによる血管内皮機改善効果を減弱させる, 第85回日本内分泌学会学術総会, Apr. 2012.
365.	Ken-ichi Aihara, Sumiko Yoshida, 近藤絵里, Takeshi Kondo, 倉橋清衛, Mizuho Kinouchi, Itsuro Endo, Nanako Kataoka, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto : ヘパリンコファクターⅡは耐糖能制御因子である, 第85回日本内分泌学会学術総会, Apr. 2012.
366.	Sumiko Yoshida, Yuichi Fujinaka, Ken-ichi Aihara, 鈴木麗子, Mizuho Kinouchi, 近藤絵里, 安藝菜奈子, Itsuro Endo, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto : 当院検診受診者における耐糖能異常の特徴, 第109回日本内科学会総会・講演会, Apr. 2012.
367.	Akio Kuroda : 医師の立場からのカーボカウントの実際について, 第46回糖尿病学の進歩, Mar. 2012.
368.	立花綾香, 田岡志保, 荻野寛隆, 高橋真美子, Ken-ichi Aihara, Sumiko Yoshida, Itsuro Endo, Akio Kuroda, Munehide Matsuhisa, 福森智治 and Toshio Matsumoto : 低血圧で推移したvon Hippel-Lindau 病・褐色細胞腫の1手術例, 第21回臨床内分泌代謝Update in Hamamatsu, Jan. 2012.
369.	田岡志保, 立花綾香, 荻野寛隆, 高橋真美子, Ken-ichi Aihara, Sumiko Yoshida, 近藤絵里, 倉橋清衛, Itsuro Endo, Toshio Matsumoto, Nanako Kataoka, Akio Kuroda and Munehide Matsuhisa : 周術期血糖管理にリラグルチドが有用であった2型糖尿病患者の2例, 第21回臨床内分泌代謝Update in Hamamatsu, Jan. 2012.
370.	Miwa Yamaguchi, Yumiko Kotani, Akio Kuroda, Ichiro Yokota, Munehide Matsuhisa, Kokichi Arisawa and Shoji Kagami : 徳島市学校給食の副食糖質量の検討, 第15回日本病態栄養学会年次学術集会, Jan. 2012.
371.	Miwa Yamaguchi, Akiko Matsumura, Yumiko Kotani, Akio Kuroda, Ichiro Yokota, Munehide Matsuhisa, Kokichi Arisawa and Shoji Kagami : 外来栄養指導でカーボカウントの継続が見られた例, 第15回日本病態栄養学会年次学術集会, Jan. 2012.
372.	Akio Kuroda, 新居沙央理, Sumiko Yoshida, 近藤絵里, Itsuro Endo, Ken-ichi Aihara, 松本友里, Nanako Kataoka, Toshio Matsumoto and Munehide Matsuhisa : 新たなインスリンポンプParadigm722によってカーボカウントのみで血糖管理が可能となった1症例, 第11回日本先進糖尿病治療研究会, Nov. 2011.
373.	Akio Kuroda : 食品交換表に基づくカーボカウント導入の実際, 日本糖尿病学会中国四国地方会第49回総会ランチョンセミナー, Nov. 2011.
374.	Akio Kuroda : 糖尿病合併妊娠における血管管理の最適化, 第27回日本糖尿病・妊娠学会年次学術集会, Nov. 2011.
375.	木戸里佳, 鶴尾美穂, Akio Kuroda, Sumiko Yoshida, Tomoyuki Yuasa, 瀬尾浩二, 笠松哲司, Toshio Matsumoto, Munehide Matsuhisa and 寺沢敏秀 : カーボカウント併用CS11療法が有効であった高齢発症1型糖尿病症例, 日本糖尿病学会中国四国地方会第49回総会, Nov. 2011.
376.	新居沙央里, Akio Kuroda, Sumiko Yoshida, 近藤絵里, Itsuro Endo, Ken-ichi Aihara, 松本友里, Nanako Kataoka, Munehide Matsuhisa and Toshio Matsumoto : 新たなインスリンポンプParadigm722によりカーボカウントのみで血糖管理が可能となった1例, 日本糖尿病学会中国四国地方会第49回総会, Nov. 2011.
377.	Miwa Yamaguchi, Yumiko Kotani, Ichiro Yokota, Akio Kuroda, Munehide Matsuhisa, Kokichi Arisawa and Shoji Kagami : 学校給食の副食糖質量の検討, 日本糖尿病学会中国四国地方会第49回総会, Nov. 2011.
378.	堀筋富士子, 森岡隆子, 片田英子, 鶴尾美穂, 木戸里佳, Tomoyuki Yuasa, Akio Kuroda, Munehide Matsuhisa, Toshio Matsumoto and 寺沢敏秀 : サイトローテーションシート(SLS)を使用したインスリン自己注射の指導, 日本糖尿病学会中国四国地方会第49回総会, Nov. 2011.
379.	秋田賢子, 木戸里佳, 鶴尾美穂, Sumiko Yoshida, Mizuho Kinouchi, Tomoyuki Yuasa, Akio Kuroda, Munehide Matsuhisa, Toshio Matsumoto and 寺沢敏秀 : カーボカウントを導入した高齢1型糖尿病の3例, 日本糖尿病学会中国四国地方会第49回総会, Nov. 2011.
380.	Mizuho Kinouchi, Ken-ichi Aihara, Yuichi Fujinaka, 鈴木麗子, Sumiko Yoshida, 近藤絵里, Itsuro Endo, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto : 内臓脂肪肥満とアルブミン尿の連関に関する検討, 日本糖尿病学会中国四国地方会第49回総会, Nov. 2011.
381.	鶴尾美穂, 寺沢敏秀, 木戸里佳, Tomoyuki Yuasa, Sumiko Yoshida, 笠松哲司, Akio Kuroda, Munehide Matsuhisa, Toshio Matsumoto and Masashi Akaike : 粥状動脈硬化病変を呈した糖尿病合併高Lp(a)血症の姉妹例, 日本糖尿病学会中国四国地方会第49回総会, Nov. 2011.
382.	鈴木麗子, 大和光, 菊恵木田, Ken-ichi Aihara, Itsuro Endo, Nanako Kataoka, 近藤絵里, Toshio Matsumoto, Akio Kuroda and Munehide Matsuhisa : フットケア外来におけるインスリン皮下硬結の実態調査, 日本糖尿病学会中国四国地方会第49回総会, Nov. 2011.
383.	Ken-ichi Aihara, Yuichi Fujinaka, 鈴木麗子, Mizuho Kinouchi, Sumiko Yoshida, 近藤絵里, Nanako Kataoka, 倉橋清衛, Itsuro Endo, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto : 慢性腎臓病と内臓脂肪蓄積病態の連関, 第32回日本肥満学会, Sep. 2011.
384.	Sumiko Yoshida, Yuichi Fujinaka, Ken-ichi Aihara, 鈴木麗子, Mizuho Kinouchi, 近藤絵里, Nanako Kataoka, 倉橋清衛, Itsuro Endo, Akio Kuroda, Munehide Matsuhisa and Toshio Matsumoto : メタボリックシンドローム検診受診者における耐糖能異常の検討, 第32回日本肥満学会, Sep. 2011.
385.	Ken-ichi Aihara, Sumiko Yoshida, 近藤絵里, 倉橋清衛, Takeshi Kondo, Mizuho Kinouchi, Itsuro Endo, Toshio Matsumoto, Nanako Kataoka, Akio Kuroda and Munehide Matsuhisa : 慢性腎臓病におけるエイコサペンタエン酸の意義に関する臨床的検討, 第11回日本内分泌学会四国支部学術集会, Sep. 2011.
386.	Miwa Yamaguchi, Yumiko Kotani, Ichiro Yokota, Akio Kuroda, Munehide Matsuhisa and Shoji Kagami : 小児期発症1型糖尿病患者へのカーボカウント教育の試み, 小児思春期糖尿病学会, Jul. 2011.
387.	安田哲行, 金藤秀明, 高原充佳, 光井絵理, 小豆澤深雪, 入江陽子, 仲豊子, 宮下和幸, 藤澤慶子, 藤木典隆, 山本恒彦, Akio Kuroda and 下村伊一郎 : 潜在性甲状腺機能低下症は2型糖尿病腎症と関連する, 第54回日本糖尿病学会年次学術集会, May 2011.
388.	坂本扶美枝, 片上直人, 高原充佳, Akio Kuroda, 安田哲行, 松岡孝昭, Munehide Matsuhisa, 金藤秀明 and 下村伊一郎 : 若年1型糖尿病におけるYKL-40測定の有用性についての検討, 第54回糖尿病学会年次学術集会, May 2011.
389.	藤澤慶子, 安田哲行, 金藤秀明, 光井絵理, 入江陽子, 小豆澤深雪, 宮下和幸, 仲豊子, 藤木典隆, 山本恒彦, Akio Kuroda and 下村伊一郎 : 日本人2型糖尿病患者に対するシタグりプチン単剤投与の有用性の検討, 第54回日本糖尿病学会年次学術集会, May 2011.
390.	Akio Kuroda and Munehide Matsuhisa : 1型糖尿病以外の糖尿病とカーボカウント, 第54回日本糖尿病学会年次学術集会, May 2011.
391.	Akio Kuroda : 食品交換表とカーボカウントの融合∼カーボカウントの実践, 第45回糖尿病学の進歩, Feb. 2011.

Et cetera, Workshop:

1.	Hiroyasu Mori, Akio Kuroda, Michiko Araki, Reiko Suzuki, Mami Ohishi, Satoshi Taniguchi, Motoyuki Tamaki, Yuko Akehi, Hiroshi Sakaue, Kiyoe Kurahashi, Takeshi Kondo, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki and Munehide Matsuhisa : Advanced glycation end-products are a risk for muscle weakness in patients with type2 diabetes., American Diabetes Association 78th Scientific Sessions, Jun. 2017.
2.	Akio Kuroda, Satoshi Taniguchi, Akehi Yuko, Hiroyasu Mori, Motoyuki Tamaki, Suzuki Reiko, Hwa In and Munehide Matsuhisa : The comparison of glucose readings of continuous glucose monitoring and bedside artificial pancreas during glucose clamp study, American Diabetes Association 76th Scientific Sessions, Jun. 2016.
3.	Akio Kuroda, Satoshi Taniguchi, Akehi Yuko, Hiroyasu Mori, Motoyuki Tamaki, Suzuki Reiko, Hwa In and Munehide Matsuhisa : The comparison of glucose readings of continuous glucose monitoring and bedside artificial pancreas during glucose clamp study, Advanced Technologiies & Treatments for Diabetes, Feb. 2016.
4.	Akio Kuroda, Tenma Jin, Horie Toru, Hiroyasu Mori, Motoyuki Tamaki, Ken-ichi Aihara and Munehide Matsuhisa : Non-invasive measurement of skin autofluorescence as a beneficial surrogate marker for atherosclerosis in patients with type 2 diabetes., 第75回アメリカ糖尿病学会ポスター発表, Jun. 2015.
5.	Akio Kuroda : 実践カーボカウント, 第11回中四国糖尿病研修セミナー, Mar. 2014.
6.	Akio Kuroda : カーボカウントを利用している患者でのSMBGの指導法, 第13回日本先進糖尿病治療研究会ランチョンセミナー, Nov. 2013.
7.	Akio Kuroda : いかに小児1型糖尿病を治療すべきか?-実際の治療のアイデアー, 第19回日本小児・思春期糖尿病研究会年次学術集会シンポジウム, Jul. 2013.
8.	Akio Kuroda and Munehide Matsuhisa : 予防から重症合併症の治療，そして先進治療まで院内外で広範なチーム医療を展開する, DM Trend Journal, Vol.6, No.23, 6-7, Mar. 2013.
9.	Akio Kuroda : 先進的糖尿病治療, 日本糖尿病協会徳島県支部交流会, May 2012.
10.	Sumiko Yoshida, 近藤絵里, 倉橋清衛, Mizuho Kinouchi, Nanako Kataoka, Itsuro Endo, Ken-ichi Aihara, Toshio Matsumoto, Akio Kuroda and Munehide Matsuhisa : 当科での1型糖尿病に対するインスリンポンプ療法導入経験, 第17回徳島内分泌研究会, Nov. 2011.
11.	Munehide Matsuhisa and Akio Kuroda : 1型糖尿病診療のUp to Date, 第1回AWA DM.comでの講演, Apr. 2011.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

Evaluation for the maturation of insulin-producing cells differentiated from ADSC by the methylation status (Project/Area Number: 19K09045 )
Novel method utilizing bisulfite conversion with dual amplification-refractory mutation system polymerase chain reaction to detect circulating pancreatic beta cell cfDNA. (Project/Area Number: 18K07448 )
Detection of pancreatic beta cell DNA in the circulation utilizing epigenetic modification (Project/Area Number: 15K06910 )
Search by Researcher Number (70571412)

Associate Professor : Kuroda, Akio

Research

Field of Study

Subject of Study

Book / Paper

Book:

Academic Paper (Judged Full Paper):

Academic Paper (Unrefereed Paper):

Review, Commentary:

Proceeding of International Conference:

Proceeding of Domestic Conference:

Et cetera, Workshop:

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)